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Abstract
The major aim of this thesis was to study the regulation of testosterone
production in the human testis. The technique used to isolate human
Leydig cells was improved, so that Leydig cells responsive to hCG were
obtained consistently in large yields. There was marked subject variation
in both the basal levels of testosterone produced and in the
responsiveness of the cells to hCG. Sertoli cells are believed to modulate
Leydig cell function via the action of secreted factors. The nature of these
factors is not known, although in the rat GnRH and AVP are potential
candidates. Basal testosterone production by isolated rat Leydig cells is
stimulated by GnRH and AVP, and comparable effects on isolated human
Leydig cells were demonstrated. This evidence of comparable control
mechanisms in the rat and human testis was supported by the finding
that proteins secreted by isolated rat and human Leydig cells were
remarkably similar when analysed by 2-dimensional SDS-PAGE. In
addition, rat and human Leydig cells showed comparable responses to the
deleterious effects of a variety of toxicants in vitro.
A morphological examination of the relationship between Leydig
cells and other components of the human testis distinguished light and
dark Leydig cells on the basis of differential toluidine blue staining.
Morphometric analysis of testicular cellular components was correlated
with the ability of isolated Leydig cells to produce testosterone in vitro.
No relationship was found between either the total number of Leydig
cells, or the proportion of light and dark Leydig cells per testis and
testosterone production or hCG responsiveness in vitro. The number of
light or dark Leydig cells showed significant positive correlations with
different testicular components, perhaps indicating specific roles for these
two subpopulations.
The cascade of regulatory interactions between germ cells, Sertoli
cells and Leydig cells was investigated in the rat. The absence of pachytene
spermatocytes or round spermatids in vivo was associated with increased
testosterone production in vitro by Leydig cells subsequently isolated
from the affected testes and was also associated with the secretion of a
novel Leydig cell protein in vitro.
xi
Interactions between rat Leydig cells and stage-dissected
seminiferous tubules were studied using in vitro co-cultures. The role of
germ cells was determined by isolating seminiferous tubules from control
rats or rats in which a single germ cell type had been depleted selectively.
Seminiferous tubules at stages II-V inhibited basal testosterone
production by isolated Leydig cells. Metabolism of testosterone by
seminiferous tubules was highest at stages VI-VIII, stage VII being the
androgen-dependent stage.
In conclusion, these studies have demonstrated the isolation of
human Leydig cells, which, in vitro, respond to the same stimuli as rat
Leydig cells, and secrete many very similar proteins, suggesting the
modulation of Leydig cell function in the two species is comparable. In
the rat, one mechanism of controlling Leydig cell function may involve
modulation by specific germ cell types, presumably mediated via Sertoli
cells. The morphological analysis of the human testis, and the
correlations subsequently made support the existence of such an
interaction in man.
1. Introduction.
In the West 5% or more of the male population are subfertile. A recent
review of studies published between 1938-1991 revealed a marked decline
in sperm counts in men without a history of infertility. (Carlsen et al.,
1992). One factor believed to have contributed to this decline is increased
exposure to various environmental chemicals (Sharpe, 1992b). Both
studies emphasised the present lack of understanding of the mechanisms
controlling spermatogenesis, which in turn limits the treatment of male
infertility. Thus it is essential that the processes that control testicular
function are more thoroughly investigated. Testosterone is an essential
requirement of spermatogenesis, therefore the mechanisms that regulate
testosterone production are potential sites for malfunctions that could
result in impaired sperm output.
Increasingly, evidence suggests that testicular function is controlled
by many complex cell-cell interactions (for review see Skinner, 1991,
Sharpe, 1992). The complexity of the interactions that occur in the rat
testis was demonstrated by Onoda et al. (1991). The addition of
conditioned medium from rat Sertoli cell cultures to cultures of rat
Leydig cells stimulated testosterone production. If the Sertoli cells had
been co-cultured with pachytene spermatocytes, the ability of the Sertoli
cell conditioned medium to stimulate Leydig cell steroidogenesis
declined. The study thus demonstrated that specific germ cell types, via an
action on Sertoli cells, can influence Leydig cell function.
In fact, there is evidence in the rat that Leydig cells respond to
many alterations in cellular composition and cell-cell interactions.
Experimentally induced damage to the seminiferous epithelium results
in Leydig cell hypertrophy (Aoki & Fawcett, 1978, Risbridger et al., 1981,
Jegou et al., 1984), and the production of testosterone by isolated Leydig
cells is influenced by co-culture with Sertoli cells or by the addition of
Sertoli cell conditioned medium (Verhoeven & Cailleau, 1986, 1990).
Disruption of such intercellular regulatory pathways may be one possible
cause of infertility. However, very little is known about the control of
testicular function in man, and it is not clear whether the rat and human
testis would have similar local regulatory mechanisms.
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The primary purpose of this thesis was therefore to investigate the
regulation of testosterone production in the human testis. The secondary
aim was to study the cascade of regulatory interactions between germ
cells, Sertoli cells and Leydig cells that may occur in the rat testis.
Therefore the first experimental chapter describes the isolation and
culture of human Leydig cells, and characterises their performance in
vitro. Subsequent chapters assess both the effects of putative paracrine
regulators of rat Leydig cell function on testosterone production by
human Leydig cells and the comparative susceptibility of rat and human
Leydig cells to toxicant effects. Proteins secreted by rat and human Leydig
cells under basal and hCG-stimulating conditions were also examined.
The nature of cell-cell communication in the rat testis was
investigated using an ex vivo technique. Specific germ cell types were
depleted from the testis in vivo. Leydig cells were subsequently isolated
from these testes and the effect of this depletion on their ability to
produce testosterone in vitro was examined. Further examination of cell-
cell interactions involved co-culturing Leydig cells with seminiferous
tubules known to be at particular stages of the spermatogenic cycle. The
influence of germ cells on the interactions between the epithelium and
the interstitium was assessed by isolating seminiferous tubules from both
control and germ cell-depleted rats.
2. Review of the literature
2.1. Introduction
The mammalian testis has two functions, the production of male
gametes, and the production of male sex hormones. These two functions
are very closely related; spermatogenesis can only proceed in the presence
of adequate levels of androgens and the successful delivery of sperm
depends on the development of secondary sexual characteristics and
normal sexual behaviour, which are both controlled by androgens.
The first person to describe the endocrine role of the testis was
Berthold in 1849 (see Burger & de Kretser, 1981 for translation) who
recorded that castration of cockerels resulted in decreased comb size and
less aggressive behaviour. This change did not occur if the testes were
transplanted to the abdominal cavity. Berthold concluded that the testis
was able to affect the blood so that it in turn could affect the entire
organism. In fact, testicular steroids with the ability to restore sexual
characteristics in castrated animals ('androgens') were not isolated until
the 1930s and 40s (see Setchell, 1978 for review).
Although Leydig cells were first described in 1850, their function
remained unknown until 1903 when Bouin & Ancel suggested that
Leydig cells were the site of production of the male sex hormones. This
was based on the observation that despite the induction of tubular
atrophy by experimental cryptorchidism, male characteristics remained
unaffected, suggesting that the undamaged interstitial tissue was the
source of androgen. The function of Leydig cells was not established
conclusively until Hall et al. (1969) separated tubular and interstitial
tissue and demonstrated that in vitro, interstitial tissue could convert 3H-
cholesterol to testosterone but tubular tissue could not. Also, when 3H-
cholesterol was injected i.v. into male rats and interstitial and tubular
tissues were separated after death, the radioactivity in interstitial tissue
significantly exceeded that measured in tubular tissue (Parvinen et al.,
1970). Cooke et al. (1972) measured both the endogenous testosterone
concentrations in isolated interstitial and tubular tissue and the
testosterone concentrations during in vitro incubations. The highest
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concentration of testosterone was in interstitial tissue and this
concentration increased during the incubation, suggesting de novo
synthesis of testosterone from endogenous precursors. This increase in
testosterone concentration in vitro was not observed with seminiferous
tubular tissue. Previously the key steroidogenic enzyme 3(3-
hydroxysteroid dehydrogenase (3J3-HSD) had been localised to Leydig cells
(Levy et ah, 1959) and Woods & Domm (1966) had used fluorescent
labelled antibodies to localise testosterone to Leydig cells. These combined
approaches established the Leydig cell of the rat as the producer of sex
steroids. Kawano et al. (1973) showed that the interstitial tissue of the
adult human testis was the major site of conversion of pregnenolone to
testosterone.
Sertoli cells were first described in 1865, and while their close
association with the spermatogenic process has always been appreciated,
specific functions of Sertoli cells have only been described in the past 20
years. These will be discussed in section 2.3.2.4. and 2.3.2.5.
The role of the pituitary in controlling testicular function was
demonstrated by Smith (1930), who showed that hypophysectomy caused
testicular regression and abolition of spermatogenesis. Fevold et al. (1931)
demonstrated that the anterior lobe of the pituitary gland secreted two
substances which could regulate ovarian development. Based on their
effects on the ovary these substances were named follicle-stimulating
hormone (FSH) and luteinizing hormone (LF1). In 1936 Greep et al.
investigated the effects of LH and FSH on the gonads and secondary
sexual structures of normal and hypophysectomised immature male rats.
In 28 day old hypophysectomised rats in which the gonads and secondary
sexual structures showed marked atrophy, FSH had a strikingly selective
effect on tubular histology, with the seminiferous epithelium increasing
in size. FSH had no effect on the size of the seminal vesicles or prostate.
In contrast, LH caused hypertrophy of the interstitial tissue and was also
able to increase the size of the accessory organs. Similar distinct actions of
LH and FSH were later demonstrated in adult rats (Greep & Fevold, 1937)
and in the mouse (Randolph et al., 1959). The ability of human pituitary
gonadotrophins to restore fertility to hypophysectomised adult men was
also demonstrated (Gemzell & Kjessler, 1964, MacLeod et al., 1966). In 1967
Mancini et al. found that when injected into rats, labelled LH
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concentrated in Leydig cells, while labelled FSH accumulated primarily in
Sertoli cells.
Hypothalamic extracts from several species, including man, were
shown to contain a substance(s) capable of stimulating the release of LH
and FSH from the pituitary (McCann & Ramirez, 1964, Schally et al.,
1970). It was initially thought that two separate substances, 'luteinizing
hormone releasing hormone' (LHRH) and 'follicle-stimulating hormone
releasing hormone' (FSHRH) were responsible for such effects, but
preparations of LHRH of increasing purity were always able to stimulate
the release of both LH and FSH (Kastin et al., 1969, Schally et al., 1971).
While this suggested that only one releasing hormone existed, this was
only confirmed with the determination of the structure of a
hypothalamic peptide with both LHRH/FSHRH activities (gonadotrophin
releasing hormone, GnRH; Matsuo et al., 1971, Schally et al., 1971).
Synthetic GnRH was shown to increase plasma LH and FSH in castrated
rats (Matsuo et al., 1971) and in normal men (Yen et al., 1972).
In rats removal of the testes was found to result in marked
increases in plasma LH and FSH levels. However, subsequent
administration of testosterone and oestradiol returned gonadotrophin
levels to normal (Swerdloff & Walsh, 1973). This negative feedback
control allows the testis to maintain tonic serum concentrations of
gonadotrophins.
In summary, the research discussed above describes how endocrine
secretions from the hypothalamus, anterior pituitary and testes control
the male reproductive system. GnRH controls the secretion of the
gonadotrophins, LH and FSH by the anterior pituitary. Through actions
on the Sertoli cells, FSH is involved in testicular development at puberty
and in the adult may have a co-operative role with testosterone in
driving spermatogenesis. LH stimulates Leydig cells to secrete
testosterone and other androgens. Testosterone is responsible for the
development and maintenance accessory sex organs and for the
maintenance of spermatogenesis. Further, testosterone is able to regulate
the level of its own production through a negative feedback effect on the
anterior pituitary. Together the studies discussed above define the
hypothalamic-pituitary-testicular axis. The regulation and coordination of
this axis is discussed in more detail in the following section.
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2.2. Endocrine control of the testis
2.2.1. LH
LH belongs to a family of glycoprotein hormones the common structure
of which consists of 2 non-covalently linked subunits, a and P (Liao et al.,
1969). Other members of this family are thyroid stimulating hormone
(TSH), FSH and hCG. The 92 amino acid a subunit is common to all these
hormones (Liao & Pierce, 1971), but each has a unique P subunit which
confers specific biological activity via target tissue receptor recognition
(Pierce et al., 1971). Until recently the individual subunits in the
dissociated state were thought to have no intrinsic biological activity (Catt
et al., 1973). However, by using synthetic preparations of a subunit,
Erickson et al. (1990) demonstrated that peptides corresponding to regions
of hCG binding were able to stimulate steroidogenesis in crude
preparations of rat Leydig cells. The authors propose that these regions of
the a subunit align with the P subunit and are involved in binding the
LH receptor, as well as the ligand. LH binding to its receptor may occur in
two stages, whereby initial binding of the p subunit ensures specificity,
while subsequent binding of the a subunit confers stability (Metsikko et
al., 1990).
LH is secreted in episodic bursts by gonadotrophs in the pars distalis
of the anterior pituitary with each species having its own frequency of LH
pulses. In man LH pulses occur at approximately 90 minute intervals
(Nankin & Troen, 1971, Santen & Bardin, 1973). In the rat the timing of
LH pulses appears to be very variable (Gay & Sheth, 1972, Ellis &
Desjardins, 1982).
2.2.2. Hypothalamic control of LH secretion
The episodic nature of LH secretion is controlled by the pulsatile secretion
of GnRH from the arcuate nucleus of the hypothalamus (for review see
Knobil, 1980). The pattern of GnRH secretion was described by Carmel et
al. (1976) who measured pulsatile GnRH release into the portal blood of
female Rhesus monkeys and noted peak intervals of between 1-3 hours.
The fluctuations in GnRH levels appeared to be associated with increases
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in plasma LH levels. Ellis et al. (1983) administered either ovine anti-
GnRH antiserum or a GnRH antagonist to castrated male rats and showed
that both treatments were able to abolish LH pulses. In man, GnRH
extracted from plasma was found to release LH from incubated rat
hemipituitaries (Elkind-Hirsch et al., 1982). Infusions of synthetic GnRH
into the antecubital vein of both men and women has been shown to
result in increased serum LH and FSH levels (Yen et al., 1972, Dufau et al.,
1976, Elkind-Hirsch et al., 1982).
GnRH has been shown to bind to specific high affinity receptors on
gonadotroph cell membranes (Theoleyre et al., 1976). GnRH receptors do
not appear to use the adenylate cyclase/cAMP second messenger pathway
(Clayton et al., 1978, Benoist et al., 1981). In fact, it has since been shown
that following receptor binding, GnRH stimulates phosphoinositide
turnover for which no rise in intracellular calcium levels is needed. The
activation of phospholipase C (PLC) is believed to be mediated via a
pertussis toxin-insensitive G-protein. The formation of inositol-1,4,5-
trisphosphate (IP3) enhances calcium release from intracellular stores and
this in turn may be responsible for the translocation of subspecies of
protein kinase C (PKC) from the cytosol to the membrane. In turn
activated PKC phosphorylates substrate proteins which activate secretory
reactions and participate in gonadotrophin gene expression. An influx of
extracellular calcium through membrane ion channels further elevates
the intracellular calcium concentration, contributing to the sustained
phase of gonadotrophin release. GnRH also triggers the release of
arachidonic acid (AA) and the formation of lipoxygenase and/or
epoxygenase products which are involved in exocytosis (for review see
Naor, 1990).
2.2.3. Site of LH action
In 1936 Greep et al demonstrated that LH caused proliferation of
interstitial but not tubular tissue in hypophysectomised immature male
rats. Later, LH labelled with various histochemical agents was localised to
Leydig cells in the testis of adult rats (Mancini et al., 1967). Radiolabeled
LH has also been shown to accumulate in rat interstitial cells (de Kretser
et al., 1969) due to the presence of specific high affinity, low capacity
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receptors (Catt et al., 1971). Specific, high affinity, low capacity binding of
125I-hCG to adult human testicular homogenates has also been
demonstrated (Hsu et al., 1978, Sharpe et al., 1980).
The LH receptor is localised at the cell surface and is a member of a
family of receptors which all contain 7 transmembrane spanning
domains. The receptor has an large extracellular domain which comprises
the hormone binding site, (see Bahl, 1977, Metsikko et al., 1990 for
review). A 'hand-and-glove' model for hCG-receptor binding has been
recently proposed (Schwarz et al., 1991).
The human LH receptor was isolated and cloned from human
ovarian RNA by Minegish et al. (1990). The extracellular domain showed
85% homology to the rat LH receptor (McFarland et al., 1989) and the
putative membrane spanning domain had 90% homology with the LH
receptor found in the rat. The importance of the heterologous regions was
demonstrated by Jia et al. (1991). The authors found that when human
ovarian cDNA for LH was transfected into a human embryonic kidney
cell line, the expressed receptors would recognise human LH/CG but not
rat, equine or ovine LH/CG. In contrast the rat LH receptor is able to
recognise LH/CG from all of the above species (Farmer et al., 1977).
2.2.4. Mechanism of LH action
In 1977, Dufau et al demonstrated that the incremental testosterone
response of purified rat Leydig cells to increasing concentrations of hCG,
was accompanied by a simultaneous increase in the levels of endogenous
cAMP bound to the regulatory unit of protein kinase. The production of
cAMP is dependent on the activation of membrane bound adenylate
cyclase (Kuehl et al., 1970, Dorrington & Fritz, 1974, Mendelson et al.,
1975). The binding of cAMP to the regulatory unit of protein kinase causes
the enzyme to dissociate, and the freed catalytic subunit is able to activate
specific proteins by phosphorylation (Podesta et al., 1978, Catt & Dufau,
1976). Similarly, in the human, hCG injected directly into the testis was
found to increase the spermatic vein concentrations of both cAMP and
testosterone. The rise in cAMP levels preceded the rise in testosterone
levels (Yasukawa et al., 1981).
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In this way LH increases the activities of steroidogenic enzymes
such as cholesterol P450 side-chain cleavage (Anderson et al, 1985). This
enzyme catalyses the conversion of cholesterol to pregnenolone, which is
the rate limiting step of testicular steroidogenesis (Waterman & Simpson,
1985). Cholesterol is the precursor for testosterone synthesis and is
synthesized in rat Leydig cell mitochondria (Pignataro et al., 1983) from
acetate (Morris & Chaikoff, 1959). LH accelerates the entry of cholesterol
into mitochondria (Hall et al., 1967). Thus the main effect of LH is to
increase the availability of steroid substrate by accelerating the
metabolism of cholesterol.
However, it appears that not all the effects of LH are mediated
through the cAMP second messenger system. Testosterone production
can be stimulated by amounts of LH that have no detectable effects on
intracellular cAMP levels (Cooke et al., 1976). Recent studies have shown
that low, non-stimulatory levels of LH and cAMP have a marked
synergistic effect on testosterone synthesis (Choi & Cooke, 1992),
suggesting independent pathways are involved. Prolonged exposure to
LH causes Leydig cell desensitization and the cells become refractory to LH
stimulation (see below). This desensitization cannot be mimicked by
cAMP analogues, but is mimicked by PKC activators such as phorbol
esters (Rose & Band, 1988). Further studies led the authors to propose that
activation of adenylate cyclase may be dependent on the action of PKC.
In addition, LH has been shown to stimulate the release of
arachidonic acid from Leydig cells (Chaudry et al., 1989). The release of
arachidonic acid from phospholipids is dependent on the action of either
phospholipase A2 (PLA2) or PLC. In purified rat Leydig cells, inhibitors of
PLA2 inhibited LH-stimulated steroidogenesis without affecting LH-
induced cAMP formation, and PLA2 was able to stimulate basal and LH-
stimulated testosterone production without affecting cAMP levels
(Abayasekara et al., 1990). Based on these results a model of LH action has
been proposed whereby LH increases the intracellular calcium
concentration, either by the opening of membrane ion channels or by
release from intracellular stores. The increased calcium levels activate
PLA2, stimulating the formation of arachidonic acid metabolites which
can act as second messengers. When the levels of LH are high, cAMP is
also stimulated and may play a co-operative role (Cooke, 1990).
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2.2.5. Modulation of Leydig cell response to LH
LH is able to down-regulate the number of its own receptors and thus
limit its own potential maximal stimulatory effect. Hsueh et al. (1976)
demonstrated that administration of a single dose of hCG to either
immature whole or hypophysectomised rats was followed by a marked
reduction in LH binding capacity to testicular homogenates in vitro,
between 3 and 24 hours later. A similar desensitizing effect of LH on its
receptors in the human was implied by the results of an experiment by
Saez & Forest (1979). An initial injection of hCG was shown to stimulate
plasma testosterone levels in 13 normal male volunteers. Subsequent
injections of hCG 24 hours later failed to induce a significant increase in
testosterone levels. Iodinated hCG was shown to bind to human testicular
tissue obtained from infertile men undergoing biopsy (Sharpe et al., 1980).
Tissue obtained from men who had been treated 24 hours earlier with
hCG showed significantly lower hCG binding than in comparable
untreated men. Thus it appears that hCG is able to negatively regulate
Leydig cell LH receptors in man.
The binding of either ovine LH or hCG to rat gonadal
homogenates, testicular membrane preparations or purified Leydig cells is
followed by a prolonged loss of LH-receptors. This decrease in receptor
number is both time and dose-dependent and results in an increased ED50
for steroid production. A decrease in the maximal steroid response to
subsequent hormonal stimulation is also seen. The time-scale of receptor
loss indicates that the decrease in binding cannot be due to receptor
occupancy, but is caused by depletion of LH-receptors from the plasma
membrane. The disappearance of functional LH receptors is accompanied
by a decrease in the ability of LH to stimulate adenylate cyclase activity
and cAMP formation in the testis (for review see Catt et al., 1979).
In rat ovarian membrane preparations, down-regulation of the LH
receptor was found to involve internalisation and proteolysis by
endogenous proteinases (Kellokumpu & Rajaniemi, 1985). In the same
system, the protease inhibitor, aprotinin, has been shown to inhibit the
association of hCG to its receptor, although it did not affect hCG binding
to solubilised receptors (Wilks & Hui, 1987). In the rat the LH receptor
exists in a dynamic state of continuous recycling, in which activation of
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the transducing system is followed by uncoupling, internalisation and
recycling. (Habberfield et al., 1987, Cooke & West, 1992). Isolated rat Leydig
cells in culture exhibit continuous proteolytic cleavage of the LH receptor
with release of the extracellular domain. In the rat desensitization to
LH/hCG does not involve receptor down-regulation (i.e. internalisation
and degradation) (West & Cooke, 1991).
2.2.6. Feedback control of LH
Androgens and oestrogens are able to modulate LH secretion through
negative feedback effects. Sherins & Loriaux (1973) studied the effects of
testosterone and oestradiol on plasma FSH and LH concentrations. Four
day continuous infusions of either steroid resulted in plasma FSH, LH
and testosterone levels falling below control levels by the end of the
infusions. The negative feedback effects of infusions of testosterone and
oestradiol on plasma LH levels were confirmed in a later study which had
the advantage of using more physiological doses of the two steroids
(Stewart-Bentley et al., 1974). As oestrogen can be formed by the
aromatisation of circulating testosterone (Longscope et al., 1969), it was
not clear which of these steroids was involved in controlling peripheral
gonadotrophin levels. Stewart-Bentley et al. (1974) demonstrated that LH
levels could be suppressed by the infusion of a non-aromatisable
androgen such as dihydrotestosterone (DHT). Using the aromatase
inhibitor, A^-testolactone to prevent oestrogen formation from
testosterone, Marynick et al. (1979) confirmed that testosterone was able to
suppress serum LH levels independently of its peripheral aromatisation
to serum oestrogen. Testosterone has also been shown to have a negative
feedback effect on LH secretion in the rat (Ellis & Desjardins, 1982). In
fact, in man androgens and oestrogens have been shown to have
differential effects on gonadotrophin regulation. Testosterone and non-
aromatisable androgens were found to decrease the frequency of LH
pulses without affecting the amplitude of the pulses. On the other hand,
oestradiol affected LH secretion by decreasing pulse amplitude without
affecting their rate of production (Santen, 1975).
Chapter Two Literature Review 12
2.2.7. FSH
FSH belongs to the same glycoprotein family as LH and is also secreted by
pituitary gonadotrophs. FSH and LH share a common a subunit, but the p
subunit of FSH is unique (see Gharib et al., 1990 for review). FSH has a
higher Mr than LH, due to its having a greater carbohydrate composition.
For the same reason the plasma half-life of FSH is longer at 3-4 hours
than that of LH, at 1.5-2.5 hours (Coble et al., 1969, Santen & Bardin, 1973).
The pattern of FSH secretion, like that of LH, is episodic. However, FSH
levels show very small fluctuations in contrast to the frequent secretory
spikes of LH (Santen & Bardin, 1973).
2.2.8. Hypothalamic control of FSH secretion
In rats, the release of both LH and FSH from pituitary gonadotrophs is
controlled by a single releasing factor, GnRH (Schally et al., 1971). GnRH
has been shown to stimulate the release of LH and FSH from enriched rat
gonadotroph populations in vitro (Benoist et al., 1981). Yen et al. (1972)
demonstrated that administration of synthetic GnRH to normal adult
men elicited a prompt increase in LH levels that was accompanied by a
smaller but concomitant rise in circulating FSH levels. Similarly, Santen
& Bardin (1973) described small pulsatile changes in serum FSH levels
subsequent to GnRH challenge; although small, these increments were
found to coincide with LH pulses more frequently than could be ascribed
to chance. However, a separate study with normal male subjects, showed
that while synthetic GnRH was able to stimulate release of both LH and
FSH, the fluctuations in their serum levels were asynchronous
(Mortimer et al., 1974). The authors suggest that the asynchronous release
of LH and FSH is due to differential effects of GnRH on the mechanisms
responsible for the release of LH and FSH from gonadotrophs.
2.2.9. Site of FSH action
The testicular effects of FSH were described by Greep et al. (1936). In
immature, hypophysectomised rats the effects of FSH were found to be
concentrated solely on the seminiferous epithelium. FSH labelled with
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ferritin or fluorescent markers was found to localise around the nuclei
and in the apical area of Sertoli cells. It was also found in between
germinal spaces which were presumed to be cytoplasmic branches of
Sertoli cells (Mancini et al, 1967). Means & Vaitukatis (1972) reported
binding of 3H-FSH to the seminiferous epithelium, although the specific
cell type binding the FSH could not be distinguished.
FSH has no effect on adenylate cyclase activity in interstitial cell
preparations, but increases adenylate cyclase activity in seminiferous
tubule preparations (Kuehl et al., 1970). FSH was also shown to increase
cAMP accumulation in normal, fully regressed hypophysectomised, and
cryptorchid rats. As the two latter types have testes that are enriched in
Sertoli cell and spermatogonia, either of these cell types was potentially
the site of FSH action. However, testicular irradiation can be used to
produce rats with remarkably few spermatogonia. These rats show the
same response to FSH as seen in the treatment groups described above.
Thus it was deduced that the Sertoli cell was the target cell for FSH
(Dorrington & Fritz, 1974).
The presence of FSH receptors in the human testis has been
demonstrated using testicular biopsy tissue from infertile patients
(Namiki et al., 1984). The number of high affinity FSH binding sites was
found to decrease in parallel with the degree of spermatogenic
impairment seen in the biopsy tissue.
2.2.10. Mechanism of FSH action
FSH binds specifically to Sertoli cells and via increased cAMP production
(Kuehl et al., 1970) activates protein kinases and stimulates end responses
such as the production of androgen-binding protein (ABP), plasminogen
activator and oestrogen (Hansson et al., 1974, Dorrington et al., 1978).
During puberty, FSH is of critical importance in initiating
spermatogenesis. The number of FSH binding sites per testis increases
during the neonatal period when Sertoli cells are actively dividing.
Maximum numbers are attained at approximately 15 days (Fakunding et
al., 1976). Passive immunisation of immature rats with an FSH antiserum
was found to decrease testicular size and to disrupt the morphology of the
seminiferous epithelium (Raj & Dym, 1976).
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The role of FSH in the adult rat is less clear cut. Dym et al. (1979)
reported that administration of FSH antiserum to adult rats did not affect
either ABP levels, the morphology of the seminiferous epithelium, or
fertility, suggesting that in the adult rat, FSH may not be required for the
maintenance of spermatogenesis. In addition, it had previously been
shown that while FSH could stimulate cAMP production in testicular
slices or seminiferous tubules isolated from immature rats, it had no
effect on cAMP levels in tissue preparations from mature rats (Kuehl et
al., 1970). In contrast, in adult Rhesus monkeys, active or passive
immunisation against FSH impaired spermatogenic function and
decreased sperm counts within 4 weeks of immunisation (Wickings &
Nieschlag, 1980), suggesting that FSH does have a role to play in
spermatogenesis. Using a highly purified, LH-free FSH preparation,
Bartlett et al. (1989) demonstrated that treating hypophysectomised adult
rats with this preparation of FSH maintained testicular weights and
numbers of preleptotene spermatocytes, pachytene spermatocytes and
round spermatids, at higher levels than seen in untreated
hypophysectomised rats. Testosterone implants were also able to
maintain spermatogenesis, and combinations of FSH and testosterone
maintained spermatogenesis and testicular weights at almost normal
levels. The results of these experiments suggest that FSH does have a role
in the maintenance of spermatogenesis in adult rats as well as in adult
primates. In man induction of FSH deficiency by chronic administration
of hCG resulted in partial suppression of sperm production, and
replacement of FSH by injection returned sperm production almost to
control levels. This suggests that in man, as in the rat and Rhesus
monkey, while normal levels of FSH are not an absolute requirement for
sperm production, FSH is necessary for the maintenance of qualitatively
normal spermatogenesis (Matsumoto et al., 1986).
At all stages of development the actions of FSH and testosterone
seem to be highly integrated. A model for the synergistic action of FSH
and testosterone in maintaining spermatogenesis was proposed by Sharpe
(1989a): FSH determines the number of viable cells to enter meiosis while
testosterone controls their subsequent development. FSH alone would
therefore be unable to maintain spermatogenesis as the continued
development of germ cells would fail due to the absence of androgenic
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support. Testosterone, however, as seen in so many studies, would be able
to maintain qualitatively normal spermatogenesis, as the supply of
differentiated spermatogonia would be reduced but not abolished in the
absence of FSH.
FSH is implicated in the control of Leydig cell maturation. For
example, in the sexually immature rat testis, the absence of exposure to
FSH results in insensitivity to LH, implying that exposure to FSH induces
responsiveness to LH (Odell et al., 1973). In addition, Kerr & Sharpe (1985)
reported that administration of FSH to immature, hypophysectomised
rats resulted in a significantly greater number of Leydig cells compared to
the numbers seen in untreated rats. These changes were a consequence of
increased hypertrophy of immature Leydig cells to adult type Leydig cells,
and of Leydig cell hyperplasia. A cascade is thus initiated whereby FSH is
responsible for the differentiation of the adult population of Leydig cells,
which become responsive to LH and produce androgens which act locally
to support spermatogenesis. These effects of FSH are presumed to be
mediated via Sertoli cells as Leydig cells do not have FSH receptors
(Means & Vaitukatis, 1972).
The stimulation of cAMP in the rat seminiferous epithelium by
FSH varies in a cyclic manner, with the highest degree of stimulation
occurring at stages II-VI, and the lowest at stages VII-VIII (Gordeladze et
al., 1982, Nikula et ah, 1990). These changes coincide with cyclic changes in
the activity of PKC, which has been shown to modulate cAMP production
in cultured Sertoli cells (Nikula et al., 1987). The authors suggest that the
variation in FSH/PKC response with the stage of the spermatogenic cycle
is possibly due to the paracrine modulation of Sertoli cell function by
germ cells.
2.2.11. Feedback control of FSH
The increases in LH and FSH levels caused by castration can be prevented
by administration of testosterone or oestradiol. In the rat, there is some
evidence that testosterone preferentially suppresses LH, while oestradiol
has parallel effects on LH and FSH (Swerdloff & Walsh, 1973). Sherins &
Loriaux (1973) described how administration of either testosterone or
oestradiol to normal adult men suppressed both plasma FSH and LH
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concentrations. Suppression of FSH levels by testosterone independent of
its aromatisation to oestrogen has been demonstrated (Marynick et al.,
1979). However, in cases of disrupted spermatogenesis FSH is selectively
elevated. Morphological investigation of testicular biopsy tissue from
patients with oligospermia or azoospermia, revealed that when
spermatogenesis was arrested prior to spermatid formation, serum FSH
concentrations were above normal. However, when spermatids were
observed in the biopsy tissue, FSH levels were within the normal range
(Franchimont et al., 1972). The authors suggested that the transformation
of spermatocytes to spermatids induces the formation of a substance
which depresses FSH secretion. Recent support for this interpretation
comes from the study by Allenby et al. (1991) which showed that secretion
of inhibin was reduced only by depletion of elongate spermatids from the
seminiferous epithelium and this led to an increase in blood FSH levels.
Similar associations between elevated serum FSH levels and testicular
damage were also described by de Kretser et al. (1974), who found that the
most significant correlations were between serum FSH and the mean
number of spermatogonia per testis. Krueger et al. (1974) used chronic
vitamin A deficiency to cause germ cell degeneration. No increase in FSH
levels was seen when only spermatogonia and Sertoli cells were present,
suggesting that either of these cell types was the site of origin of the FSH
inhibitory substance.
Testicular extracts were found to contain a proteinaceous subject,
named inhibin, that was capable of suppressing FSH release either in
vivo or in vitro (Franchimont et al., 1978, Davies et al., 1978). Isolated
Sertoli cells were found to release a substance with similar FSH-
suppressing properties into the culture medium (Steinberger &
Steinberger, 1976).
Inhibin has been characterised as a gonadal glycoprotein that
preferentially suppresses FSH secretion (Burger & Igarashi, 1988), by
reducing FSH (3 mRNA concentrations (Attardi et al., 1989) and blocking
GnRH stimulated LH and FSH release (Kotsuji et al., 1988). Leydig cells
also secrete immunoactive inhibin (Risbridger et al., 1989), though the
contribution that Leydig cells make to inhibin levels in the testis and
periphery is unclear, as Maddocks & Sharpe (1989) demonstrated that
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destruction of Leydig cells by EDS had no effect on the levels of
immunoactive inhibin in serum or interstitial fluid.
Measurement of inhibin levels in peripheral and spermatic vein
serum in men with varicocele-associated oligospermia has shown that
inhibin is released from the human testis in well-defined pulses that
coincide with episodes of testosterone release. As FSH pulses do not
coincide with LH pulses, the association of inhibin and testosterone
pulses implies that LH may have an important role in the regulation of
inhibin release in men (Winters, 1990). This may be related to the Leydig
cell being one source of immunoactive inhibin.
An antiserum to the a subunit of inhibin has been used to
immunoneutralise inhibin in peripheral blood. In the immature male rat
inhibin immunoneutralisation causes dramatic increases in plasma FSH
concentrations, while inhibin immunoneutralisation in the adult had no
effect on gonadotrophin secretion (Culler & Negro-Vilar, 1988). Following
a series of experiments that examined the effects of both inhibin
immunoneutralisation and selective removal of Leydig cells with EDS,
Culler (1990) proposed that the suppressive effect of the testes on LH and
FSH secretion was mainly due to the secretion of a Leydig cell factor,
presumably testosterone.
2.3. Structure of the testis
2.3.1. Interstitial Tissue
The loose connective tissue found between seminiferous tubules contains
Leydig cells, endothelial elements, lymphatics, small nerves,
macrophages and blood vessels. The connective tissue stroma, consisting
of a ground substance interlaced with collagen fibres and fibroblasts,
supports the cells within the interstitium (Christensen, 1975, Kerr, 1989).
Leydig cells are a heterogeneous population of cells, located either
singly or in clusters in the intertubular tissue. The interstitium provides a
unique environment in which Leydig cells synthesize and secrete
testosterone into the peripheral blood supply and the seminiferous
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tubules. There are several recognised patterns of organisation of the
testicular interstitium. For example, electron micrographs of perfused rat
testis, show a sparse interstitium with a relatively small volume of Leydig
cells (1-5% of the total testicular volume) and a minimum of connective
tissue. The majority of the intertubular area is occupied by peritubular
lymphatic sinusoids. In contrast, in the human testis the interstitium
consists of random clusters of Leydig cells scattered in very loose, fluid-
filled, connective tissue. Leydig cells comprise between 5-12% of the total
testicular volume (Fawcett et al., 1973, Christensen, 1975, Kaler & Neaves,
1978). Clusters of Leydig cells are connected by numerous gap junctions,
and these are considered to be a site of direct intercellular
communication, and are perhaps important in coordinating steroid
synthesis (Schulze, 1984).
2.3.1.1. Leydig cell structure and heterogeneity
Leydig cells are polygonal and have a diameter of 15-20pM. Their
prominent nucleus is round or oval and has one or more prominent
nucleoli. Leydig cells contain organelles which reflect their function as
steroid producing cells. The most abundant organelle is the smooth
endoplasmic reticulum (SER). This is composed of interconnected
membrane tubules which form a continuous network throughout the
cytoplasm. Scattered patches of rough endoplasmic reticulum (RER)
interconnect with the SER. Mitochondria are found throughout the
cytoplasm. A Golgi complex is usually found at one pole of the nucleus
and centrioles are usually in the Golgi region. The cytoplasm also
contains lipid droplets, microtubules and microfilaments, lysosomes and
vacuoles. In the human, Leydig cell cytoplasm may also contain rod-
shaped crystals of Reinke. These are proteinaecous and found in various
sizes and numbers. Reinke crystals are not necessarily present and their
function is unknown. Leydig cells also contain peroxisomes. These are
granules of approximately 0.2pm diameter, bounded by a single
membrane, which contain several oxidases and a catalase. Their function
in Leydig cells is unclear. (Christensen, 1975, Schulze, 1984, Kerr, 1989).
Flowever, Leydig cell peroxisomes contain sterol carrier protein-2 (SCP2)
which participates in the intracellular transport of cholesterol to
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mitochondria. Hence peroxisomes may use SCP2 to provide cholesterol
for conversion to testosterone (Mendis-Handagama et al., 1990).
Most of the enzymes involved in producing testosterone are
located in the SER. Thus, the abundance of SER provides a large surface
area for steroidogenic reactions. It has been estimated that the total
membrane surface area of SER in a human Leydig cell is 4000pm2. The
SER in the rat is even more abundant, with a total membrane surface area
two or more times greater (Christensen, 1975).
The capacity of Leydig cells to produce testosterone is strongly
correlated with the volume of Leydig cell SER. The ability of a perfused
testis to produce testosterone in response to LH was related to the mean
volume density of SER, as assessed at the electron microscopic level in
the contralateral testis. These two factors were found to be linearly and
positively correlated in 5 species (r=0.99 in rat, rabbit, guinea pig, dog and
hamster, Zirkin et al., 1980).
Leydig cell lipid droplets contain predominantly cholesterol esters
and neutral fats. The esters can be released into the cytoplasm where they
are hydrolysed by soluble esterases to provide free cholesterol for steroid
synthesis (Christensen, 1975, Schulze, 1984, Ewing & Zirkin, 1983). In a
population of human Leydig cells the size and number of lipid droplets
varies between cells. As the droplets contain precursors for steroid
synthesis, it has been suggested that cells with fewer or smaller droplets
are more steroidogenically active than those with more droplets. In
agreement with this, the number of lipid droplets decreases after LH
stimulation and increases temporally following hypophysectomy
(Christensen, 1975). The variation in lipid droplets from cell to cell has
been interpreted as evidence for a Leydig cell secretory cycle. In fact, the
heterogeneity of Leydig cells in both rat and human testes is a well
documented phenomenon. In the human, Schulze (1984) described a
heterogeneous population of Leydig cells, which are variably stained
(light versus dark) with toluidine blue. One of the issues addressed in this
thesis is whether light and dark Leydig cells can be distinguished on
morphological (size, distribution) or functional (steroidogenic capacity)
grounds.
The heterogeneity of Leydig cells is illustrated by the separation of
populations of different densities by density gradient centrifugation. This
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is the case for both rat (Payne et al., 1980, Cooke et al, 1981) and human
(Papadopoulos et al., 1987a, Simpson et al., 1987) Leydig cells.
Papadopoulos et al. (1987a) described 2 populations of human Leydig cells
with densities between 1.045-1.055g/ml and 1.075g/ml. The Leydig cells in
the first group had higher basal levels of cAMP and testosterone than
those in the second group but were less responsive to hCG. Simpson et al.
(1987) also demonstrated that human Leydig cells can be separated on the
basis of density, but not at the same densities as Papadopoulos et al.
(1987a). Further, Simpson et al. (1987) found no difference in the
steroidogenic capacity of Leydig cells of different densities.
Payne et al. (1980) separated Leydig cells on metrizamide gradients
and found two populations of differing densities that had equal ability to
bind 125I-hCG. However, one population showed a much lower response
to hCG or cAMP. The authors suggested that this population was
composed of immature Leydig cells that had the ability to bind hCG but
no capacity to respond. The results of this study may be open to other
interpretations as it is known that metrizamide can enter cells. However,
a second study which used Percoll gradients gave very similar results.
Cooke et al. (1981) used Percoll to isolate Leydig cells with a range of
densities, and a range in their responsiveness to hCG. All Leydig cells
were able to bind hCG. The Leydig cells with the highest testosterone
output were found to comprise only 6% of the total population,
indicating that in the rat testis at any one time there are a large number of
Leydig cells which have a low response to hCG. The authors suggested
that in the rat, Leydig cells may be undergoing a continuous cycle of
metabolic activity. This hypothesis is supported by the work of Bergh
(1983, 1985), who showed that when the testosterone requirement of
seminiferous tubules is at its peak at stage VII, adjacent Leydig cells are
larger than the Leydig cells adjacent to tubules at other, less testosterone
dependent stages. Using tissue obtained after death, Regadera et al. (1991)
demonstrated that human Leydig cells do not show a uniform ability to
bind an anti-testosterone antibody. The degree of staining in Leydig cells
ranged from very intense to none at all. Again, such differences may be
due to cyclical changes in the functional activity of Leydig cells.
As all Leydig cells within the interstitium are exposed to
equivalent amounts of circulating gonadotrophins, the hypothesis of a
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Leydig cell cycle must necessarily imply regulation by locally produced
factors. This will be discussed in more detail in section 2.4.
2.3.1.2. Leydig cell steroidogenesis
The primary precursor of androgen synthesis is the 27-carbon sterol,
cholesterol, which can be obtained from three separate sources. The main
source is de novo synthesis from acetate, which occurs in the SER. Leydig
cell lipid droplets contain cholesterol esters which can be hydrolysed to
cholesterol by plasma esterases. Finally, cholesterol can be obtained
directly from the circulating blood supply. It is probably transported to the
Leydig cell by lipoproteins which are thought to interact with membrane
lipid receptors (Ewing & Zirkin, 1983, Rommerts & van der Molen, 1989).
Cholesterol is transported to the mitochondria where it is
converted to pregnenolone by removal of the 6-carbon side chain on the
C-17 of cholesterol. The reaction is catalysed by a P450-dependent side
chain cleavage enzyme, P450scc, which is regulated by LH. Pregnenolone
can be converted to testosterone through either the A4 or A5 pathway. The
difference refers to the position of the unsaturated bond in the
intermediates formed in the conversion process. In the A4 pathway, the
unsaturated bond is between C-4 and C-5 of ring A, and in the A5 pathway
it is between C-5 and C-6 of ring B. The rate of conversion of testosterone
via each pathway is different in different species. In the rat the A4
pathway predominates, while the A5 is the preferred route of testosterone
synthesis in the human testis.
The conversion of pregnenolone occurs in the SER. In the A4
pathway the intermediates, progesterone, 17-hydroxyprogesterone and
androstenedione are formed by the actions of 3|3-hydroxysteroid
dehydrogenase (3PHSD), P450 17a-hydroxylase and C17-20 lyase
respectively. In the A5 pathway the latter two enzymes are responsible for
the formation of 17-hydroxypregnenolone and dehydroepiandrosterone.
Androstenedione is converted to testosterone by 17(3-hydroxysteroid
dehydrogenase (17[3-HSD). Dehydroepiandrosterone is converted to
testosterone by prior conversion to either androstenedione or
androstenediol (for review see Preslock, 1980, Rommerts & van der
Molen, 1989).
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A decrease in activity after hypophysectomy in the adult rat
demonstrates that steroidogenic enzymes require the continued presence
of LH for their activity. Administration of hCG reverses the inhibitory
effects of hypophysectomy (Purvis et al., 1981, Rommerts & van der
Molen, 1989 for review). The acute stimulatory effect of LH is to increase
the rate of transport of cholesterol into the inner mitochondrial
membrane where it associates with P450scc. Chronic stimulation by LH is
required for optimal synthesis of P450 enzymes, though the mechanism
by which LH (and cAMP) regulates transcription of the P450 genes has not
been established (Payne, 1990). In bovine adrenocortical (John et al., 1986)
and MA-10 (Hales et al., 1990) cell cultures cAMP is able to induce
increases in the steady state levels of transcription of P450scc and P450 17a-
hydroxylase mRNAs. These increases have been shown to reflect
increases in the rate of gene transcription.
Keeney & Mason (1992) have shown that the LH-dependent
expression of 30HSD is regulated via a cAMP-dependent signalling
pathway. Positive regulation by LH, dibutyryl cAMP, forskolin and
cholera toxin was seen at all stages from the transcription of the 3(3HSD
gene to translation of the mRNA and formation of a functional enzyme.
Testosterone appears to be secreted immediately after its synthesis.
The process does not seem to involve secretory vesicles, as none have
been observed in Leydig cells. Also, the rate of testosterone secretion
correlates highly with the intratesticular testosterone content (Eik-Nes,
1971). Testosterone probably enters target cells by passive diffusion. Three
possible fates await testosterone in the various target cells it reaches
(Wilson, 1992). It can combine with the androgen receptor to form a
hormone-receptor complex in the nucleus, it may be aromatised to
dihydrotestosterone which has a higher affinity for the androgen receptor,
or it may be aromatised to oestrogen and mediate effects through the
oestrogen receptor.
The androgen receptor belongs to a family of gene regulatory
proteins, which are characterised by their organisation into functional
domains. The receptor has sites for specific, high affinity ligand binding,
for DNA-binding to the steroid response element of the target gene and
for transcriptional modulation (O'Malley & Tsai, 1992). In the rat testis,
androgen receptors have been localised to Sertoli cells (Grootegood et al.,
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1977), Leydig cells and peritubular cells (Sar et al., 1990). The presence of
androgen receptors on Leydig cells implies the existence of a short loop
negative feedback effect of testosterone on its own production. This was
demonstrated by Darney & Ewing (1981), who infused testosterone
directly into a perfused rat testis and found that testosterone levels in the
perfusate fell to 50% of the control within 20 minutes. A similar control
system probably exists in man, as androgen receptors have been localised
to Leydig cells using immunohistochemical techniques (Sar et al., 1990)
and androgen receptor mRNA has been found in purified human Leydig
cells (Namiki et al., 1991). However, testicular arterioles also have
androgen receptors (Bergh, 1991) therefore the possibility exists that
infusion of testosterone might, through an action at these receptors,
decrease testicular blood flow, thereby reducing the entry of LH to the
testis and the escape of testosterone from it. This could also account for
the reported decrease of testosterone levels in the perfusate.
2.3.1.3. Other Leydig cell products
The major function of Leydig cells is the production of androgen. Indeed,
as the chemical removal of Leydig cells with EDS in conjunction with
simultaneous administration of exogenous testosterone, can maintain
quantitatively normal spermatogenesis, the importance of Leydig cell
products other than testosterone is not obvious (Ratnasooriya & Sharpe,
1989). However, as there is increasing evidence for the existence of local,
cell to cell, regulatory mechanisms in the testis, the importance of other
Leydig cell products in maintaining optimal conditions for
spermatogenesis may be clarified.
Oestradiol The formation of oestradiol from testosterone requires the
action of an aromatase enzyme. Antibodies directed against this enzyme
have been used to demonstrate its existence in immature and adult rat
Leydig cells. No other cell type contained the enzyme, hence the Leydig
cell is the site of oestradiol synthesis in the adult rat testis (Kurosumi et
al., 1985). Administration of oestrogen suppresses plasma testosterone
levels in rat and man. This was thought to be solely due to an effect on
pituitary gonadotrophins (see Purvis & Hansson, 1978 for review).
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However, Bartke et al. (1977) demonstrated that addition of oestrogen to
testicular cultures significantly inhibited the accumulation of testosterone
into the culture medium. Also, the administration of oestrogen in rat and
man results in a drop in testosterone levels before there is a detectable
change in LH levels (Purvis & Hansson, 1978). Oestrogen receptors have
been localised to rat Leydig cells (Mulder et al., 1973), though one study
failed to detect binding of an anti-oestrogen receptor antibody to human
Leydig cells (Due et al., 1989). Thus intratesticular oestrogens, like
testosterone, could exert a direct regulatory effect on testosterone
synthesis. Monitoring changes in the levels of steroid precursors
following incubation of testicular homogenates with oestrogen
demonstrated that the primary effect of oestrogen was to decrease the
activity of C17-20 lyase (Kalla et al., 1980). This effect of oestrogen has also
been observed in microsomes prepared from neonatal pig testis (Onoda &
Hall, 1981). It is possible that oestrogen has a direct inhibitory effect on the
P450 enzyme as the oestrogenic suppression of testosterone levels is not
blocked by the anti-oestrogen, tamoxifen (Damber et al., 1983).
Oxytocin Immunoreactive oxytocin-like material has been detected in
both human and rat testes (Nicholson et al., 1984), and has been
specifically localised to Leydig cells (Guldenaar & Pickering, 1985).
Isolation of oxytocin mRNA from bovine Leydig cells confirms that
Leydig cells are the testicular source of oxytocin (Ivell & Burbach, 1991).
The effects of oxytocin on Leydig cells are unclear. One study
demonstrated that oxytocin had an inhibitory effect on testosterone
production by isolated mouse Leydig cells (Tahri-Joutei & Pointis, 1988).
However, no effect of oxytocin on cultures of purified rat Leydig cells has
been demonstrated (Sharpe & Cooper, 1987).
Oxytocin appears to have a role in controlling the contractions of
the myoid cells which surround seminiferous tubules. These contractions
may be responsible in part for the transportation of spermatozoa to the
rete testis (Wathes, 1984).
POMC-peptides Testicular pro-opiomelanocortin derived peptides
include ACTH, a-MSH and (3-endorphin. Their production by Leydig cells
has been demonstrated in rat and man (Bardin et al., 1984). POMC mRNA
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has been localised to Leydig cells in the adult rat testis (Pintar et al., 1984).
However, the removal of Leydig cells from the rat testes following
administration of EDS, did not result in changes in the levels of total
testicular POM-C mRNA, nor of POM-C peptides (Li et ah, 1989). The
authors were also unable to detect ACTH or P-endorphin in conditioned
media from a purified adult rat Leydig cell preparation, suggesting that
Leydig cells are not an important source of POM-C peptides in vivo.
However, Eskeland et al. (1992) were able to measure P-endorphin
production by adult rat Leydig cells in vitro, and also demonstrated that
CRF was able to stimulate the release of P-endorphin.
Opiate receptors have been localised to Sertoli cells (Fabbri et al.,
1988) and P-endorphin has been shown to inhibit FSH-induced cAMP
accumulation. In young rats P-endorphin also inhibits ABP production,
but has no effect on ABP secretion in adult rats (Fabbri et al., 1988, Gerandi
et al., 1984). In contrast, other POMC peptides such as ACTH and a-MSH
stimulate Sertoli cell cAMP formation (see Heindel & Treinen, 1989 for
review). The secretion of P-endorphin from cultured mouse Leydig cells
is under hormonal control; GnRH inhibits P-endorphin production
while hCG had a stimulatory effect (Fabbri & Dufau, 1988).
Inhibin In the testis the major site of production of inhibin is the
Sertoli cell (for review see Ying, 1988). However, immunoreactive and
bioactive inhibin have been detected in the culture medium of Leydig
cells from adult rats (Risbridger et al., 1989). A separate study found that
Leydig cells were only able to produce immunoactive inhibin (de Winter
et al., 1992). Precipitation of 35S-methionine labelled proteins revealed
that mature rat Leydig cells secrete a 44kDa inhibin-related protein,
possibly proaNaC (de Winter et al., 1992). It has been reported that
administration of hCG increases serum levels of immunoactive inhibin
in adult rats (Sharpe et al., 1988) and in man (McLachlan et al., 1988).
However the destruction of Leydig cells by EDS does not lead to any
decrease in the levels of immunoactive inhibin in blood or testis
(Maddocks & Sharpe, 1989). The contribution that Leydig cells make to the
levels of inhibin in the testis and periphery requires further study.
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2.3.1.4. Macrophages
Macrophages are common in interstitial tissue and may be associated
with Leydig cell clusters. In the rat, macrophages are believed to constitute
approximately 25% of the cells in the interstitium (Niemi et al., 1986).
Conditioned medium from cultured rat macrophages can stimulate basal
and LH-stimulated testosterone production by purified Leydig cells.
Macrophages that had been cultured in the presence of FSH were more
able to stimulate testosterone production than macrophages that had been
cultured under control conditions (Yee & Hutson, 1985). However,
neither of these findings have been confirmed independently. Sertoli
cells secrete interleukin-la, which may regulate some functions of
macrophages (Bellve & Zheng, 1989). If testicular macrophages are
influenced by Sertoli cells and can themselves affect Leydig cell function,
then testicular macrophages may have an important role in coordinating
testicular function. Evidence exists to support this hypothesis;
interleukin-ip (IL-1(3) is one of the major cytokines released by
macrophages (Dinarello, 1991) and IL-lp has direct effects on isolated
Leydig cells. However, there is some disagreement over the nature of the
effects that IL-lp has on Leydig cell function. IL-ip has been reported to
inhibit hCG and cAMP-stimulated testosterone formation in primary
cultures of Leydig cells (Calkins et al., 1990), and to inhibit P450scc mRNA
expression in isolated adult rat Leydig cells (Lin et al., 1991). In contrast,
Warren et al. (1990) demonstrated that IL-ip was able to stimulate the
basal secretion of testosterone and to augment maximally hCG-stimulated
testosterone production.
2.3.2. Seminiferous Epithelium
The epithelium of each adult seminiferous tubule is composed of two
populations of cells. There are the non-proliferating, immobile
supporting elements, the Sertoli cells, plus a mobile population of
dividing and differentiating germ cells (Schulze, 1984, Trainer, 1987).
There is a close morphological relationship between Sertoli cells
and developing germ cells. The cytoplasm of each Sertoli cell extends
from the basal lamina to the tubule lumen and sends out processes which
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surround germ cells, so that every germ cell is contacted and supported by
a number of adjacent Sertoli cells. In this way the Sertoli cell creates a
lattice-like network of cellular extensions and processes within which
germ cells proceed through the stages of spermatogenesis. Hence the
Sertoli cell is in contact with all generations of germ cells at the same time
(Schulze, 1984, Tindall et al., 1985).
Developing germ cells are found in characteristic associations
throughout the seminiferous epithelium. In the rat, germ cells are
arranged in a regular pattern, or stage, which often occupies the complete
tubular cross-section. Stages are arranged mostly in serial continuity along
the length of a tubule. In the rat 14 germ cell associations or stages are
recognised, according to the characteristics of the acrosome of the
spermatids as seen by periodic acid-Schiff staining (Leblond & Clermont,
1952). In man, the arrangement of germ cell stages has been deduced by
following the spatial position and degree of development of various
populations of primary spermatocytes. In this way it has been shown that
in the human testis the developmental sequence of germ cells is arranged
along a spiral (Schulze & Rehder, 1984). The close morphological
association of Sertoli cells and germ cells implies that the Sertoli cell plays
an important role in spermatogenesis.
2.3.2.1. Organisation of spermatogenesis
There are four basic germ cell types; spermatogonia, primary and
secondary spermatocytes and spermatids, and three main phases of
spermatogenesis; spermatogonial multiplication, meiosis and
spermiogenesis.
Spermatogonia are large diploid cells which arise from the
gonocytes of the fetal testes. Morphologically, A, intermediate and B type
spermatogonia can be distinguished. They undergo several mitoses
(usually 5 or 6) before entering the first stage of meiosis, when they are
classified as preleptotene spermatocytes. In this stage the chromosomes
begin to spiral and contract. The next developmental step is the formation
of zygotene spermatocytes, which are characterised by the pairing off of
analogous chromosomes, which begin to thicken as they gather together.
This is followed by the pachytene stage, the longest meiotic step.
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Pachytene spermatocytes are distinguished by thickened chromosomes
which are held together only at the centromere. As the nucleus reaches its
maximal size, duplication is complete and tetraploid diplotene
spermatocytes are formed. These undergo division to give rise to two
secondary (diploid) spermatocytes, which in turn undergo a further
mitotic division to form haploid cells. Spermiogenesis is the process by
which mature elongate spermatids are formed. Its regulation is not
understood but it involves nuclear condensation, acrosome formation,
the development of a tail and the arrangement of mitochondria into a
helix to form the midpiece of the spermatozoon (Roosen-Runge, 1962). In
the rat, one wave of spermatogenesis, i.e. the formation of a mature
spermatid from a type A spermatogonium, takes 65 days (Clermont &
Harvey, 1965). In man, the time taken for total germ cell maturation is
70±4 days, although spermatogenesis proceeds along the same pathway as
that described for spermatogenesis in the rat (for review see Trainer,
1987).
2.3.2.2. Sertoli Cells
Sertoli cells are tall, columnar cells which extend from the basal lamina to
the lumen of the seminiferous tubule. They have a characteristic, highly
lobulated nucleus with prominent nucleoli. The nucleus is generally
found in the second layer of the epithelium, that is, above spermatogonia.
Sertoli cell cytoplasm contains mitochondria, Golgi apparatus, abundant
SER, also RER and a three-dimensional network of intermediate
filaments. The Sertoli cell cytoskeleton also contains microfilaments and
microtubules. At least one cytoskeletal element is believed to be involved
in every cellular process. A feature of Sertoli cell cytoplasm is that SER is
often found in concentric aggregations around lipid droplets or lysosomes
(Schulze, 1984, Tindall et al, 1985).
2.3.2.3. Formation of the blood-testis barrier
Close to the base of the seminiferous epithelium, contact surfaces of
adjacent Sertoli cells show symmetrically developed specialised junctions;
these form what is known as the blood-testis-barrier. This is a
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permeability barrier around seminiferous tubules which was discovered
when proteins that were abundant in plasma and testicular lymph were
found only in very low concentrations in rete testis fluid (Setchell, 1967).
Dym & Fawcett (1970) demonstrated that when lanthanum, a small
molecular weight, electron-opaque substance, was introduced into the
testis, it was able to permeate the space between spermatogonia and
surrounding germ cells, but was prevented from going deeper into the
epithelium by focal tight junctions on the interfaces between adjacent
Sertoli cells. The authors described how pairs of Sertoli cell are joined
above the spermatogonia resting on the basal lamina, but below the
spermatocytes. These Sertoli cell junctions divide the epithelium into a
basal and an adluminal compartment. The basal compartment therefore
contains the spermatogonia and preleptotene spermatocytes, while the
adluminal compartment contains late spermatocytes and developing
spermatids. The pattern of Sertoli cell junctions must be modified at
certain stages of the spermatogenic cycle to allow preleptotene
spermatocytes to move from the basal to the adluminal compartment.
There are two functional components to the blood-testis-barrier.
The first is the peritubular layer of myoid cells in the boundary tissue of
the seminiferous tubule. Intercellular junctions between adjacent myoid
cells which prevent several substances from entering a seminiferous
tubule. The morphological site of the blood-testis barrier is the series of
junctional specialisations between adjacent Sertoli cells. There are three
different types of junctions between Sertoli cells. There are zones of close
contact and also desmosome-like junctions which have an adhesive-like
capacity to connect adjacent cells. They are also found between Sertoli cell
and spermatogonia and spermatocytes. The most common connection
made between two Sertoli cells is the tight junction. These consist of focal
fusions of the outer leaflets of opposing cell membranes. One constituent
of Sertoli cell junctional complexes is actin. In other non-muscle cells
actin is controlled by calcium which regulates a relaxation-contraction
cycle. It has been hypothesised that free calcium released from the
endoplasmic reticulum could become bound to calmodulin and promote
the motile force of the microfilaments (Means et al., 1980). Junctional
specialisations are also found between Sertoli cells facing germ cells. It is
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therefore possible that active changes in Sertoli cell shape may affect the
movement of germ cells from the base to the lumen of the tubule.
The existence of the blood-testis barrier means that blood-borne
nutrients and gonadotrophins which have successfully crossed the
peritubular myoid layer, have direct access to spermatogonia and
preleptotene spermatocytes, but to reach later germ cells must pass
through Sertoli cell cytoplasm. A further consequence of the formation of
Sertoli cell tight junctions is the polar differentiation of Sertoli cell
cytoplasm. Basal cytoplasm contains an abundance of organelles and
inclusions, while apical cytoplasm contains only axially oriented
mitochondria, cisternae of the SER, microtubules and filaments, and
occasionally, glycogen. For these reasons it is believed that the function of
the blood-testis barrier is to isolate late spermatocytes and early
spermatids in order to provide the optimal environment as they undergo
meiosis and spermiogenesis (Dym & Fawcett, 1970, Schulze, 1984, Tindall
et al., 1985).
2.3.2.4. Sertoli cell functions
Specific functions ascribed to Sertoli cells include fluid production,
phagocytosis, maturation and release of spermatozoa and protein
synthesis. Seminiferous tubule fluid (STF) has higher concentrations of
potassium and bicarbonate than are found in plasma, and lower
concentrations of sodium and chloride. This gradient is maintained by
the Sertoli cell tight junctions and Sertoli cell cytoplasm (Setchell, 1974)
Sertoli cells have pronounced endocytic activity, phagocytosing
both degenerating germ cells and the residual cytoplasm left behind when
mature spermatozoa are released (Black, 1971). The nature of the Sertoli
cell factors required for maturation of spermatids remains unclear.
Recently, it has been proposed that dialogue between Sertoli cells and
residual bodies is important in paracrine regulation of this process.
According to the hypothesis proposed by Jegou et al. (1992), residual
bodies may regulate Sertoli cell function by two pathways. The mRNA
released by Sertoli cell phagocytosis of the residual body may code for a
factor(s) which controls Sertoli cell gene expression. The expressed Sertoli
cell proteins may then regulate different events at the germ cell level. The
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actual process of phagocytosis of residual bodies may trigger the
production of a factor(s) able to regulate Sertoli or germ cell function. A
postulated mechanism for the release of the mature spermatozoa, or
spermiation involves a physiological change in Sertoli cell junctional
specialisations resulting in the loss of adhesion and the consequent
release of the sperm head from its attachment site (Ross, 1976).
2.3.2.5. Synthesis and secretion of Sertoli cell proteins
An important function of Sertoli cells is the active secretion of proteins.
Cultured Sertoli cells will incorporate 35S-methionine into newly
synthesized proteins that are then released into the culture medium. The
secreted radiolabeled proteins can be visualised by 2-dimensional gel
electrophoresis. Using this technique, Sertoli cells in vitro have been
found to secrete over a hundred different proteins (Wright et al., 1983,
Sharpe et al., 1992). As very few secretory vesicles have been seen in
Sertoli cells either in vivo or in vitro, it appears that the proteins secreted
by Sertoli cells are needed immediately by the surrounding germ cells
(Tindall et al., 1985). The rate of production of Sertoli cell proteins in
vitro can be assessed by measuring the rate of incorporation of 3H-leucine.
Using this technique, Rommerts et al. (1978) demonstrated that FSH,
cAMP and testosterone were all able to stimulate the secretion of labelled
proteins from cultured immature Sertoli cells.
Sertoli cells secrete their products in a bidirectional manner.
Substances can either be secreted via the apex of the Sertoli cell into STF,
or via the base of the cell into interstitial fluid, and from there into the
peripheral blood supply. Unidirectional secretion has not been
demonstrated for any Sertoli cell product, yet the secretion of many is
known to be predominantly in one direction (for review see Sharpe,
1988). Bicameral chambers enable the study in vitro of the polarized
secretion of proteins by cultured Sertoli cells. This system has been used
to demonstrate bidirectional secretion of radiolabeled Sertoli cell proteins
in vitro (Djakiew & Dym, 1988).
Radiolabeled proteins secreted by segments of seminiferous
tubules cut into distinct spermatogenic stages can be visualised by 2-
dimensional gel electrophoresis. This technique has been used to
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illustrate how the pattern of proteins secreted varies from one
spermatogenic stage to the next, with the secretion of at least 15 different
proteins following a cyclical pattern (Wright, 1983, McKinnell et al., 1992).
The ability of Sertoli cells to secrete proteins in a directed and cyclical
manner and the significance of this to regulation of spermatogenesis will
be discussed with reference to specific Sertoli cell proteins.
Androgen binding protein (ABP) ABP is a 105kDa protein composed
of two subunits. It shows high affinity binding for testosterone and
dihydrotestosterone. It is secreted into STF then through the rete testis
and efferent ducts into the epididymis (for review see Tindall et al., 1985).
Results of a series of experiments have confirmed that Sertoli cells are the
site of ABP synthesis. Androgen binding capacity was measured in
interstitial and tubular tissue and found to be maximal in tubular tissue;
destruction of germ cells by irradiation was found not to affect testicular
ABP levels (see Hansson et al., 1976 for review). Most conclusively,
immature rat Sertoli cell cultures produce ABP in vitro. Cultures of
human Sertoli cells also produce an androgen binding activity which co-
elutes with rat ABP (Lipshultz et al., 1982). The rat testis contains a testis-
specific form of ABP (French & Ritzen, 1973), but it is not clear if this is
the case in man. Purvis et al. (1978) demonstrated that the androgen
binding component of the human testis shared the same physicochemical
properties as testosterone binding globulin (TeBG, or sex hormone
binding globulin), which is found in the serum of man but not the rat.
Cheng et al. (1985) isolated two molecular species of human testicular
ABP. One form was very similar to TeBG, but the other was different
from TeBG with regard to the molecular weight of its monomers, its
carbohydrate structure and peptide sequence.
The secretion of ABP by Sertoli cells in vitro is stimulated by FSH,
cAMP and testosterone (Fritz et al., 1976, Rommerts et al., 1978). In the rat
approximately 80% of ABP is secreted into the tubule lumen, the
remaining 20% is found in interstitial fluid (Mather et al., 1983).
However, it has been demonstrated that under conditions of impaired
spermatogenesis, for example following testosterone withdrawal
consequent to Leydig cell destruction or induction of unilateral
cryptorchidism, the pattern of ABP secretion changes. In such situations,
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although the rate of production and the total testicular content of ABP
decrease, the amount of ABP secreted into interstitial fluid increases by as
much as 200% (Sharpe & Bartlett, 1987 and Sharpe, 1988 for review). The
physiological significance of such changes is unclear.
The secretion of ABP is stage-dependent. Ritzen et al. (1982)
cultured stage dissected tubules from adult rats and found that ABP
secretion into the culture medium was highest between stages VIII-XI and
lowest between stages II-V. This coincides with the distribution of ABP
mRNA measured in stage-synchronised rats (Parvinen, 1992 for review).
Gerard et al. (1991), demonstrated that ABP and TeBG are
endocytosed by germ cells, suggesting that steroid binding proteins may
act as transmembrane steroid carriers during spermatogenesis.
Inhibin and Activin Inhibin can selectively suppress FSH synthesis
and release from gonadotrophs in the anterior pituitary. Its production by
Sertoli cells was demonstrated by Steinberger & Steinberger (1976). Co-
culture of anterior pituitary cells and immature Sertoli cells, or the
addition of Sertoli cell conditioned medium to cultured anterior pituitary
cells resulted in a significant decrease in the levels of FSH in the culture
medium.
Inhibin exists as a heterodimer of a and P (either Pa or Pb)
subunits, linked by disulphide bridges. Thus two forms of inhibin are
recognised on the basis of the form of the P subunit which they contain,
namely inhibin-A and inhibin-B. Activin exists as a homodimer of
inhibin P subunits, activin A (PaPa) and activin AB (PaPb) forms are
recognised (see Ying, 1988, de Kretser & Robertson, 1989 for review). The
mRNA for the a, Pa and Pb subunits of inhibin has been localised to
Sertoli cells (Toebosch et al., 1988). In Sertoli cells the production of
inhibin is stimulated by the actions of FSH, cAMP analogues and
phosphodiesterase inhibitors, suggesting that FSH stimulates inhibin
production via a cAMP-dependent mechanism (de Kretser & Robertson,
1989).
The expression of inhibin a and Pb subunit mRNA is cyclical. The
highest expression occurs in stages XIII-I, and the lowest level of
expression is seen in stages VII-VIII. The secretion of immunoreactive
inhibin follows the same pattern (for review see Parvinen, 1992). By using
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flow cytometry to selectively analyse specific populations of rat
spermatocytes in culture, Woodruff et al. (1992) demonstrated that
inhibin-A binds to several subpopulations of germ cells. The implication
is that spermatogonia, spermatocytes and early spermatids have specific
receptors through which inhibin-A can exert direct effects. In fact, inhibin
has been postulated to have a role in regulating spermatogonial numbers
(van-Dissel-Emiliani et al., 1989). Inhibin purified from rat Sertoli cell
conditioned medium was found to decrease the numbers of
differentiating spermatogonia in adult mice testes, with spermatogonia in
stages I-VI being most sensitive to the effects of inhibin.
Activin stimulates the secretion of FSH by pituitary cells in vitro
(Ying, 1988). Activin may also have a role in mediating Sertoli cell-Leydig
cell interactions. Lin et al. (1989) demonstrated an inhibitory effect of
activin on hCG-stimulated cAMP and testosterone formation in cultured
adult rat Leydig cells. Using cultures of immature porcine Leydig cells,
Mauduit et al. (1991) found that activin A inhibited hCG-stimulated
dehydroepiandrosterone accumulation, possibly via partial inhibition of
P450scC.
Transferrin Transferrin is a single glycoprotein with an Mr of 76.5kDa. It
probably functions as an iron transport protein. Sertoli cells in vitro
secrete transferrin (Skinner & Griswold, 1980). Measurement by
radioimmunoassay has shown that transferrin levels in STF and rete
testis fluid are much lower than the levels found in serum and lymph,
suggesting that Sertoli cell transferrin is secreted basally (Sylvester &
Griswold, 1984), although transferrin is also produced by the liver and
secreted into blood and lymph, and the study failed to distinguish
between liver and Sertoli cell forms. In the same study, indirect
immunofluoresence techniques were used to localise transferrin to the
interstitium and also to the developing acrosome and nuclear cap of
early spermatids. Early spermatids are able to bind and internalise
transferrin by a receptor-mediated endocytotic process (Segretain et al.,
1992). Sertoli cell transferrin may thus serve as an intermediate in the
transport of iron from serum transferrin to germ cells in the adluminal
compartment of the seminiferous epithelium. In this context, it has been
demonstrated that the addition of pachytene spermatocyte conditioned
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medium to cultured Sertoli cells stimulates transferrin secretion (Djakiew
& Dym, 1988).
Quantification of silver grains in in situ hybridisation studies
demonstrated that while a transferrin RNA probe bound exclusively to
Sertoli cell sequences, the levels of mRNA were highest in stages XIII-XIV
and fell at stage VIII to a low at stage IX (Morales et al., 1987). This
coincides with the study by Wright et al. (1983) who showed that
transferrin secretion was maximal at stages XIII-XIV and lowest at stages
VII-VIII. The expression of transferrin mRNA by Sertoli cells in vitro is
hormonally regulated, being stimulated by FSH in combination with
insulin, retinol and testosterone. FSH alone had minimal effects on
mRNA levels (Huggenvik et al., 1987).
Sulphated-Glycoprotein-2 (SGP-2) SGP-2 consists of two subunits of
37 and 47kDa, linked by disulphide bonds (Collard & Griswold, 1987).
Localisation by in situ hybridisation has shown that Sertoli cells are the
only testicular cells which express SGP-2 mRNA (Morales et al., 1987).
Immunofluoresence techniques have localised secreted SGP-2 to the
acrosome and distal tail portion of mature spermatozoa (Sylvester et al.,
1984).
The function of SGP-2 in the testis is unclear, it may be involved in
lipid transport/metabolism on the sperm surface membrane (Sylvester et
al., 1991). Alternatively, SGP-2 has been shown to be similar to a serum
protein which is a potent inhibitor of terminal complement complexes.
The complement system consists of over 20 plasma proteins that together
form a macromolecular protein complex that causes lysis of cell
membranes on target cells such as bacteria and viruses. The localisation of
SGP-2 on the surface of sperm, and its function as a complement inhibitor
has lead to a proposed role for SGP-2 in preventing the complement
mediated immobilisation of sperm cells in the female reproductive tract
(Jenne & Tschopp, 1989).
In support of this hypothesis, the highest levels of
immunoreactive SGP-2 are found at stages VII-VIII, before spermiation,
and the lowest levels are found immediately after spermiation at stages
XIII-I (Kangasniemi et al., 1992). However, 2D-SDS PAGE analysis of
radiolabeled proteins secreted by seminiferous tubules in vitro, does not
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show any differences in the amounts of SGP-2 secreted by seminiferous
tubules grouped in stages II-V, VI-VIII or IX-I (McKinnell & Sharpe, 1992).
2.4. Paracrine control of the testis
2.4.1. Morphological evidence for local regulation of testicular function
The mammalian testis is divided into tubular and interstitial
compartments, with the tubular compartment being further divided into
basal and adluminal sections. Spermatogenesis takes place in the tubular
compartment and is a highly organised and complex process, throughout
which there is an intimate association between Sertoli cells and all
generations of developing germ cells.
The complexity of the spermatogenic process together with the
structural arrangement of the testis points to an active interaction
between different testicular cells. The regulation of testicular function is
predominantly controlled by the action of pituitary gonadotrophins;
hypophysectomy leads to testicular regression and malfunction. These
effects are due to the absence of the hormone with the greatest influence
on spermatogenesis, testosterone. Morphologically, gonadotrophin
deprivation (for example due to hypophysectomy or the use of antisera to
LH and FSH) is characterised by a marked increase in the rate of
degeneration of mid-pachytene primary spermatocytes and step 7 and 19
spermatids, all of which are characteristically present in stage VII. These
changes could be prevented by the administration of LH but not FSH. The
same effects were caused by agents which blocked the action of androgens
on Sertoli cells. Together such experiments indicate a special requirement
for testosterone at stage VII (for review see Sharpe, 1983, 1992).
The first evidence indicating a role for local, cell to cell interactions
in regulating testicular function also came from morphological studies. In
1978, Aoki & Fawcett implanted silastic capsules containing cyproterone
acetate into one or both rat testes. The implants caused focal tubular
involution, such that the tubules in the vicinity of the implants
contained only Sertoli cells, being completely devoid of germ cells other
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than spermatogonia. However, these effects were only apparent in
tubules within a few millimetres radius of the implant. The remaining
seminiferous tubules were unaffected. A further effect was the dramatic
hypertrophy of interstitial tissue immediately adjacent to the affected
tubules. In particular there was a large increase in the SER content of
affected Leydig cells. Ewing & Zirkin (1983) showed that SER volume was
directly related to steroidogenic output. Leydig cells adjacent to
undamaged tubules were themselves unchanged. The authors concluded
that the changes in volume and ultrastructure of Leydig cells could not be
caused by an imbalance in feedback to the hypothalamo-pituitary axis, as
any consequent elevation in serum gonadotrophins would cause a
general stimulatory response in all of the Leydig cells, and not a specific
local response in the area of the damaged seminiferous tubules. Thus, it
was speculated that a diffusable product of the seminiferous epithelium
may normally act on Leydig cells to modulate their sensitivity to LH, and
damage to the tubules interfered with the production of this factor.
Conversely, tubular damage might cause the release of a substance that
has a direct stimulatory effect on Leydig cells.
Further evidence of direct interactions between seminiferous
tubules and Leydig cells came from Risbridger et al. (1981). In the
experimentally cryptorchid adult rat, Leydig cells show hypertrophy and
hyper-responsiveness to hCG when cultured in vitro. A loss in 125I-hCG
binding is also seen in vitro. Experiments with unilaterally cryptorchid
rats have shown that these changes cannot be due to elevations in serum
LH levels. Leydig cells in the scrotal testis did not show the changes seen
in Leydig cells in the abdominal testis despite being exposed to the same
elevated levels of LH. Hence the changes in the abdominal testis must
have been due to the actions of local factors.
Short term exposure of the testis to heat is accompanied by damage
to the seminiferous epithelium (Chowdhury & Steinberger, 1964). Heat
treatment also disrupts Sertoli cell function (assessed by decreasing ABP
and STF production in vitro). The authors found that Sertoli cell function
was not altered until between 2 and 4 weeks after exposure to heat. Thus,
the impairment of Sertoli cell function is not a direct result of heating the
Sertoli cell but was secondary to the immediate effects of heat on germ
cell function. Restoration of spermatogenesis restored the measured
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Sertoli cell parameters to normal. Leydig cell function was also altered,
with Leydig cells becoming hypertrophic and showing increased
responsiveness to hCG in vitro. Again, the changes in Leydig cell
function were separated in time from the actual thermal stress. The
alterations in Leydig cell function were therefore not due to the heat but
may have resulted from specific germ cell changes either directly, or
secondary to the disruption of Sertoli cells. Normal Leydig cell function
was also restored as spermatogenesis recovered (Jegou et ah, 1984). In the
course of this study serum LH and testosterone levels were not
significantly altered at any stage.
These studies demonstrate that changes in testicular function occur
independently of gonadotrophin action and thus support the hypothesis
that cell to cell interactions have a vital role to play in supporting
spermatogenesis.
2.4.2. Interactions between Sertoli cells and Leydig cells
Morphological evidence of a relationship between Sertoli cells and Leydig
cells was provided by Bergh (1983, 1985), who demonstrated that the cell
profile area of peritubular Leydig cells was dependent on the stage of the
tubules the Leydig cells were closest to. Leydig cells were heterogeneous
with respect to cell size, with the largest cells surrounding stage VII-VIII
tubules and the smallest around tubules at stages IX-XIV. The probability
that all these Leydig cells were exposed to equivalent amounts of LH,
suggests that Leydig cell size is controlled at least partly via the
seminiferous tubules. In a similar study in rats and monkeys, Fouquet
(1987) found that in the rat, Leydig cells with the greatest intracellular
volume of SER were associated primarily with stage VII-VIII tubules.
However, in the monkey there was no relationship between either Leydig
cell size or SER volume and the stage of the seminiferous epithelium.
Evidence from in vitro studies does support the hypothesis that
Sertoli cells can modulate Leydig cell function. Co-cultures of Leydig cells
with Sertoli cells, or the addition of Sertoli cell conditioned medium
(SCCM) to Leydig cells in vitro stimulates steroid production. For
example, Verhoeven & Cailleau (1985, 1986) demonstrated that SCCM
prepared from cultures of immature Sertoli cells was able to stimulate
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steroidogenesis in immature Leydig cells. Similar effects of SCCM have
also been demonstrated with cells isolated from adult rats (Papadopoulos
et al., 1987b). Conditioned medium prepared from cultures of human
Sertoli cells is able to stimulate testosterone production by isolated
human Leydig cells (Papadopoulos, 1991). Leydig cell steroidogenesis is
also stimulated by co-culture with Sertoli cells (Verhoeven & Cailleau,
1990). If a factor is secreted by Sertoli cells in order to influence Leydig cell
function, it must travel through interstitial fluid (IF), and it has been
shown that the addition of IF to cultured rat Leydig cells results in
stimulation of testosterone production (Sharpe & Cooper, 1984).
Many studies have examined the effects of staged seminiferous
tubule segments on Leydig cell function, either using co-culture or by
preparing seminiferous tubule conditioned medium (STCM). Results
from such studies have been highly variable. Co-culture of seminiferous
tubules at any stage with Leydig cells has been reported to enhance both
basal and hCG-stimulated testosterone production (Verhoeven &
Cailleau, 1986, Papadopoulos et al., 1987b), to have no effect on basal or
hCG-stimulated testosterone production (Parvinen et al., 1984), or to have
no effect on basal testosterone production but to inhibit hCG-stimulated
testosterone production (Syed et al., 1988). To confuse things further,
some authors have reported that only tubules at specific stages can affect
testosterone production. For example stage IX-I tubules have been
reported to have an inhibitory effect (Vihko & Huhtaniemi, 1989). In
contrast, Syed et al. (1985) reported that stages VIII-XI and XIII-I stimulated
basal and hCG-stimulated testosterone production. In one experiment,
STCM prepared from human seminiferous tubules was found to
stimulate basal and hCG-stimulated testosterone production by human
Leydig cells (Verhoeven & Cailleau, 1987). One of the aims of this thesis
was to clarify how the addition of conditioned medium or the presence of
seminiferous tubules in the culture dish could affect Leydig cell
testosterone production.
Attempts have been made to purify the Sertoli cell factor(s) that
stimulates steroidogenesis. The active stimulatory principle in both
human and rat STCM has an Mr of 10-30kDa (Verhoeven & Cailleau,
1986, 1987). It appears that seminiferous tubules may secrete several
factors which affect Leydig cell function, as Syed et al. (1988) measured an
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inhibitory activity in STSM with an Mr of 40-50kDa. Human Sertoli cells
secrete a stimulatory factor with an Mr of 79kDa, which has been shown
to be different from transferrin, albumin and testibumin (Papadopoulos,
1991). The stimulatory action of IF on steroidogenesis is thought to be
mediated via a 57-75kDa glycoprotein (Jansz et ah, 1990).
There is no direct information on the nature of the communicators
between Sertoli cells and Leydig cells, though there are several factors
which have been shown to affect Leydig cell function in vitro, and for
which there is some evidence of Sertoli cell production, for example,
GnRH and AVP.
Sertoli cells in vitro produce a GnRH-like activity ('testicular
GnRH'), which can also be detected in IF (Nagendranath et al., 1983,
Sharpe et al., 1981). In the testis only Leydig cells have GnRH-receptors
(Bourne et al., 1980), and the addition of GnRH or its agonists to isolated
Leydig cells has, in the short term, stimulatory effects on basal
testosterone production both in vivo (Sharpe et al., 1983) and in vitro
(Sharpe & Cooper, 1982). However, the physiological role of testicular
GnRH has not been established beyond doubt as the stimulatory effect of
co-culture of seminiferous tubules on Leydig cell steroidogenesis was not
affected by the presence of GnRH antagonists (Parvinen et al., 1984).
Attempts to purify testicular GnRH have shown that it is different from
hypothalamic GnRH and that more than one form may exist (Bhasin et
al., 1983). To date testicular GnRH has not been isolated. There is some
controversy about the direct role of GnRH in the human testis due to
conflicting reports about the presence (Popkin et al., 1985) and the absence
(Clayton & Huhtaniemi, 1982) of GnRH receptors.
Another peptide which may have a role as a Sertoli cell-Leydig cell
communicator is AVP. An AVP-like substance is present in rat testicular
extracts (Kasson et al., 1985) and in IF (Pomerantz et al., 1988). AVP
receptors have been localised to rat Leydig cells (Meidan & Hsueh, 1985)
and addition of AVP to cultured rat Leydig cells has short-term
stimulatory effects (Sharpe & Cooper, 1987). However, the physiological
role of AVP in the testis is questioned by data showing an extremely low
level of expression of AVP mRNA in the rat testis (Ivell, 1992).
Despite the knowledge that testosterone is vital for
spermatogenesis, the means by which testosterone and other Leydig cell
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products affect Sertoli cell function remain unknown. The only known
effects of testosterone on Sertoli cells is to stimulate ABP and transferrin
secretion, neither of which are directly involved in spermatogenesis (see
Saez et al.,1987 for review). Recently, Sharpe et al. (1992) have used the
EDS model to deplete rat testes of Leydig cells and used 2-dimensional
SDS-PAGE to examine radiolabeled proteins secreted by Leydig cell-
depleted rats either with or without exogenous testosterone. In this way
seven androgen regulated proteins were identified. Using stage-dissected
seminiferous tubules the study demonstrated that the effects of
testosterone on protein secretion were restricted to the stage VI-VIII
grouping.
2.4.3. Interactions between peritubular myoid cells and other testicular
cells
Peritubular cells are found in the basement membrane of seminiferous
tubules and consist of one or more layers of contractile myoid cells in
association with undifferentiated mesenchymal cells. Sertoli cells and
peritubular cells are often found in direct contact (Schulze, 1984). Sertoli
cells and peritubular cells are thought to produce separate components of
the basement membrane (Skinner et al., 1985) and co-culture of Sertoli
cells with peritubular cells increases the attachment and viability of
Sertoli cells (Tung & Fritz, 1980). The presence of peritubular cells also
stimulated the production of ABP by Sertoli cells and it was postulated
that peritubular cells might influence Sertoli cell functions (Tung & Fritz,
1980). A factor designated P-Mod-S was purified from conditioned
medium from peritubular cell cultures. P-Mod-S stimulates Sertoli cell
protein production and secretion, including ABP and transferrin, which
are widely used as markers of Sertoli cell function (Skinner et al., 1988). P-
Mod-S also stimulates the production of inhibin by Sertoli cells (Skinner
et al., 1989). Isolated peritubular cells respond to androgens, and the
production of P-Mod-S is believed to be controlled by androgens (Skinner
& Fritz, 1985). Thus, Leydig cells produce testosterone in response to LH,
and testosterone stimulates the production of P-Mod-S which then
modulates Sertoli cell functions (see Skinner, 1991 for review). P-Mod-S
does not appear to be involved in bidirectional communication by also
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mediating Sertoli cell effects on Leydig cells, as Risbridger & Skinner
(1992) have shown that P-Mod-S and other peritubular cell proteins do
not affect steroidogenesis by cultured Leydig cells.
2.4.4. Interactions between Sertoli cells and germ cells
The cyclicity of Sertoli cell morphology and function, in an environment
where each Sertoli cell is believed to be exposed to equal levels of
gonadotrophins, strongly implies that Sertoli cell function is modulated
by germ cells. Sertoli cell nuclear morphology and cellular lipid content
vary cyclically (see Sharpe, 1983 for review). As has been discussed
previously, the testosterone requirement of Sertoli cells varies in a
cyclical manner, as do the number of FSH receptors. The maximum
expression of FSH receptors is found at stage I, and the minimum at
stages VI-VIII. These changes are reflected by simultaneous changes in the
amounts of cAMP produced in response to FSH (see Parvinen, 1992 for
review). Other cyclical changes in Sertoli cell activity can be related to
specific events of the spermatogenic cycle. Sertoli cells secrete a protease
plasminogen activator (PA; Lacroix et al., 1977) in a cyclical manner, with
maximum secretion at stages VII-VIII (Vihko et al., 1984). It is at these
stages that spermiation and translocation of preleptotene spermatocytes to
the adluminal compartment occur. Ingestion of residual bodies,
spermiation and translocation all require restructuring and modification
of Sertoli cell cytoplasm, and for these reasons the secretion of PA is
thought to be maximal at these stages (Sharpe, 1986).
Direct evidence for Sertoli cell-germ cell interactions comes from
studies examining the functions of Sertoli cells in vitro following
experimental alteration of the germ cell population in vivo. Germ cells
can be depleted from the testis by X-irradiation, cryptorchidism, local
heating or by administration of the germ cell specific toxin, methoxyacetic
acid (MAA). Further evidence has come from coculturing Sertoli cells
with specific types of germ cells. For example the addition of enriched
preparations of pachytene spermatocytes or round spermatids to cultures
of immature rat Sertoli cells modulates the secretion of oestradiol (Jegou
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et al, 1988), transferrin (Le Magueresse et al., 1988) and ABP (Galdieri et
al, 1984).
Djakiew & Dym (1988) investigated the feedback between germ cells
and Sertoli cells using a bicameral culture chamber which allows Sertoli
cells to form confluent epithelial sheets between which Sertoli cell tight
junctions form. Immature rat Sertoli cells were shown to secrete the
majority of their proteins into the apical rather than the basal medium.
Pachytene spermatocytes were isolated from adult rats and conditioned
medium collected. The addition of pachytene spermatocyte conditioned
medium to the apical surface of cultured Sertoli cells resulted in an
increase in overall protein secretion by Sertoli cells. In addition at least
two proteins were secreted by Sertoli cells in response to pachytene
spermatocyte conditioned medium that were not observed in control
Sertoli cell cultures. Thus it appears that pachytene spermatocytes are able
to alter the composition of the surrounding milieu by modifying Sertoli
cell protein secretion.
In a similar experiment, conditioned medium collected from
round spermatids isolated from adult rats was lyophilised to prepare a
concentrate of round spermatid proteins. The addition of round
spermatid proteins to immature Sertoli cells cultured in bicameral
chambers stimulated Sertoli cell protein secretion. Round spermatid
proteins affected the polarity of Sertoli cell protein secretion, by
stimulating apical more than basal secretion (Onoda & Djakiew, 1990).
Pachytene spermatocytes and round spermatids may affect Sertoli
cell protein secretion by increasing gene expression. Coculturing
immature Sertoli cells with either pachytene spermatocytes or round
spermatids increases the expression of the PPenk gene, which is an opioid
precursor gene found in Sertoli cells (Fujisawa et al., 1992).
An important drawback of the in vitro approach is that isolated
Sertoli cells are prepared from immature rats and are cocultured with
germ cells prepared from adult rats. Immature Sertoli cells in vivo have
only been exposed to pachytene spermatocytes and it may be that various
functions of Sertoli cells are controlled by the most mature germ cells
present in accordance with the progressive maturational changes in
Sertoli cell function (Allenby et al., 1991, Jegou, 1991, Sharpe, 1992). A
technique has been developed to circumvent this problem; the glycol
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ether methoxyacetic acid (MAA) is a germ cell specific toxin which
depletes the testis of pachytene spermatocytes without inducing any other
adverse effects (Creasy et al., 1985). The occurrence of maturation
depletion allows the generation of testes with successive but selected
populations of germ cells missing.
This technique was used by Bartlett et al. (1988) to demonstrate that
the absence of pachytene spermatocytes or elongate spermatids, but not of
round spermatids, could increase the levels of serum FSH and ABP.
These changes were found to be independent of changes in the levels of
serum FSH and the levels of testosterone measured in serum or IF.
Hence, in vivo studies also suggest that Sertoli cell function is modified
by germ cells. More specifically, germ cell depletion in vivo using MAA
has demonstrated that seminiferous tubule lumen diameter may be
regulated by elongate spermatids. The diameter of the lumen and the area
of the seminiferous epithelium vary cyclically. Lumen size is maximal at
stages VII and VIII and minimal immediately after spermiation at stage IX
(Wing & Christensen, 1982). In the absence of elongate spermatids the
increase in lumen size normally seen at stage VII fails to occur. The
absence of no other germ cell type had this effect (Sharpe, 1989b).
The volume of IF is believed to be controlled by Sertoli cells
(Maddocks & Sharpe, 1989b). Maturation depletion of germ cells using
MAA has shown that only the absence of late spermatids can affect the
volume of IF. In the absence of elongate spermatids IF volume increased,
again suggesting a role for germ cells in modifying Sertoli cell function.
The absence of elongate spermatids is also closely associated with a
marked decrease in the secretion of immunoactive Sertoli cell inhibin in
vitro and decreased plasma levels in vivo, a change associated with
increased levels of serum FSH (Allenby et al., 1991).
Three potential routes by which late spermatids might influence
Sertoli cell function are outlined by Jegou et al. (1992). Firstly, alterations
in the type of adhesive contact between late spermatids and Sertoli cells
may influence signalling between the two cells. Secondly, there may be a
direct cytoskeletal link between the late spermatid-Sertoli cell interface
and the nuclear transcription machinery so that externally imposed
changes in shape might directly influence Sertoli cell gene transcription.
Finally, when Sertoli cells phagocytes spermatid residual bodies they are
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ingesting as much as 70% of the total spermatid cytoplasm. It has been
proposed that residual bodies may regulate Sertoli cell function via
mRNA coding for a factor(s) which controls Sertoli cell gene expression
or more simply that phagocytosis triggers the production of a factor which
regulates Sertoli cell and/or germ cell function.
As Sertoli cells support germ cells through all their developmental
stages they obviously have a great influence over germ cell function. For
example, spermatocytes and spermatids require lactate to support
metabolism but are unable to convert glucose and thus depend on Sertoli
cells to meet their energy requirements (Jutte et al., 1982). In addition,
Sertoli cells produce a mitogenic substance named seminiferous growth
factor (SGF) which is believed to have a role in promoting the
proliferation of spermatogonia (see Bellve & Feig, 1984 for review).
2.4.5. Germ cell-Sertoli cell-Leydig cell Interactions
In many situations when damage to the germ cell complement of the
seminiferous epithelium affects Sertoli cell functions, changes in Leydig
cell function are also apparent. As discussed above, Aoki & Fawcett (1978)
demonstrated that damage to germ cells in the seminiferous epithelium
was associated with Leydig cell hypertrophy. When germ cells are
adversely affected by local heating, Sertoli cell function is disrupted
secondary to the initial effect of the heat. The changes in Sertoli cell
behaviour are associated with disrupted Leydig cell function and normal
Leydig cell function is restored in concert with the recovery of the
germinal epithelium (Jegou et al., 1984).
Rat IF contains a factor which stimulates testosterone secretion by
isolated Leydig cells. However, IF collected from germ cell-depleted
cryptorchid testes has a higher stimulatory effect than control IF (Sharpe
& Cooper, 1984). Similarly, Papadopoulos et al. (1987b) demonstrated that
seminiferous tubule conditioned medium collected from irradiated rats
(missing -95% of their germ cells) had a higher stimulatory effect on
isolated rat Leydig cells than medium collected from control cultures.
Studies such as these suggest a cellular interaction that extends
from germ cells to Sertoli cells to Leydig cells, yet do not eliminate the
possibility that changes in Leydig cell function are related simply to
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disrupted Sertoli cell function. A direct effect of germ cells on Leydig cells
via an effect on Sertoli cells has been demonstrated in vitro. Onoda et al.
(1991) showed that immature rat Sertoli cells cultured in bicameral
chambers secrete a factor which stimulates steroidogenesis in cultured rat
Leydig cells and 80% of this bioactivity is secreted in a basal direction. The
addition of pachytene spermatocyte proteins to the apical compartment of
the bicameral chamber inhibited the basally directed Sertoli cell secretion
of the Leydig cell stimulatory factor. Co-culture of pachytene
spermatocytes and Sertoli cells resulted in a similar inhibition of
production of the Leydig cell stimulatory factor. Addition of round
spermatid proteins or co-culture of round spermatids and Sertoli cells did
not inhibit the production of this factor to any great extent. Thus, the
Sertoli cell secretion of a protein(s) which stimulates Leydig cell
steroidogenesis is specifically modified by pachytene spermatocytes.
Total protein secretion by cultured rat seminiferous tubules has
been assessed by 2D-SDS PAGE (Sharpe et al., 1992). The production of
seven proteins was found to be androgen-dependent. The influence of
germ cells on Sertoli cell protein secretion has been examined using
MAA to deplete specific germ cell types in vivo and looking for changes
in the proteins secreted by seminiferous tubules in vitro. This technique
has been used to demonstrate how germ cells can affect seminiferous
tubule function, but surprisingly it was also found that the secretion of
the androgen-dependent proteins was dependent on a normal
complement of germ cells (McKinnell & Sharpe, 1992). Thus testicular
function appears to be regulated by a complex, but highly organised
cascade of cell-cell interactions which operates in both directions across
the interstitium and seminiferous epithelium.
2.5. Aims of this thesis
This review has discussed the organisation and regulation of testicular
function. In particular it has shown how the structured anatomy of the
mammalian testis and the complexity of spermatogenesis suggest the
need for local regulation, mediated by factors other than pituitary
gonadotrophins. This review has tried to emphasise that the little known
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about the regulation of testicular function has been determined in species
other than man. Consequently there is a sparsity of information about
human testicular function and many of the discoveries made in other
species still need to be related to man.
The aims of this thesis were two-fold and centred on the use of
human Leydig cells in vitro and the use of ex vivo techniques in the rat
to clarify the cascade of regulatory interactions between germ cells, Sertoli
cells and Leydig cells. To achieve these aims, a morphological
examination of the relationships between Leydig cells and other cells in
the human testis was made (chapter 4). The ability of human Leydig cells
to function in vitro was determined (chapter 5), and the action on human
Leydig cells, of factors believed to mediate communication between
Sertoli cells and Leydig cells in the rat, was investigated in chapter 6.
Toxicants known to affect the function of rat Leydig cells were tested for
their ability to disrupt human Leydig cell function (chapter 10).
Cell interactions in the rat testis were assessed by depleting specific
germ cell types in vivo and determining the effects on Leydig cell
functions such as testosterone (chapter 7) and protein (chapter 8)
production in vitro. Further assessment of these interactions was
achieved by coculturing Leydig cells and seminiferous tubules or by
adding seminiferous tubule conditioned medium to Leydig cells (chapter
9).
3. General Materials and Methods
This chapter describes techniques common to a number of studies in the




All animals used in these studies were male Wistar rats bred in the MRC
Reproductive Biology Unit in Edinburgh. Rats were housed under a
conventional 12h light : 12h dark cycle at 21 °C with food and water
available ad libitum. Animals were killed by asphyxiation with 100%
CO2 followed by cervical dislocation.
3.1.2. Patients
Testicular tissue was collected from 29 men, aged 54-89 years (mean ±
S.D.= 72.9±9.5), who were undergoing orchidectomy as the primary
treatment for prostatic carcinoma. No patient had any endocrine disease
or any chronic systemic illness known to affect Leydig cell function.
3.2. Solutions for Tissue Dispersion and Cell Culture
3.2.1. Preparation of media
Incubation medium 1 (rat). Incubations of rat testes were in medium
199 containing Hank's salts and 20mM HEPES buffer (M199H; Flow Labs,
Irvine, Scotland) supplemented with 0.5mg/ml collagenase (143
units/mg, Worthington Biochemical Corporation, Cambridge Bioscience,
Cambridge) ,0.1% trypsin inhibitor (Sigma Chemical Co., Poole, Dorset)
and 1.5mg/ml Bovine Serum Albumin (BSA; Fraction V, Sigma).
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Incubation medium 2 (human). Incubations of human testes were in
M199H supplemented with 0.75mg/ml collagenase, 0.1% trypsin inhibitor
and 2.5mg/ml BSA.
Dispersion medium. Cells were washed and harvested in M199H
containing 0.5mg/ml BSA.
Culture medium. Cells were incubated for periods of either 4 or
20 hours in medium 199 containing Earle's salts ( M199E; Flow Labs,
Irvine, Scotland), 0.5mg/ml BSA, 2mM L-glutamine (Gibco Ltd., Paisley,
Scotland), 100 IU/ml penicillin (Gibco) and 100|ig/ml streptomycin
(Gibco).
3.2.2. Formation of discontinuous Percoll gradients
Percoll (Pharmacia Ltd. U.K.) contains colloidal silica coated with
polyvinylpyrrolidone to reduce toxicity. It's low osmolality (20
mOsmoles/kg H2O) means that before use it must be rendered isotonic.
To achieve this, stock Percoll was mixed with 10 times normal strength
M199H. This gives a solution, termed isotonic Percoll, with a density of
1.12 g/ml. This was then diluted further with M199H to form the
constitutive layers of a discontinuous gradient. These were comprised of
5 distinct bands with densities of 1.0, 1.03, 1.05, 1.07, and 1.09 g/ml. The
relative proportions of isotonic Percoll and M199H needed to form layers
of these densities are shown in Table 3.1. Gradients were formed by
layering the bands by hand using a 0.5x90mm spinal needle (Becton
Dickinson, Oxford) and beginning with the 1.09mg/ml layer. Gradients
were stored overnight at 4°C but were allowed to reach room temperature
before use.
3.3. Preparation of Leydig cells
3.3.1. Preparation of rat Leydig cells
Leydig cells were isolated from the testes of 4 rats aged 70-120 days. Testes
were removed via an incision in the scrotal sac, cut free from the
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epididymides and during collection were kept in M199H pre-warmed to
37°C. The testes were then decapsulated and placed in pairs into 7mls
incubation medium 1 in four 25ml universal containers (Mackay and
Lynn, Edinburgh). The tissue was incubated in a shaking water bath at 70
cycles/min for 40-50 min at 37°C . The universals were arranged so that
the shaking motion was longitudinal. The contents of each universal
were diluted with dispersion medium, and the universal was swirled
forty times. Tissue and tubule fragments were allowed to settle and the
cell suspension was collected in a 25ml syringe and filtered through a 2.5
inch Swinnex filter (Millipore, Hertfordshire), containing 60|im gauze to
remove undispersed tissue and tubule fragments. This step was repeated
but with a gentler mixing action. The filtrate was centrifuged (Minifuge
T, Heraeus Christ, Germany) at 160g for 10 min at room temperature, and
the sedimented cells resuspended in a total of approximately 10ml of
dispersion medium to give a crude interstitial cell suspension.
3.3.2. Percoll purification of rat Leydig cells
The crude cell suspension was loaded onto 2 Percoll gradients in 5ml
batches and centrifuged at 500# for 24 min at room temperature. The band
that contains Leydig cells is located between the layers with a density of
1.07 and 1.09g (Simpson et al. 1987), (see Figure.3.1.). The cells were
aspirated using a plastic Pasteur pipette (Becton Dickinson, Oxford),
washed in dispersion medium and harvested by centrifugation at 20Og for
10 min at room temperature. Sedimented cells were resuspended in
lOmls dispersion medium, counted with a Neuberg haemocytometer and
diluted to 250,000 cells/ml in culture medium. Cells were plated at a
density of 50,000 cells/well in a total volume of 200gl in 48-well tissue
culture plates (Co-star, Nucleopore U.K. Ltd., Buckinghamshire). Plates
were incubated at 32°C in a humidified atmosphere of 95% air/5% CO2
for an initial period of 2 hours Cpre-incubation'), after which time the
medium was removed and fresh medium and treatment solutions were
added to a total volume of 300pl. Medium was aspirated using a pipette at
4 and at 20h and stored at -20°C until analysed.
Chapter Three General Methods 51
Table 3.1. Formation of discontinuous Percoll gradients.
Volumes of isotonic Percoll and M199H required for the preparation of
fractions of increasing density used in the formation of discontinuous
Percoll gradients.
Table 3.1. Formation of Discontinuous Percoll Gradients.
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Figure 3.1. Schematic representation of the pattern of
fractionation of rat and human testicular cells on discontinuous
Percoll gradients.
Successive layers of Percoll with densities of 1.09, 1.07, 1.05, 1.03 and
l.OOg/ml were used. The layers within which rat and human Leydig cells
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3.3.3. Preparation of human Leydig cells
Human Leydig cells were prepared for culture using adaptations of the
method described above for the rat.
Testicular tissue was placed on ice immediately after excision and taken
from the Western General Hospital to the Reproductive Biology Unit as
quickly as possible (30-60 min after removal).
After weighing, the human testes were cut into approximately 10mm3
pieces and 8-10mgs of tissue placed in a 25ml universal containing 7mls
of incubation medium 2. Dispersion occurred during an incubation for
45-60 min. Several blocks of tissue were processed for histological
purposes and further blocks were processed so that the tissue would be
suitable for immunocytochemistry (see below).
Cell suspensions were treated as above until the Leydig cells were
harvested. Human Leydig cells concentrate in 2 layers on discontinuous
Percoll gradients, namely at the 1.07/1.09g interface and at the 1.05/1.07g
interface. (Simpson et al. , 1987), (see Figure. 3.1.). Both layers were
aspirated and resuspended in a maximum volume of 5mls of culture
medium. The cell plating regime was as described in section 3.3.2.
3.3.4. Assessment of cell viability
The viability of Leydig cell preparations was determined by measuring
intracellular levels of adenosine triphosphate (ATP). This was done using
the 1243-102 ATP monitoring kit from Bio-orbit, Berkshire. The assay is
based on the quantitative measurement of light. Firefly luciferase is used
to catalyse a reaction between ATP, luciferin and oxygen which results in
the production of oxyluciferin, adenosine monophosphate and light. To
measure ATP at the end of a culture period cells were washed with 0.1M
Tris-acetate, 2mM EDTA buffer, pH 7.75 (assay buffer) and transferred
from the bottom of the plates into fresh assay buffer using a rubber
policeman. Concentrations of 50,000 cells in 100|il assay buffer were then
sonicated for 30-60 seconds using an MSE Soniprep 150, (MSE
instruments Ltd., U.K.). Samples were diluted in 200|il monitoring
reagent and 600gl assay buffer, and this solution was diluted a further 1: 4
in assay buffer, before measurement of luminescence in a luminometer.
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In order to calibrate the assay system a known concentration of ATP
standard was then added to each sample and a second luminescence
reading taken.
Typical ATP levels were between 200-600 pmoles/106 cells. No drug
treatment used caused ATP levels to fall below 75% of the control value
in that experiment.
3.3.5. Characterisation of Leydig cells
Leydig cells were identified histochemically by staining for 36-
hydroxysteroid dehydrogenase (36-HSD). Aliquots of 250,000 cells/ml
from each experiment were stored at -20°C until required. The staining
solution consisted of 0.7mls 1.6mg/ml nicotinamide (Sigma) in 0.1M
phosphate buffered saline (PBS), 0.8mls 3mg/ml NAD+ free salt (Sigma)
in PBS, O.lmls 2mg/ml 5-androstan-36-ol-17-one (Sigma) in dimethyl
formamide (BDH Ltd., Thornliebank, Glasgow), 1ml lmg/ml nitroblue
tetrazolium (NBT) (Sigma) in PBS and 4mls PBS. Defrosted aliquots of
Leydig cells were centrifuged onto glass slides using a cytospin (Shandon-
Elliott, U.K.). Samples were spun at 1000 rpm for 5 min. The slides were
then incubated in NBT solution at 37°C for at least 30 min. If required,
slides were fixed in 50% ethanol/10% formaldehyde for counting at a
later date. Preparations were counted with a haemocytometer. A
minimum of 5 fields of 100-150 cells were counted each time. Cells that
were colourless were scored as negative and dark blue/purple cells were
scored as Leydig cells. The percentage of Leydig cells in rat preparations
ranged from 76-88%, and in human preparations from 62-77%.
3.4. Measurement of Testosterone
3.4.1. Iodination of testosterone tracer
Testosterone-3-carboxymethyl oximino-histamine (T-CMO) was
iodinated by the Chloramine-T method (Hunter & Greenwood, 1962).
The T-CMO conjugate was stored at -40°C as a lpg/pl stock solution in
ethanol. 5|ig of the conjugate was dried down then redissolved in 40|il
0.5M phosphate buffered saline (PBS). 20pl Na 125j (2mCi, Amersham
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International, Aylesbury, Buckinghamshire) was added and the
iodination initiated by the addition of 10(il fresh chloramine-T (lmg/ml
in 0.05M PBS; BDH) solution . The mixture was vortexed and the reaction
allowed to proceed for 2 min before being terminated by the addition of
10(0.1 sodium metabisulphite solution (lmg/ml in 0.05M PBS; BDH).
3.4.2. Tracer purification
Unincorporated 125j/ labelled and unlabelled CMO-T were separated by
HPLC (LKB Pharmacia Ltd., U.K.) using a 40-100% gradient of acetonitrile
in 0.05% triflouroacetic acid (Aldrich, Poole, Dorset), at a pump speed of
0.4ml/minute. A Mini-Assay gamma counter (Type 6-20, Mini
Instruments, Essex) was used to count the fractions. Fractions forming the
peak of activity corresponding to 125i_cmO-T (see Figure 3.2.) were
pooled to obtain lOOpCi/ml in ethanol. This was stored at 4°C for up to 2
months.
3.4.3. Testosterone standards
Standards were prepared from a solution containing lmg testosterone in
100 ml ethanol. 500pl were diluted in 20ml ethanol to give a working
stock solution. 640pl of this solution were evaporated to dryness under
nitrogen vapour at 40°C and the residue reconstituted in 25ml PBS
containing 10% gelatin (PGBS, pH 7.4, plus 0.01% thiomersalate).This
gave a concentration of 640pg/100pl, which was the top standard.
Standards of 320, 160, 80, 40, 20, 10, 5 and 2.5 pg/100(il were prepared by
double dilution. All solutions were allowed to equilibrate at room
temperature overnight before use. Standards were stored at 4°C for a
maximum of 3 months. A representative testosterone standard curve is
shown in Figure 3.3.
3.4.4. Assay procedure
Testosterone concentrations in Leydig cell incubation media were assayed
in duplicate after appropriate dilution. lOOpl aliquots of standards,
samples and quality control media (high and low QCs) were incubated
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with 500|tl PGBS, 100|il testosterone antiserum (1: 350,000 dilution) and
lOOpl 125i_cmO-T (approximately 12,000cpm).Two standard curves were
included at the beginning and end of all assays. Standards and QCs were
assayed in triplicate. Also included were tubes containing either 700pl
PGBS (NSB) or 600(0.1 PGBS plus lOOjil testosterone antiserum (Bo). NSB
tubes were used to measure non-specific binding of the tracer to the assay
tubes, whilst the Bo tubes determined the maximal binding of the tracer
in the absence of testosterone. Tubes containing lOOpl tracer only were
used to determine the total amount of activity added to each tube (total
counts; TC). After vortexing, the tubes were incubated at room
temperature for 3 hours before the addition of 100pl normal sheep serum
(1: 1000 dilution; Scottish Antibody Production Unit) and lOOpl donkey
anti-goat second antibody (1:25 dilution; Scottish Antibody Production
Unit). After vortexing tubes were incubated at 4°C overnight.
Then, 1 ml wash buffer (0.9% saline plus 0.2% Triton X-100) was added to
all tubes (except TCs). The assay was then centrifuged at 4°C for 30 min at
2500 rpm. The supernatant was removed and the tubes allowed to drain.
The precipitate was counted for 60 seconds in a gamma counter (1261
Multigamma, LKB Wallac, Turku, Finland). Data was fed directly into an
Apple Macintosh computer running the program Assayzap (Biosoft,
Cambridge). Assay results (including fitted standard curves, % tracer
binding and QC values) were generated directly by Assayzap.
3.4.5. Assay sensitivity and variation
The intra-assay coefficient of variation was 4.1%. The limit of sensitivity
of the assay (defined as 2 standard deviations from the zero point) was
94% B/Bo which was lower than the minimum standard used (i.e. <2.5
pg). The inter-assay coefficients of variation for the low (4.93 pg/tube) and
high (81.15 pg/tube) QC's were 21% and 16.2% respectively.
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Figure 3.2. Purification of 125I-testosterone tracer.
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Figure 3.3. A representative testosterone standard curve.
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3.5 Histology
All tissue fixation, processing, embedding, sectioning and toluidine blue
staining was kindly performed by Mr Mike Millar.
3.5.1. Tissue fixation
Small blocks of tissue selected from at least three different areas of the
testis were immersed in 'Superfix' solution (12% paraformaldehyde,
0.26% picric acid, 3% glutaraldehyde buffered with 0.2M cacodylate)
overnight.
3.5.2. Processing of fixed testicular tissue
Tissue blocks were washed several times in 0.2M cacodylate buffer for a
minimum of 4 hours, and then post-fixed in 2% osmium tetroxide (in
0.2M cacodylate) for 2-3 hours at 4°C. The cacodylate washes were repeated
for at least 30 min before 2 further 15 minute washes in 0.05M maleate
buffer. Blocks were then post-fixed in 1% uranyl acetate for 2 hours at
room temperature, then washed again in maleate buffer for 2 periods of
15 min. After this the blocks were washed twice in increasing
concentrations of ethanol (70,80,90 and 95%) for 10 min each, then several
times in 100% ethanol for 1 hour. They were then washed twice in neat
propylene oxide for 30 min, before being pre-embedded in a 50: 50
mixture (v/v) of propylene oxide: epon araldite for 24 hours. After this
time the 50: 50 was poured off and the blocks placed in an oven at 60°C for
10 min to evaporate excess propylene oxide. Blocks were then transferred
to liquid araldite for at least 6 hours and then into fresh liquid araldite for
a minimum of 12 hours. The blocks were then embedded in fresh liquid
araldite in flat-bottomed, cylindrical plastic capsules. These were placed in
an oven at 60°C for 24-36 hours to allow the araldite to polymerize.
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3.5.3. Sectioning
Following the removal of excess araldite from the edges of testicular
blocks, semi-thin sections were cut to 0.5-0.75|iM, using glass or diamond
knives, on a Reichert Jung microtome, model no. 2050.
Paraffin blocks were sectioned to 3-4|iM with a hand-operated microtome
and a D-profile knife.
3.5.4. Staining
Plastic sections were stained by applying toluidine blue for a few seconds.
The toluidine blue was always freshly filtered before use.
3.5.5. Microscopy and photography
Sections were examined and photographed using a Zeiss
photomicroscope (Zeiss, Welwyn Garden City).
3.6. Data analysis
Experimental results were assessed initially by one-way analysis of
variance (ANOVA) using a statistical package designed for the Apple
Macintosh (CLR ANOVA; Clear Lake Research, Houston, Texas).
Student's t-test was used for pairwise comparisons subsequent to
ANOVA.
4. Characterisation of human Leydig cells
4.1. Introduction
Most studies of reproductive function are necessarily carried out in
species other than man. The majority of studies concerning the function
of Leydig cells have been performed in the rat or mouse. The use of one
animal as a model for another is perfectly acceptable if sufficient data are
available to validate the model. However this does not seem to be the
case at present with respect to human Leydig cell function. The majority
of studies performed with human testicular tissue have utilised whole
testis pieces (Hsu et al., 1978; Rodriguez-Rigau et al., 1980; Huhtaniemi et
al., 1982; Bolton et al., 1985), testicular homogenates (Hirsh et ah, 1981), or
crude interstitial cell suspensions (Huhtaniemi et al., 1982). Two of these
studies (Huhtaniemi et al., 1982; Bolton et al., 1985) found that human
Leydig cells were only weakly responsive to stimulation by hCG, showing
a tenth of the response of rat Leydig cells to hCG. However the first study
to use purified human Leydig cells (Simpson et al., 1987) found that,
allowing for individual variation, human Leydig cells were equally
responsive to the effects of hCG as rat Leydig cells. Thus the finding of
Huhtaniemi et al. (1982) that human Leydig cells were not regulated by
hCG in the same way as rat Leydig cells can be attributed to the isolation
and incubation techniques used. The experiments described in this
chapter confirm in a large sample population (n=27) that, allowing for
individual variation, highly purified human Leydig cells show a response
to hCG that is comparable to the response shown by rat Leydig cells. They
also prove that the population of Leydig cells isolated by Percoll gradient
purification is analogous to the population present in the intact testis.
A major concern regarding the use of human testicular tissue is
that the usual source is elderly men who are undergoing orchidectomy as
treatment for prostatic carcinoma. It is feared that Leydig cells isolated
from such a population would be unrepresentative of the younger
population due to age-related changes in Leydig cell function (for review
see Tsitsouras, 1987; Werner et al., 1991) . While the exact influence of
ageing on reproductive function remains unclear, the results of several
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studies using testes from men of different ages have shown qualitatively
normal spermatogenesis in the testes of elderly men. Sharpe et al. (1980)
found that the number of LH receptors per Leydig cell did not decline
with age, and Paniagua et al. (1987) demonstrated normal testicular
histology up to the age of 80 in a significant proportion of a large elderly
population studied. In fact many studies have been unable to correlate
testicular function with age (Hsu et al., 1978; Harman et al., 1982; Johnson
et al., 1988). In the studies described in this chapter, using a population
whose ages spanned 4 decades (54-89 years), no correlations were found
between basic testicular functions and age.
Human Leydig cells exist as a heterogeneous population. At the
light microscopic level Leydig cells are stained variably with toluidine
blue, allowing a distinction to be made between light and darkly staining
cells. Electron microscopy has shown that there is no difference in the
quantity of membranes or in organelle composition between the two cell
types (Schulze, 1984). An attempt was made to separate these two cell
variants using the technique of elutriation, and to assess testosterone
production in the populations distinguished in this way.
4.2. Experimental Procedures
4.2.1. Basic responsiveness of human Leydig cells
To establish basal and hCG-stimulated testosterone production, Leydig
cells from every individual were incubated at a density of 50,000
cells/well in 200pl culture medium. After a pre-incubation period of 2h,
this medium was removed and replaced with either 300|il fresh culture
medium alone, or with 300|il culture medium containing a
supramaximal concentration of hCG (30IU/ml; Chorulon, Intervet U.K.
Ltd, Cambridge). A more detailed dose response to hCG (O.Ol-lOOmlU/ml)
was undertaken on 4 separate occasions. In all cases, cells were incubated
for a further 20h after addition of treatment, then medium was aspirated
and stored at -20°C until assayed.
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4.2.2. Comparison of the ratio of light: dark Leydig cells isolated by Percoll
purification with the ratio found in situ
On two different occasions Leydig cells were Percoll-purified as described
in chapter 3. The Leydig cell bands were sedimented as normal then
resuspended in 2 ml dispersion medium. The number of cells was
counted in a haemocytometer and sufficient cells removed to allow
measurement of basal and hCG-stimulated testosterone production. The
remaining cells were prepared for fixation as described below.
Cell counting was undertaken using a 100,000mm2 graticule (Graticules
Ltd., Tonbridge, Kent) in the eyepiece of a Zeiss photomicroscope. With
sections prepared from isolated Leydig cell pellets the number of Leydig
cells falling beneath the intersection points of the graticule were counted.
This was done for 10 fields on a section from each Percoll layer. When
counting Leydig cells in whole testis sections, the total number of Leydig
cells in the area covered by the graticule was counted in 10 fields in two
sections from different areas of the testis.
4.2.3. Elutriation of crude Leydig cell preparations
In an attempt to assess the extent to which human Leydig cells form a
homogeneous population, and to try and separate light and dark Leydig
cells, a crude Leydig cell suspension, prepared as described in chapter 3,
was subdivided further using the technique of elutriation. A 10 ml
suspension of crude Leydig cells in dispersion medium was subjected to
elutriation (JE-6B elutriator rotor, Beckman Ltd.) at a constant rotor speed
of 2000 rpm. Fractions were collected at different flow rates chosen to
select out specific particle sizes. The elutriatior calibration curve and the
flow rate nomogram are shown in Figure 4.1. Using the nomogram, flow
rates were selected to allow separation of cells with average diameters of
14, 16 and 19|iM. Cells concentrating in these 3 fractions were then spun
at 160g for lOmin to form a pellet. Each pellet was then resuspended in 2
ml dispersion medium and each layered onto a separate Percoll gradient.
Leydig cell layers from each gradient (i.e. from each fraction) were
collected as described in chapter 3, centrifuged at 200# then resuspended
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Figure 4.1 Elutriation Calibration Curve and Flow Rate
Nomogram
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in culture medium. The Leydig cell content of each fraction was
determined using a haemocytometer, and sufficient cells removed to
allow measurement of basal and hCG-stimulated testosterone production
(triplicate wells). The remaining cell suspension was sedimented at 13,000
rpm for 10 min (Biofuge-A, Heraeus Sepatech) and the pellet then
resuspended in 0.1M PBS. The centrifugation was then repeated, and the
PBS removed and replaced with Superfix. A pellet from each fraction was
then processed histologically, as described in Chapter 3. Medium from the
dead volume on either side of the cell-containing fractions, was not
taken through the Percoll purification step, but was sedimented at 160g,
resuspended in 0.1M PBS and sedimented at 13,000 rpm for 10 min, as
above, then resuspended in Superfix, and processed for histology.
4.3. Results
4.3.1. Basic responsiveness of human Leydig cells
The variability in basal testosterone production by isolated human Leydig
cells is illustrated in Figure 4.2. Samples have been classified into 3 groups
(low (n=9), medium (n=ll) and high (n=7)) according to their ability to
produce testosterone. A complete list of basal and hCG-stimulated
testosterone production from each individual, together with details such
as age, paired testicular weight and cell yield is given in appendix 1.
Figure 4.2. shows that the medium and high testosterone producers each
produced significantly more (p <0.01) testosterone than did the low
producers. The difference in testosterone production between the
medium and high group was also significant (p <0.05). The response to a
supramaximal dose of hCG by Leydig cells within these 3 groups is
illustrated in Figure 4.3. In all the groups hCG had a significant (p <0.01)
stimulatory effect on testosterone production. Figure 4.4. shows the
average fold response to hCG within each group. Although there was a
suggestion that Leydig cells which produced more testosterone basally
were more responsive to the effects of hCG than were Leydig cells with
lower basal levels of testosterone production, analysis of variance showed
no overall difference in responsiveness to hCG among the 3 groups
(ANOVA; p =0.28).
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In order to consider the responsiveness of human Leydig cells to
hCG in more detail, 4 experiments were performed which determined the
dose response of human Leydig cells to hCG (O.Ol-lOOmlU). Two
experiments were with Leydig cells falling into the category of low
testosterone production, and two experiments were with Leydig cells
from the medium and high categories. Dose responses to hCG are shown
in Figure 4.5. For both low and medium testosterone producers there was
no significant effect of hCG below 10mIU. The effect of concentrations of
10 and lOOmlU were significantly different from those seen at all other
concentrations (p <0.01), but were not significantly different from each
other. In the high production group significant stimulation of
testosterone production (p <0.01) was seen at concentrations above lmlU
hCG, that is testosterone production by Leydig cells in this group was
significantly stimulated by a lower concentration of hCG than was the
case in the low and medium groups.
The possibility of a relationship between donor age or the
general condition of the tissue samples, and the responsiveness of Leydig
cells subsequently isolated from the tissue was considered. In order to test
this hypothesis, factors such as age and testicular weight, which might
have had some influence on in vitro responsiveness, were compared
with experimental results such as basal or hCG-stimulated testosterone
production, the fold response to hCG or total cell yield. Any statistical
correlation between these factors was then determined (simple regression
analysis, using the Statworks (Cricket Software, Ltd., London) package for
the Apple Macintosh computer). The results are summarised in Figure
4.6. The correlation coefficient (r) between cell yield at the end of the
isolation procedure and paired testicular weight (A) was 0.28, which was
not significant. Basal testosterone production did not correlate
significantly with age (C; correlation coefficient = 0.049) nor was there a
significant correlation between the fold response to hCG and age (D;
correlation coefficient = 0.028). The relationship between basal and hCG-
stimulated testosterone production (B) was found to be statistically
significant (correlation coefficient = 0.82, p <0.001,).
The possibility of a relationship between the condition of the testes
and the responsiveness of Leydig cells subsequently isolated is considered
briefly in Figure 4.7. Examples of the diversity in testicular morphology
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found in samples from each of these groups are shown. There were no
consistent differences in the condition of either the interstitium or of the
seminiferous tubules between the low, medium and high in vitro
testosterone producing groups. The relationship between testicular
morphology and Leydig cell function in vitro is examined in more detail
in chapter 5.
4.3.2. Comparison of the ratio of light: dark Leydig cells isolated by Percoll
purification with the ratio found in situ
The ratio of light: dark Leydig cells found in layers of Leydig cells isolated
on Percoll gradients was shown to be consistent with the ratio measured
in sections of whole testicular tissue (Table 4.1.). It was not expected that
the light : dark ratios would be so similar in different individuals (here
nominated JL and JV), however the results discussed in chapter 5,
confirm that the ratio of light: dark Leydig cells in the human testis is not
constant between individuals. The morphology of each testis is shown in
Figure 4.8., as is the composition of the cellular suspension isolated by
Percoll-purification. The testicular morphology of JL and JV was
comparable as was the in vitro testosterone production by Leydig cells
isolated from these testes.
4.3.3. Elutriation of crude Leydig cell preparations
A summary of all details collected regarding elutriated fractions 2,3 and 4
is shown in Table 4.2. The majority of cells (3.8x106) were localised in
fraction 2, which contained cells with an average diameter of 14(iM. The
types of cell located in each fraction were determined morphologically.
Figure 4.9 consists of photographs showing the composition of each
fraction. Light and dark Leydig cells are present in all fractions, and there
was no significant difference between the ratios of light: dark Leydig cells
in each fraction. In fractions 2, 3 and 4 this ratio was 1:1.92,1: 2.2 and 1: 1.6
respectively. Basal testosterone production by cells from fraction 2 was
0.8±0.15 ng/106 cells, in fraction 3, 6.4ng/106 cells and in fraction 4,
46.86±11.08 ng/106 cells. Figure 4.10 shows basal and hCG-stimulated
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Figure 4.2. Basal testosterone production by human Leydig cell
cultures.
A. Low testosterone producers (n=ll). B. Medium testosterone producers
(n=9). C. High testosterone producers (n=7). Each graph shows
testosterone production over a 20h culture period. Each point is the
mean±S.D. of n experiments. *p <0.05 significantly different from low
group, **p <0.01 significantly different from low group, +p <0.01
significantly different from medium group.
testosteroneproduction (ng/106cells) t-»h-ro <_noUi
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Figure 4.3. The effects of 30IU/ml hCG on testosterone
production by human Leydig cell cultures.
A. Low testosterone producers (n=ll). B. Medium testosterone producers
(n=9). C. High testosterone producers (n=7). Each graph shows
testosterone production over a 20h culture period. The basal testosterone
values shown in Figure 4.2. are repeated in these graphs for comparison.
Each point is the mean±S.D. of n experiments. Note the differences in the














testosteroneproductiontestosteroneproduction (ng/106cells)/ ll )
Chapter Four Characterization of human Leydig cells 70
Figure 4.6. Correlation curves of testicular parameters.
A. Correlation between cell yield vs. paired testicular weight, r = 0.28. B.
Correlation between basal vs. hCG-stimulated testosterone production, r =
0.82, p <0.0001. C. Correlation between basal testosterone production vs.
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Figure 4.4. Magnitude of the response to hCG shown by human
Leydig cell cultures.
A. Low testosterone producers (n=ll). B. Medium testosterone producers
(n=9). C. High testosterone producers (n=7). Each graph shows the fold
response to 30IU/ml hCG over a 20h culture period. Each point is the
mean±S.D. of n experiments. No significant differences were found
(ANOVA, p = 0.28).
foldresponsetohCG
i'|_i* oro>fi.a\oooK)^ON
Chapter Four Characterization of human Leydig cells 72
Figure 4.5. The effects of increasing doses of hCG on testosterone
production by human Leydig cell cultures.
A. Examples of hCG dose response in 2 low testosterone producers. B. A
medium testosterone producer. C. A high testosterone producer. Each
graph shows the response to O.OOl-lOOmlU hCG over a 20h culture period.
Each point is the mean±S.D. of triplicate wells in a single experiment.
Note the differences in the scale of the y-axis between the groups. *p
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Figure 4.7 Histology of the human testis.
Examples of testicular morphology in : A. 2 low testosterone producers.
B. 2 medium testosterone producers. C. 2 high testosterone producers.
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Figure 4.8 Cellular composition of human Leydig cell layers
isolated on Percoll gradients.
A. Cells isolated from JV. B. Cells isolated from JL.
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Figure 4.10 Basal and hCG-stimulated testosterone production
by elutriated human Leydig cell fractions.
The graph shows basal testosterone production (b) and hCG-stimulated
testosterone production (s) over a 20h culture period. Each column is the
mean±S.D. of triplicate wells in a single experiment. Data without
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Table 4.1. Comparison of the numbers of light and dark Leydig
cell numbers in the whole testis and in isolated Leydig cell
suspensions.
Experimental and sample details from two individual men. Each value is
the mean±S.D. of 20 fields for whole tissue sections, and of 10 fields for
isolated Leydig cell suspensions.
Subject JL JV
Age (y) 84 82
testicular weight (g) 9.7 20.4
basal testosterone





no. light Leydig cells/
unit area (pellet)
54.25+5.7 52.63±5.85
no. light Leydig cells/
unit area (testis)
8.56±6.68 9.5±9.6
no. dark Leydig cells/
unit area (pellet)
66.75±5.65 68.13±5.44
no. dark Leydig cells/
unit area (testis)
10.56±5.95 13.8±8.2
ratio of light: dark Leydig
cells (pellet)
1 :1.23 1 :1.29
ratio of light: dark Leydig
cells (testis)
1 :1.23 1 :1.45
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Table 4.2. Basic characteristics of human Leydig cells separated
by elutriation.
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testosterone production by Leydig cells in each fraction. Basal testosterone
production was not significantly different between Leydig cells isolated in
fractions 2 and 3, but basal testosterone production by Leydig cells in
fraction 4 was significantly different (p <0.01) from Leydig cells in both
fractions 2 and 3. In fractions 2 and 3 hCG-stimulated testosterone
production was significantly different (p <0.01) than basal levels in both
fractions, but were not significantly different from each other. Both basal
and hCG-stimulated testosterone production by Leydig cells in fractions 2
and 3 were significantly different (p <0.01) from basal and hCG-stimulated
testosterone production by Leydig cells in fraction 4, although these were
not significantly different from each other.
4.4. Discussion
The aims of the studies described in this chapter were threefold. Firstly, to
investigate the ability of Leydig cells isolated from the testes of aged men
to produce testosterone in vitro, both basally and in response to hCG.
Secondly, to establish that the population of Leydig cells isolated by
Percoll gradient purification is representative of the Leydig cell
population existing in situ. This was achieved by comparing the ratio of
light: dark Leydig cells found at the end of the isolation procedure with
the ratio seen in situ. The final aim of the study was to separate light and
dark Leydig cells and to compare their capability to produce testosterone
in vitro.
Amongst the Leydig cells isolated from a total of 27 testes there was
a marked variation in testosterone production measured in vitro and also
in the response of the Leydig cells to hCG. Similar individual variations
have been reported in studies which measured intratesticular
testosterone content in whole testicular tissue fragments (Hirsh et ah,
1981; de la Torre et ah, 1982), in total testicular homogenates (Hsu et
ah,1978), and in isolated human Leydig cells (Simpson et ah, 1987). The
studies by de la Torre and Hirsh were carried out on testicular biopsy
samples obtained from both fertile and infertile populations. These were
shown to have comparable intratesticular levels of testosterone and to
exhibit similar variability in testosterone production between individuals
within the group. This is important as it demonstrates that variation in
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intratesticular testosterone content occurs in a normal, young (26-48
years) population and is not particularly associated with Leydig cells
isolated from an 'abnormal' population such as infertile men or, as in
this study, elderly men. Although several studies have investigated the
effects of ageing on reproductive function (for review see Werner et al.,
1991), it is still unclear how the functions of testicular cells decline as part
of the ageing process. Most investigators have found elevated levels of
serum FSH and LH in ageing men (Harman et al., 1982; Deslypere &
Vermeulen, 1984; Neaves et al., 1984). The changes in serum testosterone
levels, however, are much less clear. MacNaughton et al. (1991) and
Deslypere & Vermeulen (1984) found that plasma testosterone
concentrations decreased with age, while the study by Harman et al. (1982)
found no effect of ageing on plasma testosterone levels. The relationship
between age and serum gonadotrophin and testosterone levels was
examined in more detail by Paniagua et al. (1987). In this study
endocrinological and histological parameters were measured in 64 elderly
men (51-90 years) undergoing orchidectomy. These data was compared
with results obtained from 25 men (25-39 years) killed in traffic accidents.
Paniagua et al. (1987) divided the elderly men into groups according to age
and then subdivided each group into men whose testes showed complete
spermatogenesis and normal or nearly normal histology (group A) and
men whose testes showed maturation arrest of spermatogenesis in most
tubules (group B), these distinctions being made after microscopic
examination of fixed testicular sections. Up to 80 years of age, men in
group A showed hormone levels and testicular parameters similar to
those in the young control men. The implication for work on isolated
human Leydig cells is that if histological examination reveals complete
spermatogenesis together with relatively normal testicular morphology
(as is the case for the majority of samples used in this study) this is
indicative of a relatively normal population of testicular cells. Indeed,
Simpson et al. (1987) found that men with poorly responsive Leydig cells
in vitro could not be distinguished from those whose Leydig cells made
large amounts of testosterone in vitro on the basis of plasma FSH, LH or
testosterone levels. However, degenerative changes in testicular
morphology do occur as part of the ageing process. One study which
compared testicular tissue taken at autopsy from 2 groups aged 20-48 years
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and 50-76 years, found that the mean total number of Leydig cell nuclei
had decreased by 44% in the older age group, however the volume of
Leydig cell nuclei was constant between groups (Neaves et ah, 1984).
Seminiferous tubular boundary tissue is subject to age-related thickening
(Johnson et ah, 1988), possibly making cell-cell communication more
problematical. While these structural changes and also the increase in
serum gonadotrophins suggest that Leydig cells isolated from aged
human testes are not representative of the Leydig cell population in
younger men, the results of one of the studies on large numbers of men
(Paniagua et ah, 1987) found marked individual variations in all age
groups. Neaves et ah (1984) also concluded that the response of the
human testis to ageing is highly variable. Thus considering that the great
majority of testicular tissue used in the studies described in this thesis
showed complete spermatogenesis and relatively normal histology (see
chapter 5) it can be assumed that despite their age they were
representative of a total population that is itself highly variable in
nature.
In this study Leydig cells were subdivided on the basis of their
ability to produce testosterone in vitro into low, medium and high
producers. There was no significant difference in the average ages of the
men in these groups (75±9.3, 69.6±7.9, 72.1+11.8 years, respectively) nor did
they deviate from the overall average age of 72.9±9.5. The amounts of
testosterone produced by these groups differed significantly (p <0.01 low
vs medium or high, p <0.05 medium vs high). The response of all groups
to a supramaximal dose of hCG was significant (p <0.01), and although
there was a trend towards the Leydig cells which had a higher basal level
of testosterone production being more responsive to the effects of hCG,
this was not proven statistically. A study by Neaves et ah (1984) found
that although there was a 44% reduction in the number of Leydig cells
between 2 groups with age ranges of 20-48 years and 50-76 years, there was
no change in Leydig cell nuclear volume. They suggested that the poor
response of older men to hCG administration (Harman & Tsitsouras,
1980) was because the surviving Leydig cells are working close to their
maximum capacity to compensate for their reduced numbers. However
this study does not support the finding that Leydig cells in elderly men
are unresponsive to hCG. Appendix 1 shows the response of all
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preparations of isolated Leydig cells to a supramaximal dose of hCG. The
average fold response was x6, with a range between xl.8 and x22.5. In fact
the minimum response to hCG of xl.8, or 80% is equivalent to the
average response to hCG of 91 % in crude interstitial cell suspensions, and
greater than the 41% response of whole tissue preparations reported by
Huhtaniemi et al. (1982). Bolton et al. (1985) who performed hCG dose
response tests in whole testicular pieces were unable to get greater than a
3-fold increase in testosterone production. They found that the
maximum responses to hCG were seen at concentrations above 1IU
hCG/ml. Figure 4.5 shows that with highly purified isolated Leydig cells,
the low and medium testosterone producing group are significantly
stimulated by a 100-fold lower dose of hCG (0.01IU), while the high
testosterone producers are more sensitive to the effects of hCG by a
further factor of 10 (0.0001 IU hCG). Thus the lack of response of isolated
human testicular pieces or crude interstitial cell preparations that has
been reported previously does not occur in the highly purified Leydig
cells used in this study, suggesting that the lack of response described
previously was a consequence of the techniques used in the isolation of
Leydig cells. The ability of these cells to respond to hCG gives further
support to the idea that the Leydig cells isolated by the technique described
in this thesis are functioning normally.
An initial attempt at evaluating the interdependency of several
testicular factors was unsuccessful. Cell yield at the end of the isolation
procedure did not correlate with testicular weight, which reflects the
individual variations in testicular morphology discussed earlier (Johnson
et al., 1988). Neither did cell yield correlate with age which at first seems
to contrast with the study by Neaves et al. (1984) who found a decline in
Leydig cell number with age. Flowever, as most isolation techniques used
to separate testicular cell types are able to isolate only a few percent of the
total cell population (Simpson et al., 1987), it is not too surprising that this
in vivo change is not reflected in cell yields. Age was shown not to be a
significant factor in determining either basal testosterone production in
vitro or the fold response of the cells to hCG. A significant correlation (p
<0.001) existed between basal and hCG-stimulated levels of testosterone
production. This was surprising as no significant difference in response to
hCG was found between the low, medium and high testosterone
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producing groups. However it does agree with the findings of Hsu et al.
(1978) who found a very high positive correlation between specific hCG
binding and intratesticular testosterone concentration in homogenised
testicular tissue. Sharpe et al. (1980) found that LH receptor levels in the
human testis are similar at 23-42 years and 70-72 years, again leading to
the conclusion that the Leydig cells isolated by these techniques are
functioning normally.
It was shown that the relative proportions of light and dark Leydig
cells isolated by Percoll purification was an accurate reflection of the
proportions found in the whole testis. This was a very important point to
establish, it having been suggested previously that light Leydig cells may
be less efficient testosterone producers, being more predominant in
Leydig cell cultures which produce low amounts of testosterone (Simpson
et al., 1987). This study, in agreement with previous studies (Harman et
al., 1982; Paniagua et al., 1987; Johnson et al., 1988), found no correlation
between testosterone production in vitro and factors such as age, paired
testicular weight, and in the studies quoted, serum gonadotrophins and
general testicular morphology. It was thus interesting to find that the 2
subjects used in this study who were of a similar age, with similar
morphology and whose Leydig cells produced equivalent amounts of
testosterone in vitro, also had very similar ratios of light: dark Leydig
cells. As both the age and gross testicular morphology have been shown
not to correlate with testosterone production in vitro or total testicular
testosterone content, perhaps it is the ratio of light: dark Leydig cells in
the testis which determines total testosterone output. This is also
suggested by the study by Simpson et al. (1987) reported above.
It was not possible to separate light and dark Leydig cells by
elutriation. Fractions containing cells with average diameters of 14, 16
and 19(iM contained equal proportions of light: dark Leydig cells. The
Leydig cells with the highest intrinsic testosterone producing ability were
isolated in fraction 4, that is they formed the larger Leydig cell population.
However they did not form a significant part of the total Leydig cell
population (10% of the total). These cells were also the least responsive to
hCG; it is possible that they were unresponsive because they are already
working to their maximum capacity, an idea supported by the fact that the
basal level of testosterone production by cells in this fraction was twice
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the level of testosterone produced in response to hCG in either of the
other 2 fractions. Thus no conclusion can be made from this experiment
as to differential testosterone production by light and dark Leydig cells.
Papadopoulos et al. (1987a) proposed the existence of 2 populations of
Leydig cells based on the ability of cells isolated from different densities
on Percoll gradients to differentially bind iodinated hCG. However, the
densities at which these fractionated on Percoll (1.045-1.055 and
1.075g/ml) are in accord with the densities at which Leydig cells were
isolated in this study and in the study by Simpson et al. (1987). This latter
study showed no significant difference in either basal or hCG-stimulated
testosterone production between Leydig cells in either layer. The results of
the experiment reported here also argue against the existence of discrete
populations of Leydig cells but in favour of a Leydig cell population that
shows a normal bell-shaped distribution with respect to testosterone
production.
In summary, the experiments presented in this chapter have
shown that it is possible to isolate Leydig cells from ageing human testes
that are responsive to stimulation by hCG, but there is a wide variation in
the level of response between individuals. However studies in the
literature suggest that such variation is also seen in younger populations.
The ratio of light: dark Leydig cells isolated by Percoll purification was
found to be a true representation of the ratio found in the intact testis.
Finally it was shown that it is not possible to separate light and dark
Leydig cells on the basis of size, and no conclusion could be made as to
whether light and dark Leydig cells have different steroidogenic
capacities.
5. Morphology of the human testis
The previous chapter described the existence of light and dark Leydig cells
in the human testis. It was shown that the two populations could not be
separated on the basis of size, making it impossible to reach a conclusion
about possible differences in their steroidogenic capacity. The ability of
human Leydig cells to secrete testosterone in in vitro cultures was shown
to be highly variable. The studies presented in the present chapter used
morphometric techniques to estimate the total number of Leydig cells as
well as the number of light and dark Leydig cells in each testis. Other
testicular cell types were also counted and the composition of each testis
was calculated on a percentage volume basis. Correlations were made
between various morphometric factors for each testis and the ability of
Leydig cells isolated from that testis to produce testosterone in vitro, in an
attempt to explain the variations observed in the preceding chapter.
5.1. Introduction
The ability of human Leydig cells to produce testosterone varies
considerably between individuals. Such individual differences have been
reported in studies which measured intratesticular testosterone content
in whole testicular tissue fragments (Hirsh et al., 1981; de la Torre et al.,
1982), in total testicular homogenates (Hsu et al., 1978) or testosterone
production by isolated human Leydig cells (see previous chapter and
Simpson et al., 1987). Several studies have tried to explain these
variations by relating in vitro testosterone production to factors such as
age, paired testicular weight, serum gonadotrophins and general testicular
morphology (Harman et al., 1982; Paniagua et al., 1987; Johnson et al.,
1988), with no success. At the same time it is also well recognised that the
population of Leydig cells found in the human testis is highly
heterogeneous (Schulze, 1984; Paniagua et al., 1987; Simpson et al., 1987).
In particular the existence of variably staining Leydig cells has been
described, in both perfused and immersion-fixed tissue (Schulze, 1984;
Simpson et al., 1987). Simpson et al. (1987) proposed that there might be
inherent differences in the steroidogenic ability of light and dark Leydig
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cells, but to date this possibility has not been explored. Therefore the aim
of this study was to use morphometric analysis of testes from a number of
men to discover whether there was any relationship between the relative
number of light and dark Leydig cells and the subsequent steroidogenic
capacity of Leydig cells isolated from these testes.
5.2. Experimental Procedures
5.2.1. Histology
Testicular tissue from random positions was processed as described in
Chapter 3. Sections of lpM thickness were stained with toluidine blue
and examined and photographed using a Zeiss photomicroscope.
5.2.2. Random sampling
Fields were selected at random to ensure that all morphometric analysis
was performed on unbiased and representative samples.
5.2.3. Determination of average Leydig cell nuclear diameter
The average diameter of both light and dark Leydig cells in individual
testes was measured using a Plan Apo 60 x oil objective fitted to a Leitz
microscope connected to the imagan2 (Kompira Ltd., Strathclyde)
interactive image analysis system for IBM computers. In every case 25
light and 25 dark Leydig cells were measured in sections from three
different areas of the testis, to give a total of 75 measurements of nuclear
diameter for both light and dark Leydig cells for every man.
5.2.4. Determination of Leydig cell number
The number of light and dark Leydig cell nuclei in individual testes was
calculated using the Floderus equation (Floderus, 1944);
Ny=NA/D+2h
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numerical density, or, the number of light or dark
Leydig cells per unit volume of the testis
average number of light or dark Leydig cell nuclei in a
known area
average nuclear diameter of light or dark Leydig cells
height of the smallest visible nuclear cross-section,
assumed to be Vioth of D (Wing and Christensen,
1982)
To determine Na, Leydig cell nuclei were counted in 10 randomly
selected microscopic fields (100,000pm2) in 3 sections taken from different
areas of the testis. Measurements were performed using a Zeiss
microscope fitted with a Plan Apo x 20 oil objective.
The number of light and dark Leydig cells in each testis was calculated by
multiplying Ny by the volume of the testis. It has been shown previously
that the specific gravity of human testicular tissue approximates to unity
(Barbara Simpson, PhD thesis, 1987). It was therefore assumed that
testicular weight was interchangeable with testicular volume (i.e. lg =
lcm3). It is recognised that all fixed, embedded tissue blocks shrink during
the processing procedure, so that the fresh weight of the testis is greater
than the weight after fixation. However, if the degree of shrinkage is
assumed to be uniform between samples, then it is widely accepted that
the total volume of the testis can be estimated by equating with weight.
Mendis-Handagama & Ewing (1990) demonstrated that in normal rat
testes this assumption had negligible effects on the estimates of Leydig cell
numbers per testis.
5.2.5. Testicular composition
The composition of each testis was determined using a 100,000 pm2
graticule. The cell type or structure beneath every intersection point on
the graticule (121 points) was recorded in 10 fields in sections taken from
three different areas of each testis. The mean number of counts for each
item was determined and then expressed as a percentage of the total
counts possible. The volume per testis was calculated by multiplying this
by testicular volume. In this way the proportion of testicular tissue
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germ cells, interstitium, seminiferous tubule lumen, vacuoles and fat
droplets in the seminiferous epithelium, blood vessels, peritubular tissue
and the cytoplasm of light and dark Leydig cells. Different cell types were
recognised using the criteria defined by Holstein & Roosen-Runge (1987).
Light and dark Leydig cells were distinguished on the basis of their
differential staining with toluidine blue.
5.2.6. Relationships between cell types in the testis
The statistical relationships between various testicular cell types were
determined by simple regression analysis. In this way possible
relationships between cell types and testosterone production by isolated
Leydig cells, responsiveness of isolated Leydig cell to stimulation by a
supramaximal dose of hCG, age and testicular weight were also assessed.
5.3. Results
5.3.1 Determination of average Leydig cell nuclear diameter
The average nuclear diameter of light and dark Leydig cells did not differ
significantly from each other, nor were there significant differences in
light or dark nuclear diameter between individuals. The average nuclear
diameter of a light Leydig cell nucleus was 6.96±0.4pm (n=25) and the
average nuclear diameter of a dark Leydig cell nucleus was 6.76±0.38jim
(n=25). These values were then used in the Floderus equation which
calculates the total number of light and dark Leydig cells in each testis.
5.3.2. Determination of Leydig cell number
The calculated number of light and dark Leydig cells per testis for each
individual is shown in Table 5.1. The table also shows the total number of
Leydig cells per testis and the ratio of light: dark Leydig cells in that testis.
The number of Leydig cells was found to correlate significantly with
testicular weight (p <0.001), or simply, larger testes contain more Leydig
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cells. Although there was a decline in the total number of Leydig cells
with age, this was not statistically significant (p <0.09; Figure 5.1.A), and
this decline was reflected in reductions in both light and dark Leydig cells
with age (Figure 5.1.B and C). No correlation was found between basal
testosterone production by isolated Leydig cells and the total number of
Leydig cells (Figure 5.2.A), nor were the numbers of either light or dark
Leydig cells shown to be related to subsequent basal testosterone
production (Figure 5.2. B and C). The ratio of light to dark Leydig cells was
also not correlated to testosterone production (Figure 5.2.D). The response
of isolated Leydig cells to hCG, represented by the fold increase in
testosterone production upon the addition of hCG, was also unrelated to
the 4 measurements of total and relative Leydig cell populations (Figure
5.3., see also Table 5.3.).
In chapter 4, human Leydig cell preparations were classified into 3
groups according to their ability to produce testosterone in vitro (low,
medium and high producers). These divisions represent different
capacities to produce testosterone, as each refers to low, medium or high
production per 106 cells. Figure 5.4 shows the average number of Leydig
cells measured in each of these groups. The total number of Leydig cells
per testis increased from the low to medium to high groupings, with the
number of Leydig cells in the high capacity group being significantly
greater than that measured in the low capacity group (p <0.05). The
numbers of light and dark Leydig cells making up the total Leydig cell
population in each group is shown in Figure 5.5. There was no significant
difference in the number of light or dark Leydig cells within any group.
While there was no significant difference in the number of dark Leydig
cells between groups, the number of light Leydig cells was significantly
greater in the high testosterone production group when compared to the
low group (p <0.05). The significance of the ratio of light: dark Leydig cells
and the capacity to produce testosterone was also considered. The ratio
was significantly lower in the medium group when compared with the
low group (p <0.01, Figure 5.6.)
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Table 5.1. Composition of the Leydig cell population in individual
testes.
The total number of Leydig cells in each testis was calculated using the
Floderus equation. The numbers of light and dark Leydig cells and the
ratio of light to dark Leydig cells are also given.
number of Leydig cells/testis (x 10 6)
Patient no. light dark total
ratio
light: dark
1 144.61 206.66 351.28 1:1.43
2 13.75 36.68 50.42 1:2.66
3 70.43 69.02 139.45 1:0.98
4 49.73 100.16 149.89 1:2.01
5 52.54 39.86 92.39 1:0.76
6 30.24 44.53 74.77 1:1.47
7 43.11 34.23 77.34 1:0.79
8 78.93 35.79 114.71 1:0.45
9 112.28 153.68 265.97 1:1.37
10 96.15 81.51 177.66 1:0.85
11 60.74 65.44 126.18 1:1.08
12 69.48 90.35 159.83 1:1.3
13 19.55 23.67 43.2 1:1.21
14 156.14 122.84 278.98 1:0.79
15 19.94 23.58 43.53 1:1.18
16 120.6 86.12 206.72 1:0.71
17 31.46 24.2 55.66 1:0.77
18 98.51 89.7 188.21 1:0.91
19 27.37 46.34 73.71 1:1.69
20 30.61 48.53 79.14 1:1.59
21 92.18 76.28 168.46 1:0.83
22 106.59 85.57 192.16 1:0.81
23 41.42 50.34 91.76 1:1.21
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Figure 5.1. Correlation between the number of Leydig cells per
testis and age.
A. Correlation between total Leydig cell population vs. age, r = 0.349, p
<0.09.
B. Correlation between the number of light Leydig cells per testis vs. age, r
= 0.36.
C. Correlation between the number of dark Leydig cells per testis vs. age, r
= 0.368.
number of Leydig cells
per testis (xlO6)
number of light Leydig cells
per testis (xlO6)
number of dark Leydig cells
per testis (xlO6)
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Figure 5.2. Correlation between the number of Leydig cells per
testis and basal testosterone production in vitro.
A. Correlation between total Leydig cell population vs. testosterone
production, r = 0.287. B. Correlation between the number of light Leydig
cells per testis vs. testosterone production, r = 0.229. C. Correlation
between the number of dark Leydig cells per testis vs. testosterone
production, r = 0.275. D. Correlation between the ratio of light : dark
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Figure 5.3. Correlation between the number of Leydig cells per
testis and the fold response to hCG of isolated Leydig cells.
A. Correlation between total Leydig cell population vs. fold response, r =
0.019. B. Correlation between the number of light Leydig cells per testis vs.
fold response, r = 0.046. C. Correlation between the number of dark Leydig
cells per testis vs. fold response, r = 0.037. D. Correlation between the ratio
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Figure 5.4. The capacity of isolated Leydig cells to produce
testosterone in vitro (low, medium or high, ng/106 cells) and the
total number of Leydig cells per testis in each group.
Each column is the mean ±S.D. for 5 testes. *p <0.05, significantly different
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Figure 5.5. The capacity of isolated Leydig cells to produce
testosterone in vitro (low, medium or high, ng/106 cells) and the
number of light and dark Leydig cells per testis in each group.
Each column is the mean ±S.D. for 5 testes. *p <0.05, significantly different
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Figure 5.6. The capacity of isolated Leydig cells to produce
testosterone in vitro (low, medium or high, ng/106 cells) and the
ratio of light to dark Leydig cells per testis in each group.
Each column is the mean ±S.D. for 5 testes. **p <0.01, significantly-
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5.3.3. Testicular composition
The average percentage contribution of each factor to the total volume of
the testis is shown in Table 5.2. The minimum and maximum values are
also given. Considering the variation in in vitro testosterone production
by Leydig cells isolated from these testes, there is remarkable consistency
in their make-up. In parallel with this finding, the percentage
contribution of each factor measured had a positive and significant
correlation with testicular weight (see Table 5.3.).
5.3.4. Relationships between cell types in the testis
Regression analysis was calculated for every possible pairing of cell types,
and the correlation coefficients obtained are presented in Table 5.3. As
discussed above, testicular weight showed a positive correlation with all
testicular factors measured. Neither basal testosterone production by
isolated Leydig cells nor the fold response of these cells to hCG correlated
with any of the structural parameters measured. However, significant
correlations amongst several of these parameters were found. The
volume of light Leydig cell cytoplasm correlated with the volume of light
Leydig cell nuclei, and ditto for dark Leydig cell nuclei and cytoplasm.
However the correlations of cytoplasm and nuclei with other factors
measured were only comparable in dark Leydig cells and were
considerably different for light Leydig cells. These results are summarised
in Table 5.4. Dark Leydig cell nuclei and cytoplasm were shown to
correlate significantly with the volume of germ cells and tubule lumen (p
<0.001) and with the volume of fat droplets in the seminiferous
epithelium and the volume of the interstitial space (p <0.01). There was
no correlation with blood vessel volume, peritubular tissue or the
number of vacuoles in the seminiferous epithelium. The correlations
seen with light Leydig cells were quite different. Light Leydig cell nuclei
showed a relatively low correlation with germ cell volume (p <0.01) but
did not correlate with any other factor. Light Leydig cell cytoplasm
showed strong correlations with the volumes of germ cells, the
interstitium, blood vessels, peritubular tissue and the number of fat
droplets in the seminiferous epithelium (p <0.001). The correlation with
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the number of vacuoles in the seminiferous epithelium was less strong (p
<0.01) and there was no correlation between light Leydig cell cytoplasm
and the volume of the tubular lumen. Besides showing a positive
correlation with both light and dark Leydig cell volumes, germ cell
volume correlated positively with all of the other testicular structures
measured. Without considering Leydig cells, in general positive
correlations existed between most of the testicular structures measured
(see Table 5.3.). Photomicrographs of testes with different ratios of light:
dark Leydig cells are shown in Figure 5.4.
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Table 5.2. Composition of the testis in 26 men.
Data represent the average ± S.D. percentage volume occupied by each
component.
f—i—i i • i . volume of testisTesticular component . , /0/vr occupied (%)
light Leydig cell cytoplasm 0.99 ± 0.49
light Leydig cell nuclei 0.41 + 0.26
dark Leydig cell cytoplasm 1.32 ± 0.64
dark Leydig cell nuclei 0.38 ± 0.22
germ cells 41.81+9.41
interstitium 19.49 + 6.45
blood vessels 2.02 + 0.69
peritubular tissue 22.44 + 7.44
tubular lumen 3.55 ± 2.36
epithelial vacuoles 4.23 + 2.09
fat droplets 3.37 + 1.2
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Table 5.3. Correlation Coefficients of testicular parameters.
Correlations between the volumes/testis of all testicular components
measured are shown. Figures in bold represent p <0.001, figures in italics
represent p <0.01. N.S. = not significant.
Abbreviations used : basal T = basal testosterone production (ng/106 cells);
fold = fold response to a maximally-stimulating dose of hCG; LLCN =
light Leydig cell nuclei; LLCC = light Leydig cell cytoplasm; DLCN = dark
Leydig cell nuclei; DLCC = dark Leydig cell cytoplasm; intstm =
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Table 5.4. Correlations of light and dark Leydig cell nuclei and
cytoplasm with other components of the testis.
./ ./= p <0.001
./ = p <0.01
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Figure 5.4. Histology of the human testis.
Examples of testicular morphology in testes where the ratio of light: dark
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5.4. Discussion
The objective of the morphometric analysis described in this chapter was
to accumulate accurate morphometric information about the human
testis to allow correlations to be made between physiological and
biochemical findings in order to identify potentially important cell-cell
interactions in the human testis.
The average diameter of a Leydig cell nucleus was 6.86±0.39|im and
there was no difference in nuclear diameter between the light and dark
subpopulations of Leydig cells. The average number of Leydig cells per
testis was 139.12+81.89 x 106, with minimum and maximum values of
43.2 x 106 and 351.28 x 106 respectively. The number of light and dark
Leydig cells per testis is shown in Table 5.1. The numbers of Leydig cells
per testis is in agreement with the studies by Neaves et ah, (1984), who
found a range of 159-330 x 106 Leydig cells per testis in men aged between
50-76 years. Similar numbers were reported by Paniagua et ah, (1987) who
found that the number of Leydig cells per testis in men aged 51-90 years
varied between 122-382 x 106. Neaves et ah, (1984) described a 44%
reduction in the number of Leydig cells when comparing a group of men
aged 50-76 years with a group aged 20-48 years. A similar, though
statistically insignificant decline in the number of Leydig cells with
increasing age was seen in this study. The number of Leydig cells per testis
showed a positive correlation with testicular weight (p <0.001), in fact
there was a positive correlation between testicular weight and all
parameters measured (see Table 5.3.).
No correlation was found between the total number of Leydig cells
per testis and the amounts of testosterone produced by those Leydig cells
when isolated and cultured. As described in chapter 4, a marked
individual variation was found in the amounts of testosterone produced
by a unit number (106) of Leydig cells. Hirsh et ah (1981) were also unable
to demonstrate a significant correlation between the volume densities of
interstitial cells and the intratesticular testosterone content measured in
homogenized testicular fragments. The lack of correlation between the
amounts of testosterone produced per 106 Leydig cells in vitro and the
total number of Leydig cells per testis, shows that Leydig cells isolated
from small testicular populations were neither more nor less able to
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produce testosterone than Leydig cells isolated from a larger population.
This finding refutes the idea proposed by Neaves et al. (1984) that Leydig
cells from small testicular populations have to work harder than those
from larger populations in order to maintain the intratesticular levels of
testosterone necessary to drive spermatogenesis. Neaves et al. (1985)
described how Leydig cells in the human testis are subject to degeneration
and dissolution with increasing age. It is thus possible that light and dark
Leydig cells represent one population of steroid synthesising cells and a
second population of cells which are inactive due to either degeneration,
or are inactive during regeneration to replace phagocytosed Leydig cells.
To address these points and to examine more closely the correlation
between in vitro testosterone production and Leydig cell numbers,
correlations were made between the number of light or dark Leydig cells
in the testis and testosterone production per 106 isolated Leydig cells. No
correlation was found when this subdivision of the Leydig cell
population was made.
Isolated Leydig cells were subdivided into 3 groups (low, medium
and high) based on the amount of testosterone produced per 106 cells per
20h in culture. In general the capacity of Leydig cells to produce
testosterone in vitro increased in concert with the size of the in vivo
Leydig cell population. This contradicts the proposal by Neaves et al.
(1984), described above, that Leydig cells from small populations work
harder than those from larger populations. In fact the opposite appears to
be true, with Leydig cells from large populations producing more
testosterone in vitro than Leydig cells from smaller populations. The
increase in Leydig cell numbers found between the low, medium and
high groups was matched by increases in the numbers of both light and
dark Leydig cells. When the ratio of light : dark Leydig cells in these
groups was considered, on average, testes in the low and high groups both
had more dark than light Leydig cells (ratio light: dark 1 : 1.55±0.71 and 1 :
1.125±0.27, respectively). In the medium group, there were, on average,
more light than dark Leydig cells (1 : 0.83±0.24). As Leydig cells with both
low and high testosterone producing capacities had a higher proportion of
light than dark Leydig cells, it is not possible to equate the capacity or
inability to produce testosterone in vitro with the predominance of either
subpopulation of Leydig cells. In fact, in the majority of men (13/23) the
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ratio of light: dark Leydig cells was not significantly different from 50 : 50.
There was also a positive correlation (p <0.001) between light and dark
Leydig cell cytoplasmic volume indicating that larger populations of
Leydig cells contain more of both Leydig cell types. The available evidence
does not support the hypothesis that light and dark Leydig cells represent
steroidogenically active and inactive subpopulations. As there is no
evidence to the contrary it has been assumed that both light and dark
Leydig cells are able to produce testosterone.
The ability of isolated Leydig cells to respond to hCG was
represented by the fold increase in testosterone production when
comparing basal testosterone production with the amount of testosterone
produced by Leydig cells exposed to a maximally stimulating dose of hCG.
No correlation was found between the fold response to hCG and either
total Leydig cell number, the number of light and dark Leydig cells nor
the ratio of light to dark Leydig cells. It can therefore be stated that light
and dark Leydig cells cannot be differentiated on the basis of subsequent
testosterone production, neither does it appear that one subtype is more
responsive to the effects of hCG than the other. On the basis of these
correlations it is not possible to make a functional distinction between
light and dark Leydig cells.
As no correlations could be discerned between physical and
biochemical factors, the study went on to examine the relationship
between several intratesticular cell types and structures. Point counting
was undertaken in order to determine the volume of testis occupied by
each factor considered. The percentage composition of the testis was
remarkably similar between individuals (Table 5.2.). This suggested that a
biochemical, rather than a physical factor was important when
considering the variation in testosterone production by Leydig cells
isolated from these testes. It was hoped that correlations between
intratesticular cell types and structures would allow some insight into the
source and /or nature of this factor.
Both the nuclear and cytoplasmic volume of dark Leydig cells were
found to correlate with the same testicular structures and to the same
degree (see Table 5.4.). However, the volumes of light nuclei and
cytoplasm, although correlating with each other, did not show parallel
correlations with other testicular structures. It is possible that this is a
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reflection of the point counting system, as qualitatively, dark Leydig cells
appear to have cytoplasm of a uniform, regular size, while the cytoplasm
of light Leydig cells seems to be of more variable dimensions. Thus the
number of counts of dark Leydig cell cytoplasm would be relatively
consistent between sections whilst the number of counts of light Leydig
cell cytoplasm would be more variable, and so correlate less clearly with
the counts of light Leydig cell nuclei. A relationship between the
steroidogenic ability of Leydig cells and their content of smooth
endoplasmic reticulum (SER) has been demonstrated (Ewing & Zirkin,
1983), and when correlations were made between Leydig cell volume and
other testicular cell types, it was assumed that cytoplasmic rather than
nuclear correlations were of greater importance. After having been able to
draw no functional distinctions between light and dark Leydig cells on the
basis of correlations with in vitro testosterone production or fold
response to hCG, it was interesting to find that light and dark Leydig cell
cytoplasmic volume correlated with different testicular cell types and
structures. Both correlated with germ cell volume, which might be
expected as testosterone drives spermatogenesis (Steinberger, 1971). Both
also correlated with the volume of the interstitium and with the volume
of seminiferous epithelium taken up by fat droplets, although the
correlation was strongest for light rather than dark Leydig cell cytoplasm
(p <0.001 vs p <0.01). The volume of light Leydig cell cytoplasm alone
correlated with the volume of peritubular tissue and the volume of
interstitium occupied by blood vessels. Only the volume of dark Leydig
cell cytoplasm correlated with the volume of the tubular lumen. These
differential correlations could perhaps be the first indications of a
division of responsibilities between light and dark Leydig cells.
Considering first the correlations shown by light Leydig cells only,
can rational explanations for these correlations be given? If it is accepted
that the more active a cell is, the more demand it exerts on energy supply,
then a relationship between Leydig cell volume and blood vessel volume
might exist. Alternatively, Bergh & Damber (1992) demonstrated that
arterioles have androgen receptors and thus testosterone can be presumed
to have effects on the vasculature. Increasing thickness of the peritubular
wall is possibly a barrier to the transport of testosterone from the
interstitium into the seminiferous epithelium (Johnson, 1986). Thus the
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thicker the peritubular wall, perhaps the greater the amount of
testosterone needed to produce the high local concentrations that drive
spermatogenesis. While the volume of dark Leydig cell cytoplasm did not
correlate with these factors it did show a correlation with tubular lumen
volume. In their morphometric study of the rat testis, Wing &
Christensen (1982) describe variations in the size of the lumen according
to the stage of the spermatogenic cycle. There is a significant increase in
the volume of the lumen between stages V-VIII, followed by a significant
decrease in luminal volume after spermiation. The production of
seminiferous tubule fluid is testosterone-dependent (Jegou, 1983), so
perhaps this correlation is not surprising, although if this explanation is
accepted, it is not clear why the correlation is found with dark Leydig cells
only. Although the spatial organisation of the various stages of
spermatogenesis is not directly comparable between rat and man (Schulze
& Rehder, 1984), it is possible that lumen size in man could also vary in
accordance with the spermatogenic stage. As this study has not attempted
to distinguish germ cell types, lumen size is the only factor measured
which could possibly be related to the stage of spermatogenesis. Thus this
correlation might be indicative of a dialogue between the seminiferous
epithelium and dark Leydig cells.
Based on the different correlations observed between light and dark
Leydig cells and other testicular cell types, it is possible to postulate
different roles for light and dark Leydig cells. For example, one possible
interpretation of these findings is that a dialogue between the
seminiferous epithelium (probably via Sertoli cells) and Leydig cells does
exist, that it is related to the stage of the spermatogenic cycle, and is
mediated through dark rather than light Leydig cells. Thus while both
light and dark Leydig cells may be active testosterone producers, perhaps
only dark Leydig cells are responding directly to signals from the
seminiferous epithelium. Evidence does exist to support the hypothesis
of paracrine communication across the seminiferous epithelium of the
human testis into the interstitium. Verhoeven & Cailleau (1987)
demonstrated that cultured fragments of human seminiferous tubules
produce a factor(s) able to stimulate testosterone production by isolated
human Leydig cells. The authors speculated that such stimulatory factors
may act as paracrine regulatory molecules. Papadopoulos (1991)
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demonstrated that cultures of human Sertoli cells secrete a 79kDa protein
that is able to stimulate steroidogenesis by human Leydig cells. The
stimulatory effect of conditioned medium from human seminiferous
tubule cultures on testosterone production by isolated Leydig cells is
confirmed in studies described later in this thesis (chapter 9).
Bergh (1983, 1985) suggested the possibility of a Leydig cell cycle in
the rat, paralleling the spermatogenic cycle. It was demonstrated that
Leydig cells in the vicinity of stage VII-VIII tubules were significantly
larger than Leydig cells adjacent to tubules at other stages. Stages VII-VIII
have been shown to be androgen-dependent (Sharpe et al, 1988; Sharpe et
al., 1992). In a later study, Fouquet (1987), although unable to show
variations in Leydig cell profile area according to the stage of the
seminiferous epithelium of adjacent tubules, did find that SER content
was significantly higher when Leydig cells were adjacent to tubules at
stages VI-VIII compared to those at XI-XII. However, the study was unable
to correlate Leydig cell ultrastructure with the stages of the seminiferous
epithelium in adjacent tubules in the adult monkey (Macaca fascicularis).
There is some evidence for the existence of a Leydig cell cycle in the
human testis. Regadera et al. (1991) found that Leydig cells in the testes of
a 27 year old man exhibited different degrees of staining affinity for an
anti-testosterone antibody. As only 30% of morphologically normal
Leydig cells stained intensely for testosterone, and 10% showed no
staining at all, the authors suggested the differences could be due to
cyclical changes in the functional activity of Leydig cells.
It is therefore possible that a Leydig cell cycle exists in the human
testis which is controlled by factors secreted from the seminiferous
epithelium and that these signals are mediated through dark rather than
light Leydig cells. The influence of the seminiferous epithelium on the
remaining cells of the testis is suggested by the finding that of all the cell
types and structures considered, it is germ cell volume alone that
correlates significantly with all other factors measured. The idea that
germ cells have a paracrine function is gaining wider acceptance.
Accumulating evidence suggests that particular germ cell types can
modulate Sertoli cell secretory function (see succeeding chapters, also
Sharpe, 1992 and Jegou et al., 1992 for review). For example, Allenby et al.
(1991) demonstrated that the secretion of inhibin by rat seminiferous
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tubules in vitro was regulated by elongate spermatids. Reciprocal
influences also exist, in the rat it has been shown that testosterone exerts
important effects on tubular protein secretion (Sharpe et al., 1992).
Testosterone also acts on peritubular cells to stimulate the secretion of P-
Mod-S, which in turn modulates Sertoli cell function, at least in vitro.
Thus the cell-cell communication that occurs in the rat testis is complex
and is not limited to two cell interactions. Onoda et al. (1991)
demonstrated that the secretion of a Sertoli cell protein(s) that stimulated
Leydig cell steroidogenesis was modulated by the presence or absence of
pachytene spermatocytes. Thus, in the rat, the modulatory influence of
germ cells on other testicular cell types is becoming more clear. The
results of the present study, in which germ cell volume correlated with
all other testicular components, suggests that germ cells may have a
similarly important role in the human testis.
In conclusion, the studies described in this chapter have confirmed
that the number of Leydig cells present in the human testis declines with
age. No correlation was found between the number of Leydig cells per
testis and the ability of these Leydig cells to produce testosterone when
isolated and cultured. This demonstrates that it is not the size of the
testicular Leydig cell population which determines the ability of Leydig
cells to produce testosterone in vitro. The majority of testes examined
contained an equal number of light and dark Leydig cells regardless of
total population size. It was not possible to deduce if light or dark Leydig
cells had different abilities to produce testosterone. Nor was any
difference found in the fold responsiveness to stimulation by hCG of
either Leydig cell type. In spite of the considerable individual variations
in testosterone production the percentage composition of the testis on a
volume basis was remarkably consistent. This suggests that it is a
biochemical rather than a physical factor that is important with respect to
the in vitro variations found. Light and dark Leydig cell cytoplasmic
volumes correlated with different testicular factors, though the relevance
of this to their role as steroid producers was not clear. Germ cell volume
correlated with all other measurements taken, suggesting a pervading
influence of germ cells on all aspects of testicular function.
6. Intratesticular control mechanisms in rat and
man
The preceding chapters have described how it is possible to isolate Leydig
cells from the human testis which are responsive to hCG, and appear to
be representative of the normal population of Leydig cells in the human.
The aim of studies described in the present chapter was to use isolated
human Leydig cells to examine intratesticular control of steroidogenesis
in man and to compare methods of local regulation in the rat and human
testis.
6.1. Introduction
The most important physiological regulator of testosterone production by
Leydig cells is LH (Dufau, 1988), yet many other compounds have been
shown to modify rat Leydig cell function either in vivo or in vitro (for
review see Heindel & Treinen, 1989). At the same time, because so little is
known about human Leydig cell function (Sharpe, 1990) other species
must be used as models for human Leydig cells in studies of endocrine
and paracrine control of steroidogenesis. The aims of this study were
therefore to investigate how testosterone production may be modulated
locally in human Leydig cells, by examining the direct effects of various
putative paracrine agents on isolated human Leydig cells, and to compare
these findings with the effects of the same agents on testosterone
production in rat Leydig cells.
The possible paracrine effects of AVP and LHRH on steroidogenesis
in rat and man were compared. Both agents were selected for
investigation because their effects in the rat have been well-characterised.
Rat Leydig cells have LHRH receptors (Bourne et al., 1980), through which
LHRH mediates both stimulatory (short-term, Sharpe & Cooper, 1982)
and inhibitory effects (long-term, Sharpe et al., 1983). Rat Sertoli cells in
culture produce an LHRH-like activity (Sharpe et al., 1981) detectable in
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interstitial fluid. Similarly in the rat, Leydig cells have AVP (Vj)
receptors (Meidan & Hsueh, 1985), an AVP-like factor has been localised
to the testis (Kasson et al., 1985) and AVP has been shown to have in vitro
effects on rat Leydig cell testosterone production (Sharpe & Cooper, 1987,
Tahri-Joutei & Poinds, 1988).
More recently evidence has accumulated that suggests the
involvement of endogenous benzodiazepines in the intracellular
regulation of steroidogenesis in the rat. As was the case for AVP and
LHRH, peripheral benzodiazepine receptors have been localised to the rat
testis (Anhoult et al., 1986), the ligand for these receptors (diazepam
binding inhibitor, DBI) has been found in the testis (Rheame et al., 1990),
and benzodiazepines such as diazepam, have been shown to have in
vitro effects on rat Leydig cell testosterone production (Papadopoulos et
al., 1990).
The final compound to be investigated as a potential paracrine
regulator of steroidogenesis in human Leydig cells, atrial natriuretic
peptide (ANP), was included for different reasons. Unlike AVP, LHRH
and benzodiazepines, the effect of ANP on isolated rat Leydig cells is
unclear. Some groups report a stimulatory effect of ANP on rat Leydig cell
cultures (Foresta et al., 1987), and others say that while ANP is able to
stimulate testosterone production by isolated mouse Leydig cells, it has no
effect on rat Leydig cells (Muhkopadhyay et al., 1986). However, Foresta et
al. (1991) report that infusion of ANP into the cubital vein of men
increases the concentration of plasma testosterone measured in the
internal spermatic vein, without affecting the concentration of
gonadotrophins. This implies that ANP has a direct effect on human
Leydig cells.
The effects of these compounds on basal and hCG-stimulated
testosterone production by rat and human Leydig cells were therefore
investigated.
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6.2. Experimental Procedures
Rat and human Leydig cells were prepared using the methods described
in Chapter 3. The effects of various in vitro treatments on testosterone
production over periods of either 4 and/or 20h were assessed. The effects
of the treatments on both basal and hCG-stimulated testosterone
production were examined. A concentration of 30IU/ml hCG (Intervet
U.K. Ltd, Cambridge) was used to maximally stimulate Leydig cell
cultures. The hCG was diluted in culture medium. Preparation of the
drug solutions used to treat the cultures is described below.
LHRH-A : A 1.5mg/ml commercial preparation of [D-Ser(tBu)6,Pro9-
NHEt] LHRH, (buserelin, 'LHRH-A'; Hoescht AG, Frankfurt) was diluted
to concentrations between 10"8 and 10~6M using culture medium. The
stock solution was stored at 4°C.
AVP : lmg of arginine vasopressin (Sigma) was dissolved in 1ml of
culture medium. Aliquots of 15(il were stored frozen for up to 3 months.
When required, 10pl of the thawed stock solution were further diluted to
give a final concentration of 10~6M.
Diazepam : Diazepam (Sigma) was stored frozen as a stock solution of 10"
4M in 1% DMSO (BDH). Thawed aliquots were further diluted in culture
medium to concentrations between 10"8 and 10"6M.
Rat DBI : The rat specific form of diazepam binding inhibitor (rDBI;
Bachem Inc., Essex) was dissolved in double distilled water to give a stock
solution of 10"4M. Aliquots were stored frozen for up to 2 months. When
required, thawed aliquots were further diluted in culture medium to
concentrations between 10"8 and 10"6M.
Human DBI : The human specific form of diazepam binding inhibitor
(hDBI; Bachem Inc., Essex) was prepared in the same way as rDBI,
described above.
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ANP : Atrial natriuretic peptide (1-28), human sequence (ANP; Bachem
Inc., Essex) was dissolved in double distilled water to give a stock solution
of 10"4M. Aliquots were stored frozen until required and were then
diluted further in culture medium to concentrations between 10~8 and
lO^M.
6.3. Results
LHRH-A : Concentrations of 10~6-10"8M LHRH-A had significant
stimulatory effects (p <0.01)on basal testosterone production by rat Leydig
cells. The 3 doses had equivalent effects on testosterone production
during a 4h culture period (Figure 6.1.A). However, following 20h in
culture only 10~6M LHRH-A significantly stimulated testosterone
production (p <0.01; Figure 6.2.A). At neither time point did rat Leydig
cells respond to LHRH-A in the presence of a maximally-stimulating dose
of hCG (Figures 6.1.B and 6.2.B). As there was no difference in the
response of rat Leydig cells to the LHRH-A concentration range used, a
single dose of 10~6M LHRH-A was used with human Leydig cell cultures.
On at least 3 (4h cultures) and 4 (20h cultures) separate occasions human
Leydig cells were isolated and incubated with LHRH-A. Due to the
marked individual variation in testosterone production by isolated
human Leydig cells it was not possible to collate results obtained from
different cell preparations. Rather, a representative result is presented as a
figure, while results from the remaining experiments are given in an
associated table. In 2 out of 3 experiments, LHRH-A had a significant
stimulatory effect on basal testosterone synthesis after 4h of culture (p
<0.05; Figure 6.1.C and Table 6.1.). After 20h in culture LHRH-A still
significantly stimulated basal testosterone production by isolated human
Leydig cells in 3 out of 4 experiments (Figure 6.2.C and Table 6.1.). As with
rat Leydig cells, human Leydig cells did not respond to LHRH-A in the
presence of hCG.
AVP : Basal testosterone production by rat Leydig cells was stimulated by
AVP (10"6-10~8M) at 4h (p <0.01; Figure 6.3A), but this stimulatory effect
was absent after 20h of culture (Figure 6.4A). Basal testosterone
production by human Leydig cells was stimulated significantly by AVP at
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4h in 2 out of 3 experiments (p <0.05; Figure 6.3C and Table 6.2). After 20h
of culture basal testosterone production by human Leydig cells was
enhanced by AVP, although the stimulation only reached significance in
1 out of 3 experiments (Figure 6.4.C and Table 6.2.). At neither time-point
did either rat or human Leydig cells stimulated with hCG respond to AVP
(Figures 6.3.B and D, 6.4.B and D and Table 6.2.).
Diazepam : Diazepam induced a significant, dose-dependent stimulation
of basal testosterone production by rat Leydig cells during a 20h culture
period (Figure 6.5.A). When individual experiments were considered a
small consistent stimulatory effect of diazepam was seen, which was
statistically significant; however, when the results of 5 separate
experiments were pooled, this effect was obscured by the differing
responses to hCG in each experiment (Figure 6.5.B). In contrast human
Leydig cells did not respond to even the highest concentration of
diazepam either under basal or hCG-stimulated conditions (Figure 6.5.C
and D and Table 6.3.).
Rat DBI : Rat DBI also induced a significant dose-dependent stimulation
of basal testosterone production by rat Leydig cells during a 20h culture
period (Figure 6.6A), but had no effect on hCG-stimulated testosterone
production (Figure 6.6B). Fluman Leydig cells did not respond to rat DBI
under either basal or hCG-stimulated conditions (Figure 6.6 C and D and
Table 6.3).
Human DBI : Neither rat nor human Leydig cells responded to human
DBI under either basal or hCG-stimulated conditions (Figure 6.7 and
Table 6.3).
ANP : There was no response to ANP by either rat or human Leydig cells
under basal or hCG-stimulated conditions (Figure 6.8 and Table 6.4).
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Figure 6.1. The effects of LHRH-A on testosterone production by
rat and human Leydig cells cultured for 4h.
A. basal testosterone production by rat Leydig cells (n=5). B. hCG-
stimulated testosterone production by rat Leydig cells( n=5). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the meaniS.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
<0.05, **p <0.01, significantly different from basal values.
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Figure 6.2. The effects of LHRH-A on testosterone production by
rat and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=5). B. hCG-
stimulated testosterone production by rat Leydig cells( n=5). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
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Table 6.1. The effects of LHRH-A on testosterone production by
human Leydig cells cultured for 4 or 20h.
Each value in the table is the mean±S.D. of triplicate wells for further
experiments with human Leydig cells. Testosterone was measured as
ng/106 cells. The results of individual experiments have been presented
because of the variability in testosterone production between preparations
(see chapter 4). *p <0.05, **p <0.01, significantly different from basal
values.
A. 4 hours
ua(;a1 10 LCV hCG +10
LHRH-A LHRH-A
*
0.006±0.004 0.06+0.12 4.08±1.6 3.56±0.88
1.5±0.14 2.6±0.33 54.211.99 43.213.96
B. 20 hours
basal 10 ^ hCG hCG +10_6m
LHRH-A LHRH-A
**
11.411.1 17.212.1 16.415 18.317.3
235.8136.1 373.99157.7 1245.11148.6 1242.4158.18
150.46116.9 217.1122.5*
Chapter Six Intratesticular control mechanisms 118
Figure 6.3. The effects of AVP on testosterone production by rat
and human Leydig cells cultured for 4h.
A. basal testosterone production by rat Leydig cells (n=4). B. hCG-
stimulated testosterone production by rat Leydig cells( n=4). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean+S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
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Figure 6.4. The effects of AVP on testosterone production by rat
and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=5). B. hCG-
stimulated testosterone production by rat Leydig cells( n=5). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p




































Chapter Six Intratesticular control mechanisms 120
Table 6.2. The effects of AVP on testosterone production by
human Leydig cells cultured for 4 or 20h.
Each value in the table is the mean±S.D. of triplicate wells for further
experiments with human Leydig cells. Testosterone was measured as
ng/106 cells. *p <0.05, significantly different from basal values.
A. 4 hours
,1 IQ*M. hrr hCG +10_6MbaSal
AVP hCG AVP
*
0.006±0.004 0.04±0.15 4.08±1.6 5.3±1.8
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Figure 6.5. The effects of Diazepam on testosterone production
by rat and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=5). B. hCG-
stimulated testosterone production by rat Leydig cells( n=5). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
<0.05, **p <0.01, significantly different from basal values.
o10"8"710 610-8-710 6 concentrationfdiazepam(M)concen rationfdiaz pam( )
Chapter Six Intratesticular control mechanisms 122
Figure 6.6. The effects of rat DBI on testosterone production by
rat and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=4). B. hCG-
stimulated testosterone production by rat Leydig cells( n=4). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
<0.05, **p <0.01, significantly different from basal values.
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Figure 6.7. The effects of human DBI on testosterone production
by rat and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=3). B. hCG-
stimulated testosterone production by rat Leydig cells( n=3). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells.
o10"87'610"8"71 6 concentrationfhumanDBI(M)concentrationhu I( )
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Table 6.3. The effects of Diazepam, rat DBI and human DBI on
testosterone production by human Leydig cells cultured for 20h.
Each value in the table is the mean+S.D. of triplicate wells for further
experiments with human Leydig cells. Testosterone was measured as
ng/106 cells.
A. Diazepam
























0.27±0.05 0.26710.049 0.26610.05 0.20410.05 6.5911.28 6.5211.67 6.5911.28
0.51±0.01 0.3710.03
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Figure 6.8. The effects of hANP(l-28) on testosterone production
by rat and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=3). B. hCG-
stimulated testosterone production by rat Leydig cells( n=3). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
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Table 6.4. The effects of hANP(l-28) on testosterone production
by human Leydig cells cultured for 20h.
Each value in the table is the mean±S.D. of triplicate wells for further
experiments with human Leydig cells. Testosterone was measured as
ng/106 cells.
basal »»;6M hCGANP ANP
0.513±0.102 0.605±1.54 1.77±1.07 1.8±1.1
Chapter Six Intratesticular control mechanisms 127
6.4. Discussion
The experiments described in this chapter comprise an investigation into
the actions of possible local modulators of steroidogenesis in vivo, on
testosterone production by isolated human Leydig cells in vitro. A
comparison was made between the effects of these potential paracrine
regulators on human and rat Leydig cells.
The effects of both LHRH-A and AVP are well-documented in the
rat. In short-term cultures (<24h) LHRH-A has a stimulatory effect on
testosterone production by rat Leydig cells (Sharpe & Cooper, 1987, Cooke
& Sullivan, 1985). While such effects in the rat were confirmed in this
study, a novel finding was that 10~6M LHRH-A had a direct stimulatory
effect on basal, though not hCG-stimulated, testosterone production by
human Leydig cells. The effect was seen after both 4 and 20h of culture
and closely parallels the response of rat Leydig cells in vitro to LHRH-A.
Previous studies have not supported a paracrine role for LHRH in the
human testis, partly based on the apparent lack of a direct testicular effect
of LHRH-A in vivo (Rajfer et al, 1987, Vicari et al., 1986). However, these
studies examined the ability of LHRH-A to alter hCG-stimulated
testosterone production, yet the results described in this chapter for
human and rat Leydig cells, and by Sharpe & Cooper (1982; 1987) for rat
Leydig cells, demonstrate that the direct effect of LHRH-A on isolated
Leydig cells is on basal and not hCG-stimulated testosterone production.
The strongest evidence against a paracrine role for LHRH in the human
testis is the study by Clayton & Huhtaniemi (1982), which found that
while testicular binding sites for LHRH-A were easily demonstrable in the
rat, there were no high affinity binding sites for LHRH-A in either
human testis or corpus luteum (CL). However, a later study by Popkin et
al. (1985), detected low affinity binding sites for LHRH-A in both human
CL and testis. These low affinity binding sites are now well-described in
the human ovary and placenta where they have been shown to mediate
biological effects of LHRH and its agonists (Bramley, 1989). These low
affinity LHRH binding sites exhibit comparable affinity for LHRH agonists
and native LHRH. In contrast, in rat gonads LHRH agonists have 100-1000
times greater affinity for the binding site than LHRH itself. This suggests
the existence of a human binding site for LHRH with a different
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conformation to its rat counterpart. It is therefore possible that Clayton &
Huhtaniemi (1982) were unable to detect LHRH binding sites in extra-
pituitary binding sites because they were using an inappropriate agonist
for the receptor. It is also possible that human Leydig cells contain fewer
LHRH binding sites than do rat Leydig cells. This is true in the case of the
LH receptor, where rat Leydig cells are estimated to have 23,500 binding
sites/cell, and the human Leydig cell only 1,630 sites/cell (Huhtaneimi et
al, 1982). The present finding of stimulatory effects of LHRH-A on basal
testosterone production by 3 separate preparations of human Leydig cells
is consistent with the presence of low affinity LHRH binding sites in the
human testis and also with the description of the biological activity of
similar receptors in the human ovary and placenta. However, the nature
and physiological role of testicular LHRH is obscure (Sharpe, 1990) and
the functional relevance of any direct effect of LHRH in the testis is not
clear.
This study has confirmed that the peptide hormone, AVP, has
short-term stimulatory effects on basal testosterone secretion by rat Leydig
cells (Sharpe & Cooper, 1987, Tahri-Joutei & Pointis, 1988). In addition it
has shown that isolated human Leydig cells may also respond to AVP: a
significant stimulation of basal testosterone production was seen at 4h in
2 out of 3 separate preparations of human Leydig cells and in 1 out of 3
separate preparations at 20h. AVP did not affect hCG-stimulated
testosterone production by either rat or human Leydig cells at 4 or 20h of
culture. The absence of a response to AVP in the presence of a
supramaximal dose of hCG has been described previously, in purified rat
Leydig cell cultures (Sharpe & Cooper, 1987), and in purified mouse
Leydig cell cultures (Tahri-Joutei & Pointis, 1988). In the rat there is strong
evidence for a potential paracrine role for testicular AVP. Kasson et al.
(1985), established the presence of AVP-like peptides in the rat testis,
where they may have local effects on steroidogenesis (Tahri-Joutei &
Pointis, 1988) which are mediated through specific (Vi) receptors localised
to Leydig cells (Meidan & Hsueh, 1985). Kasson et al. (1985) demonstrated
the presence of an immunoreactive AVP-like substance in the rat testis.
The apparent testicular content of AVP was 600pg/testis, indicating the
presence of AVP in sufficient amounts to exert a local modulatory effect
on testicular function.
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While no study has looked for the presence of AVP receptors on human
Leydig cells, an immunoactive vasopressin-like material has been
isolated from human testicular tissue (Nicholson et al., 1984). This,
together with the results of this study showing direct stimulatory effects
of AVP on testosterone production by human Leydig cells in vitro,
supports a role for AVP as a potential paracrine regulator of human
steroidogenesis. However the physiological significance of these
observations is unclear, as Tahri-Joutei & Poinds (1989) have shown that
an intratesticular injection of AVP does not modify testosterone levels
when measured 5-6 hours later in the mouse testis, neither does such an
injection alter the amounts of testosterone measurable in rat testicular
interstitial fluid (Sharpe & Cooper, 1987).
The evidence that endogenous benzodiazepines may have a role in
the local control of steroidogenesis is reasonably strong. There are two
classes of benzodiazepine receptor, one class is entirely localised within
the CNS, while the second class of 'peripheral' benzodiazepine receptors
(PBR) is found in high levels in some steroidogenic organs, including the
testis and the adrenal cortex (De Souza et al., 1980). It is now known that
PBR are located primarily in mitochondrial membranes (Antkiewicz-
Michaluk et al., 1988) and the cell type that contains the majority of PBR is
the Leydig cell (Calvo et al., 1990). Anhoult et al. (1986) showed that the
density of rat adrenal and testicular PBR decreases after hypophysectomy.
The demonstration that PBR density could be altered by hormone
manipulation suggested a possible role for endogenous benzodiazepines
in steroidogenesis. It has since been shown that PBR agonists, such as Ro
5-4864 or diazepam, have stimulatory effects on testosterone production
by decapsulated rat testes (Ritta et al., 1987), crude interstitial cell
suspensions (Ritta & Calandra, 1989), purified rat Leydig cells and also in
MA-10 cells (Papadopoulos et al., 1990). The endogenous ligand for PBR is
believed to be a polypeptide termed diazepam binding inhibitor (DBI)
because of its ability to displace diazepam from PBR. DBI has been isolated
and characterised from rat brain (Guidotti et al., 1983), and has since been
localised to the rat testis, specifically to Leydig cells (Rheaume et al., 1990).
In agreement with the study by Papadopoulos et al. (1990), this study also
demonstrated that diazepam causes dose-dependent stimulation of basal
testosterone production by rat Leydig cells. However, isolated human
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Leydig cells showed no response to diazepam even at the highest
concentration tested. Diazepam is not a specific agonist for PBR but has
affinity for both central and peripheral benzodiazepine receptors. DBI,
which occurs in both human and rat forms is the preferred ligand for the
PBR. The effects of both forms of DBI on testosterone production by rat
and human Leydig cells were examined. Basal testosterone secretion by
rat Leydig cells was stimulated by rat DBI as has been shown previously
(Papadopoulos et al, 1991), but the human form of DBI had no effect on
testosterone production by rat Leydig cells. Testosterone secretion by
human Leydig cells was not affected by either the rat or human form of
DBI. Kreuger & Papadopoulos (1990) have shown that modulation of
steroid production by ligands of PBR involves activation of
intramitochondrial cholesterol transport. As the transfer of cholesterol
from intracellular stores to the outer mitochondrial membrane and then
to the inner mitochondrial membrane is the rate limiting step in
steroidogenesis, it is possible that one of the most crucial points in the
steroidogenic pathway may involve different control mechanisms in rat
and human Leydig cells. However, rat DBI can be digested to smaller
peptide fragments such as ODN (octadecaneuropeptide) which can also
displace diazepam from PBR. It may be that in the human testis it is a
peptide fragment of DBI which is active and isolated human Leydig cells
lack the ability to form this fragment in vitro. However, given the ability
of both diazepam and rat DBI to stimulate testosterone production in rat
Leydig cells and the inability of both diazepam and human DBI to affect
testosterone production by human Leydig cells, there is a strong
possibility that a genuine difference occurs in the mode of
intramitochondrial cholesterol transport in the rat and human testis.
ANP has also been proposed as having a role in the local
regulation of testosterone production. It has been shown to stimulate
testosterone and cGMP production in isolated mouse Leydig cells (Bex &
Corbin, 1985, Mukhopadhyay et al., 1986). Foresta & Mioni (1988) showed
that hANP (1-28) also had a stimulatory effect on testosterone and cGMP
production by rat Leydig cells; however whilst Mukhopadhyay et al. (1986)
were able to show an increase in cGMP by isolated rat Leydig cells, they
found no effect of ANP on testosterone production. Foresta et al. (1991)
demonstrated that an infusion of 100pg/ml ANP into the cubital vein
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had a significant effect on plasma testosterone measured in blood
sampled from the internal spermatic vein in men undergoing varicocele
embolization. An increase in testosterone concentration in the internal
spermatic vein was evident within 15 minutes of the ANP infusion,
while no significant rise in testosterone concentration was measurable in
peripheral plasma. There was no effect on serum gonadotrophin levels in
blood sampled from either the internal spermatic or peripheral veins.
The authors suggested that ANP exerts a stimulatory effect on testicular
steroidogenesis in men without modifying pituitary gonadotrophin
secretion, i.e. they propose that ANP has a direct effect on human Leydig
cells. The results of experiments presented in this chapter are consistent
with the findings of Mukhopadhyay et al. (1986) in that no effect of ANP
on testosterone production by rat Leydig cells was demonstrable. Neither
were human Leydig cells found to respond to ANP. When considering
the results obtained by Foresta et al. (1991), the lack of a direct effect of
ANP on isolated human Leydig cells, could indicate that the
responsiveness of human Leydig cells to ANP is lost in vitro, possibly as a
consequence of the isolation procedure. However, it is also possible that
the changes in spermatic vein testosterone levels measured by Foresta et
al. (1991) reflect changes in the rate of testicular blood flow caused by the
vasodilatory effect of ANP. Until this can be clarified there does not seem
to be any evidence for a paracrine role for ANP in the human testis.
In summary, the work described in this chapter examines how
steroidogenesis may be altered at the intratesticular level in rat and
human Leydig cells. In many respects modulation of rat and human
Leydig cell function appeared to be very similar; both rat and human
Leydig cells were stimulated to produce testosterone in vitro by AVP and
an LHRH-A, and neither showed an in vitro response to ANP. However,
differences were also discovered, as unlike rat cells, isolated human
Leydig cells did not respond to benzodiazepines. As rat Leydig cells are
often used as a model of what might happen in man, it is important to
know that human Leydig cells do not show responses that are markedly
different to those shown by rat Leydig cells. The results of the present
study suggest that, overall, rat Leydig cells are a good model for human
Leydig cells. Studies described later in this thesis on protein secretion
(chapter 8) and toxicology (chapter 10) also support this conclusion.
7. Indirect modulation of Leydig cell function by
germ cells
The previous chapter has demonstrated how isolated Leydig cells can be
used to investigate the effects of putative paracrine agents. However
while it is possible to demonstrate effects in vitro it remains uncertain
whether such results can be extrapolated to the in vivo situation.
Cultured rat Sertoli cells produce factors(s) which are able to stimulate
Leydig cell steroidogenesis in vitro, and it has been demonstrated that the
production of such factors can be modulated by germ cells. This raises the
possibility that in vivo there is a cascade of cell-cell interactions with the
presence/absence of particular germ cells leading to alterations in the
Leydig cells, presumably via the mediation of Sertoli-cell secreted factors.
The present chapter describes studies which were designed to test this
possibility.
7.1. Introduction
The ability of isolated rat Leydig cells to produce testosterone in vitro can
be affected by the addition of a large number of compounds (for review
see Heindel & Treinen, 1989 and the previous chapter). While there is
only limited evidence supporting the production and function of such
compounds in vivo, there is abundant evidence of regulatory interactions
between testicular cell types which reach across the two compartments of
the testis. Such local control systems would allow the functional
responses of cells to be more finely controlled than would be possible
through pituitary regulation alone.
Several studies have shown that damage to the seminiferous
epithelium, caused by local administration of anti-androgens (Aoki &
Fawcett, 1978), y-irradiation (Papadopoulos et al., 1987b), cryptorchidism
(Risbridger et al., 1981) or local testicular heating (Jegou et al., 1984), can
secondarily affect Leydig cell structure and/or function. More direct
evidence of a functional interaction between germ cells, Sertoli cells and
Chapter Seven Germ cell modulation of Leydig cell function 133
Leydig cells was provided by Onoda et al. (1991), who showed that Sertoli
cells in culture secrete a protein(s) which stimulates Leydig cell
steroidogenesis, and that pachytene spermatocyte (PS) proteins were able
to modulate the polarised secretion of the Sertoli cell protein(s). While
this is the first direct evidence of germ cell-Sertoli cell-Leydig cell
interactions, it still has several limitations. These include the use of
immature Sertoli cells and the separation and isolation of cell types with
consequent changes in their function. An alternative approach involving
the use of the germ cell specific toxin, methoxyacetic acid (MAA) was
outlined by Bartlett et al. (1988). Administration of MAA to rats causes
selective and stage-specific destruction of PS. A dose of 650 mg/kg results
in PS degeneration at all stages of the spermatogenic cycle except for PS at
early-mid stage VII (Foster et al., 1983, Creasy et al., 1985). At this dose
MAA has no other discernable adverse effects on the rats, and the
unaffected germ cells continue to progress normally through
spermatogenesis (Ratnasooriya & Sharpe, 1989). The mechanism by
which MAA exerts this selective effect is unknown, neither is it
understood how a subset of PS at early-mid stage VII are resistant to the
action of MAA. However, Chowdhury & Steinberger (1964) found that
local heating of the testis also only affected PS at specific stages.
The consequences of maturation depletion allow MAA to be used
to generate testes that are depleted of specific types of germ cells, while all
other testicular cells are intact, leaving the majority of cell-cell
interactions to proceed as normal. Thus at 3 days after administration of
MAA seminiferous tubules at all stages of the spermatogenic cycle except
VIII-XI are depleted of PS. By 7 days, seminiferous tubules at stages VII-
XIII have been depleted of PS, while seminiferous tubules at stages II-VI
are depleted of round spermatids (RS) because of maturation depletion.
At 14 days post-MAA treatment, all tubules apart from those at stage VIII
have no RS, while by day 21 seminiferous tubules at stages IV-VIII and IX-
XI lack elongating and elongate spermatids (ES).
The experiments described in this chapter have used MAA to
deplete the testes of specific types of germ cells in order to investigate the
effect of selective germ cell depletion in vivo on the function of Leydig
cells isolated from these testes and cultured in vitro. The effects of such
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interactions between testicular cells on the in vitro actions of a putative
paracrine regulator of Leydig cell function (LHRH) were also examined.
7.2. Experimental Procedures
7.2.1. Preparation of Methoxyacetic Acid (MAA)
To prepare a stock solution of MAA (Aldrich) suitable for oral
administration, 10.8ml MAA (pH 0.5) were diluted with concentrated
sodium hydroxide to between pH 7.0-7.4. The solution was made up to a
final volume of 45ml with saline. This solution was prepared when
required.
7.2.2. Dosing regimen
Adult male rats aged 70-100 days were administered a single oral dose of
650mg/kg MAA by gavage. Control animals received an equivalent
volume of saline alone. This dose of MAA has been shown previously to
deplete rat seminiferous tubules of the majority of pachytene and later
spermatocytes within about 24 hours of administration (Bartlett et ah,
1988).
7.2.3. Isolation of Leydig cells from germ cell depleted testes
At predetermined time points, namely, 3, 7, 14, 21 and 42 days post-
treatment, Leydig cells from 4 control and 4 treated rats were isolated in
parallel using the methods described in Chapter 3. Leydig cells from each
group were incubated for 20h. Basal and maximal hCG-stimulated
testosterone production were studied. In addition the response of the
Leydig cells to the LHRH agonist, buserelin (LHRH-A) was assessed.
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7.3. Results
The basal testosterone output of Leydig cells isolated from control and
MAA-treated rats at each time-point, is shown in Figure 7.1. Leydig cells
isolated from testes in which the major germ cell types depleted were a
combination of RS and PS (MAA+7 days), or ES (MAA+21 days) did not
differ from Leydig cells isolated from control testes in their ability to
produce testosterone in vitro, in the absence of hCG. Leydig cells isolated
3 days after MAA administration produced significantly more
testosterone in vitro (p <0.01) than did Leydig cells isolated from control
rat testes. A similar increase (p <0.05) in Leydig cell responsiveness was
observed at 14 days after MAA-treatment. At 3 days after MAA-treatment
testes are depleted of 80-100% of PS and later spermatocytes (Ratnasooriya
& Sharpe, 1989), whereas by 14 days after MAA administration
seminiferous tubules are depleted mainly of RS. The effect of in vivo
administration of MAA on the ability of isolated Leydig cells to respond
to hCG stimulation in vitro is shown in Figure 7.2. The production of
testosterone in response to hCG showed marked between-experiment
variation in both control and MAA-treated groups and overall there was
no evidence for any significant change as a result of the in vivo treatment
(ANOVA; p = 0.688). At 42 days after MAA treatment, by which time a
normal full complement of germ cells has been restored (Bartlett et al.,
1988), there was no difference in basal testosterone production in vitro by
Leydig cells isolated from either control or treated rats (Figure 7.1.1).
The effect of the addition of 10~6M LHRH-A to cultures of Leydig
cells isolated from control and MAA-treated rats, on days 3, 7, 14 and 21
after administration of MAA are shown in Figure 7.3. LHRH-A had a
stimulatory effect on basal testosterone production by isolated Leydig cells
in all instances. With Leydig cells isolated from control rats this effect
reached significance on days 3 and 14 post-treatment. Figure 7.3A shows
the response to LHRH-A of Leydig cells isolated from control and from
treated animals 3 days (d3) after administration of MAA. Leydig cells from
the control animals show a significant stimulatory response to LHRH-A
(p <0.01). The response of Leydig cells from d3 MAA-treated animals to
LHRH-A was also significant, but to a lesser degree (p <0.05). In fact, with
Leydig cells from control animals the fold increase in testosterone
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production caused by LHRH-A was x4.9, while in Leydig cells isolated
from d3 MAA-treated animals the fold response fell to xl.46. A similar
picture was evident when comparing Leydig cells from control animals
with Leydig cells isolated from MAA-treated animals at 14 days (dl4) post-
treatment (Figure7.3C). Leydig cells from control animals showed a
significant stimulatory response (x2.18-fold) to LHRH-A (p <0.05), whilst
Leydig cells from dl4 MAA-treated animals did not show a statistically
significant response to LHRH-A (xl.25-fold). At both 3 and 14 days after
MAA treatment, the decline in fold responsiveness to LHRH-A was due
to the increase in basal testosterone production (Figure 7.1.) rather than to
a decrease in the absolute amount of testosterone produced in response to
LHRH-A. When Leydig cells were isolated from MAA-treated rats at 7
and 21 days post-treatment, there was no difference in either basal
testosterone production or in testosterone production in response to
LHRH-A, between Leydig cells isolated from either treated or control
animals.
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Figure 7.1. The effects of administration of MAA on basal
testosterone secretion by rat Leydig cells at successive intervals
after treatment.
The graph shows basal testosterone secretion in control (o) and treated (•)
rats. Each point is the mean±S.D of 3 separate experiments. *p <0.05, **p
<0.01, treated value significantly different from control value at that time
point.
days after MAA treatment
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Figure 7.2. The effects of administration of MAA on hCG-
stimulated testosterone secretion by rat Leydig cells at successive
intervals after treatment.
The graph shows hCG-stimulated testosterone secretion in control (o) and
treated (•) rats. Each point is the mean±S.D of 3 separate experiments.
0 10 20 30 40 50
days after MAA treatment
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Figure 7.3. The effects of LHRH-A on basal testosterone secretion
by rat Leydig cells isolated from control and MAA-treated rats at
successive intervals after treatment.
The graph shows basal testosterone secretion in response to LHRH-A in
control (o) and treated (•) rats. A. 3 days post-MAA administration. B. 7
days post-MAA administration. C. 14 days post-MAA administration. D.
21 days post-MAA administration. Each point is the mean±S.D of 3
separate experiments. *p <0.05, **p <0.01, effect of LHRH-A significantly
different from the appropriated control.
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7.4. Discussion
The experiments described in this chapter were designed to use in vivo
depletion of specific germ cell types to examine in vitro the potential
cascade of cell-cell interactions whereby germ cells acting through Sertoli
cells might exert an influence on Leydig cell function. Also, LHRH
agonists are widely considered to have a potential paracrine role in the
rat, and possibly the human, testis (see chapter 6). Thus the effect of in
vivo germ cell depletion on the in vitro response of Leydig cells to this
potential paracrine modulator was investigated.
In the rat there is growing evidence to support the existence of
functional interactions between the various cell types and compartments
of the testis (for reviews see Sharpe, 1986, Tahka, 1989, Sharpe, 1990,
Skinner, 1991). For instance it has been shown that addition of enriched
preparations of particular germ cell types (PS or RS) to immature Sertoli
cell cultures modulates the secretion of Sertoli cell products such as
oestradiol (Jegou et al, 1988), transferrin (Le Magueresse et ah, 1988) and
ABP (Galdieri et al., 1984). It is also clear that Sertoli cell function changes
according to the stage of the spermatogenic cycle (Parvinen, 1992) and this
is considered to be a consequence of the changing germ cell complement
at each stage (Sharpe, 1986). In support of this hypothesis it has been
shown that there is a rapid decline in the secretion of a number of Sertoli
cell products following partial or major depletion of particular germ cells
from the seminiferous epithelium. Vihko et al. (1984) demonstrated that
selective depletion of preleptotene spermatocytes by X-irradiation of the
testes abolished the peak secretion of plasminogen activator which occurs
at stages VII-VIII in the normal testis. This abolition was not seen when
other classes of germ cell were depleted. Similarly, Allenby et al. (1991)
showed that the rate of secretion of immunoactive inhibin by Sertoli cells
was modulated by the depletion of ES (and possibly PS), while the
depletion of other germ cell types had no effect on inhibin secretion.
Recently it has been demonstrated that co-culture of Sertoli cells with
either PS or RS increases the expression of the preproenkephalin gene by
Sertoli cells (Fujisawa et al., 1992). Altogether results such as these imply
that there is active communication between germ cells and Sertoli cells.
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Available evidence also indicates the existence of Sertoli cell-Leydig
cell interactions. Factors which probably derive from Sertoli cells have
been shown to alter Leydig cell testosterone secretion in vitro. Rat Sertoli
cells are thought to produce 'testicular LHRH' (Sharpe et al, 1981) and
Leydig cells are the only testicular cells known to have LHRH receptors
(Bourne et al., 1980). Also, addition of Sertoli cell conditioned medium to
Leydig cell cultures enhances testosterone production (Janecki et al., 1985,
Verhoeven & Cailleau, 1985, Papadopoulos et al., 1987b, Grootenhuis et
al., 1990). In the rat, Sertoli cell secreted proteins have also been shown to
stimulate Leydig cell replicative DNA synthesis in vitro (Ojeifo et al.,
1990).
Recently Onoda et al. (1991) demonstrated that the influence of
germ cells on other testicular cell types extended beyond the seminiferous
epithelium into the interstitium to affect Leydig cell function. Cultured
Sertoli cells were shown to secrete a factor(s) which stimulated Leydig cell
steroidogenesis and PS were shown to inhibit the secretion of this
factor(s) from Sertoli cells. While this is the first direct evidence of an
interaction between germ cells, Sertoli cells and Leydig cells, indirect
evidence of such a relationship has been accumulating for over a decade.
In 1978 Aoki & Fawcett showed how testicular implants of
cyproterone acetate caused disruption of the seminiferous epithelium in
tubules within a radius of a few mm of the implant. All other tubules
were unaffected and Leydig cell hyperplasia occurred only adjacent to the
damaged tubules. These local effects on Leydig cells were independent of
changes in the level of serum gonadotrophins (changes which would
have affected all Leydig cells) and it was proposed that damage to the
seminiferous epithelium had interfered with the production of a factor(s)
with a regulatory action on Leydig cells. Similarly, induction of unilateral
testicular damage by cryptorchidism caused changes in Leydig cell and
Sertoli cell function only in the testis in which spermatogenesis had been
disrupted, again negating the influence of serum gonadotrophins and
raising the possibility that seminiferous tubules can influence Leydig cell
function (Risbridger et al., 1981). This idea is supported by the work of
Bergh (1983, 1985), who demonstrated that Leydig cells adjacent to stage
VII-VIII tubules were significantly larger than those proximal to other
stages.
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Using heat exposure of the testis to induce disruption of
spermatogenesis, Jegou et al. (1984) found that changes in Leydig cell
function were separated in time from the actual thermal stress but
occurred in association with the depletion of a specific germ cell type
(elongated spermatids). The implication was that the effects observed were
a consequence of changes in Sertoli cell function, secondary to disruption
of germ cell function. Papadopoulos et al. (1987) found that addition of
either Sertoli cell conditioned medium or seminiferous tubule
conditioned medium to cultured Leydig cells stimulated testosterone
production. However, if the seminiferous tubule conditioned medium
was collected from y-irradiated rats, the enhancement of Leydig cell
steroid output was even greater. Thus a germ cell-Sertoli cell interaction
modulates the action of Sertoli cell factors on Leydig cells.
To date, in order to study paracrine interactions in the testis it has
been necessary to work with isolated cells or co-cultures. This is not the
most satisfactory approach now that it appears that paracrine interactions
co-ordinate the functions of all testicular cell types. An alternative
approach in the study of this cascade of cell-cell interactions is to use
MAA to remove specific germ cell populations in vivo (Bartlett et al.,
1988), leaving the majority of cells, and their interactions, intact. Thus it
has been possible to expand on the work of Onoda et al. (1991), and use an
ex vivo model to demonstrate germ cell-Sertoli cell-Leydig cell
interactions.
It was found that the in vivo absence of either a majority of PS (d3
post-MAA) or RS (dl4 post-MAA) caused an increase in the basal level of
testosterone production by isolated Leydig cells in comparison with the
respective controls. As only basal testosterone levels were affected by the
administration of MAA it was possible that raised LH levels in vivo had
resulted in the increased testosterone production seen in vitro. However,
it has been demonstrated previously that serum LH levels are not
significantly affected by MAA-treatment except at days 21 and 28 post-
administration, when an increase is seen. At 21 days after MAA-
treatment, the in vivo absence of ES had no effect on in vitro testosterone
production. Serum FSH levels are affected by MAA administration, but
the pattern of increases is not consistent with the changes in Leydig cell
function described (Allenby et al., 1991).
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At d7 post-MAA treatment when an equal number of tubules were
missing PS as were missing RS, there was no difference in testosterone
production in Leydig cells isolated from control or MAA-treated animals.
This was a surprising finding considering the results obtained at d3 and
dl4 post-MAA. In a previous study, Bartlett et al. (1988) found an increase
in serum FSH 3 days after MAA treatment, FSH levels then returned to
control values before reaching a second peak at 21 days post-MAA
treatment. Levels of ABP in interstitial fluid followed an identical
pattern. The authors suggested that this biphasic response to MAA
treatment was related to the germ cell type missing from the epithelium
of the majority of tubules after treatment, and/or, to the stage of
spermatogenesis of affected tubules. This would be consistent with the
known variations in Sertoli cell function with the stage of the cycle of the
seminiferous epithelium (Parvinen, 1992). In the experiments presented
here, the first explanation does not seem likely considering the similarity
in germ cell types missing between tubules from days 3 and 7 (PS) and
from days 7 and 14 (RS) post-MAA treatment. The types of germ cells
missing from each stage of the spermatogenic cycle at 3, 7 and 14 days after
MAA administration are shown in Table 7.1. If the effects described in
Figure 7.1. are related to alterations in germ cell complement at specific
stages, then the complement of any stage at d3 and dl4 post-MAA, when
there is an in vitro effect, must be different from that at d7 post-MAA,
when there is no in vitro effect. In such a stage the germ cell
complements at d3 and dl4 post-MAA do not necessarily have to be the
same. Only two stages (I and VII, highlighted in Table 7.1.) meet this
criteria. At stage VII the differences between days 3, 7 and 14 post-MAA
are in absolute numbers, rather than the type of germ cell missing, which
is a very specific difference. If the hypothesis that the stage of
spermatogenesis in affected tubules is important in germ cell-Sertoli cell-
Leydig cell interactions is correct, it would allow the further hypothesis
that seminiferous tubules at stage I act through Sertoli cells (presumably)
to suppress Leydig cell steroidogenesis, and when stage I tubules are
damaged in any way, the production of this inhibitory factor is suppressed
or prevented and the basal level of testosterone production increases.
The disruption of the seminiferous epithelium described in this
chapter, causes, at particular time points, an increase in testosterone
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production by isolated Leydig cells. Aoki & Fawcett (1978) also found that
localised seminiferous tubule damage caused an increase in Leydig cell
activity, specifically, hyperplasia. Jegou et al. (1984) demonstrated that at
particular time points after the testis had been subjected to short-term
heating, there was an increase in testosterone production in vitro by
decapsulated testes. Sharpe et al. (1986), showed that seminiferous tubule
dysfunction consequent to EDS administration, caused an increase in the
bioactivity of interstitial fluid which in turn would cause an increase in
Leydig cell steroid production. Thus it appears that damage to the
seminiferous epithelium, in particular damage to the germ cell
population, results in an increase in the activity of Leydig cells, suggesting
that germ cells normally secretes a factor(s) which negatively regulates
Sertoli cell modulation of Leydig cell function.
The in vitro work of Onoda et al. (1991), supports this theory. The
authors showed that cultured Sertoli cells secrete a protein(s) that
stimulates Leydig cell steroidogenesis. These results suggest that Sertoli
cells normally secrete a stimulatory factor. Addition of PS proteins
suppressed the secretion of this stimulatory factor. The suppressive effect
on Leydig cell steroidogenesis of PS proteins would be in accordance with
the germ cell effects described above.
In the presence of a maximally stimulating dose of hCG, such
marked between-experiment variation occurred that it was impossible to
dissect out any effect of MAA administration (ANOVA; p = 0.688, Figure
7.2). When the effects of potential paracrine modulators of Leydig cell
function are studied in vitro, it is often the case that when a compound
has an effect on basal testosterone production, it has no effect on hCG-
stimulated testosterone production. This is the case with both AVP and
LHRH-A (see Chapter 6 for references). It is possible that paracrine effects
are swamped by the addition of such supraphysiological concentrations of
hCG.
LHRH-A has a stimulatory effect on testosterone production by
cultured Leydig cells (see Chapter 6). At those time points where in vivo
administration of MAA had not affected Leydig cell testosterone
production in vitro, namely days 7 and 21 post-MAA, there was no
difference in the response to LHRH-A of Leydig cells isolated from control
and treated animals (Figure 7.3 B and D). However, on days 3 and 14 after
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MAA treatment, there was a decline in the fold responsiveness to LHRH-
A between Leydig cells isolated from controls (p <0.01 on d3, p <0.05 on
dl4) and Leydig cells isolated from MAA treated animals (p <0,05 on d3,
not significant at dl4). The decrease in fold responsiveness was a
consequence of the increase in basal testosterone output which was not
matched by a similar increase in stimulation when LHRH-A was added to
the culture system. There are several possible explanations of this
observation. It is possible that the germ cell effects seen at d3 and dl4 post-
MAA are either mediated through LHRH receptors or use a common
second messenger system. Alternatively, the effects mediated by germ
cells could result in the down-regulation of LHRH receptors. This
explanation would mean that the stimulatory effect of LHRH (seen in
vitro) would be weakened, thereby eliminating a signal that would
counteract the inhibitory effect of the germ cell modulated signal.
In summary, the experiments presented in this chapter have
shown how germ cells, presumably acting via Sertoli cells, are able to
influence the production of testosterone by Leydig cells. Moreover, this
regulatory effect was shown to be mediated by specific germ cell types, that
is, by PS and RS, and there was a further suggestion that the modulation
was also stage-dependent, possibly being orchestrated by stage I tubules.
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Table 7.1. Representation of the germ cells depleted from each
stage of the spermatogenic cycle at 3, 7 and 14 days after
treatment with MAA.
PS = pachytene spermatocytes, RS = round spermatids, ES = elongate
spermatids, N = normal germ cell complement.
days post-MAA administration
3 7 14
i PS/RS N RS
II PS RS RS
III PS RS RS
IV PS RS RS
V PS RS RS
VI PS RS RS
lli|t
VIII N PS N
IX N PS ES
X N PS ES
XI N PS ES
XII PS PS ES
XIII PS PS ES
XIV PS PS ES
8. Leydig cell proteins
The previous chapter demonstrated how cell-cell interactions can occur
in the testis such that changes in the germ cell population of the
seminiferous epithelium can indirectly affect the function of Leydig cells
in the interstitium. It was shown that when PS or RS were the major
germ cell types missing, Leydig cell testosterone production was increased
in comparison to controls. However when approximately equal numbers
of PS and RS were depleted, no change was seen in Leydig cell
testosterone production. These apparently discordant results may possibly
be related to germ cell damage at particular stages of the spermatogenic
cycle. The experiments described in this chapter concern Leydig cell
protein production and how it may be influenced by the above alterations
in germ cell population, with the aim of identifying proteins with
potential as paracrine regulators, involved in the interactions between
the seminiferous epithelium and the interstitium.
8.1. Introduction
Cell-cell interactions appear to form an integral part of testicular
physiology (Skinner, 1991), with interactions occurring both within and
between testicular compartments. The influence of the seminiferous
epithelium on Leydig cell function is well documented (Sharpe, 1990,
1992). Conversely, the influence that Leydig cells have on the
seminiferous epithelium is absolute as it is clear that the production of
testosterone is essential for normal spermatogenesis (Sharpe, 1987).
However, it is not clear what contribution non-steroidal Leydig cell
products make towards the normal functioning of the testis. Sharpe et al.
(1988) demonstrated that when rat testes were depleted of Leydig cells by
administration of EDS, but supplemented with testosterone esters,
quantitatively normal spermatogenesis could be maintained for a period
of at least 10 weeks. This suggested that Leydig cell products other than
testosterone were not essential for the maintenance of spermatogenesis
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and fertility in the rat. However, in testes depleted of Leydig cells but
exposed to exogenous testosterone, there was a 3-4 fold increase in the
incidence of germ cell degeneration occurring in stages XIV-I. These
changes were not seen in control rats supplemented with testosterone
esters and the change was therefore assumed to be dependent on he
absence of Leydig cells.
In the absence of Leydig cells no dialogue can occur between the
epithelium and the interstitium, so while the presence of testosterone
ensures the continuation of spermatogenesis, the interactions which
might create the optimal conditions for spermatogenesis do not occur,
possibly resulting in the noted increase in germ cell degeneration. The
results presented in chapter 7 demonstrated how the absence of PS and RS
in vivo, can increase testosterone production in vitro, an effect which
appeared to be limited to germ cell depletion at stage I of the
spermatogenic cycle. Thus the study by Sharpe et al. (1988) associated
pharmacological levels of intratesticular testosterone with increased germ
cell degeneration at stages XIV-I, while the results presented in chapter 7
associated germ cell damage at stage I with increased testosterone
production. Together these studies are strongly indicative of a
bidirectional interaction between Leydig cells and the seminiferous
epithelium, which may act to regulate the amount of testosterone
produced by Leydig cells.
Few non-steroidal Leydig cell secretory products have been
identified, but those that have been characterised (POM-C peptides, IGF-1,
inhibin, Skinner, 1991) do appear to be involved in cell-cell
communication, and are therefore potential mediators of the interaction
described above. To test the hypothesis that a Leydig cell protein might
mediate an important cell-cell interaction, the pattern of Leydig cell
proteins secreted under different culture conditions was investigated.
Protein secretion was assessed by measuring 35S-methionine
incorporation into newly produced secreted proteins. The Mr and pi of
the proteins secreted by Leydig cells were found by analysis of
autoradiographs of 2-dimensional sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). Protein production
under basal and hCG-stimulated culture conditions was compared. In
addition, proteins secreted by Leydig cells isolated from rats with PS and
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RS absent from stage I were also examined, to assess the influence of the
epithelium on non-steroidal Leydig cell products.
In the study by Sharpe et al. (1988), the authors state, that although
in the rat the absence of Leydig cell products other than testosterone had a
negligible effect on sperm output and fertility, they might have more
relevance in less fertile species, such as man, in which degeneration of
spermatocytes in the final stages of meiosis (i.e. stages XTV-I) is estimated
to cause a 40% reduction in the potential yield of spermatids (Johnson et
al., 1984). With this in mind a comparison was made between the types of
proteins secreted by rat and human Leydig cells in vitro.
8.2. Experimental Procedures
8.2.1. Leydig cell culture conditions
Leydig cells were isolated according to the methods described in chapter 3.
Cells were plated out at 100,000 cells per well in 300pl culture medium.
After a 2h preincubation period, the medium was removed and replaced
with Eagles minimal essential medium without methionine (I.C.N.
Flow). This was supplemented with 4 nmol/L of L-glutamine, 100U
penicillin/ml, lOOpg/ml streptomycin, 25mmol/L Hepes (Gibco), and
0.1% polyvinyl alcohol (Sigma). Prior to incubation 60pCi 35S-methionine
(Amersham International, Amersham, England) was added to give a final
concentration of 0.75|iM methionine/well. Cells were incubated in the
presence or absence of 30U/ml hCG for 20h, then the medium was
aspirated and stored at -20°C until required.
8.2.2. Measurement of newly synthesized proteins by trichloroacetic acid
(TCA) precipitation.
10pl of sample was incubated on ice for 15-30 mins in the presence of lOpl
0.1M PBS + 1%BSA, and 1ml 10% TCA + lOmM methionine. The
solution was then centrifuged for 5 mins at 13000rpm to pellet the
precipitate. The supernatant was discarded and the pellet washed in 200(il
0.1M potassium hydroxide. A second precipitation step was performed by
the addition of 1ml 10% TCA + lOmM methionine for a further 15-30
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mins on ice. The solution was centrifuged at 13000rpm for 5 mins and
washed in 0.4M potassium hydroxide. The 35S-methionine content of the
precipitate was counted in an NE 1600 (New England Nuclear, USA)
gamma counter.
8.2.3. Isoelectric focusing (first dimension separation).
The gel mix was prepared by degassing a solution consisting of 5.5g urea
(Sigma), 1.33ml 30% acrylamide (Bio-Rad, Hemel-Hempstead, England),
2.15ml deionised distilled ('clean') water, 2ml 10% nonidet P-40 (BDH),
and 0.3ml pH 5-7 biolyte ampholines (Bio-Rad), 0.15ml pH 7-9
ampholines and 0.15ml pH 3-10 ampholines. Polymerisation was
initiated by the addition of 10(il 10% ammonium persulphate (Sigma)
and 5|il TEMED (Sigma). The tube gels were cast to a height of 12cm in
160mm x 2.5mm internal diameter glass tubes (Bio-Rad), and overlaid
with 1cm of clean water and left for approximately 2h to polymerise. The
water was then replaced with 20mM NaOH and left for a further hour.
Before mounting the gels on the electrophoresis unit (Protean II, Bio-
Rad), the NaOH at the top of the gels was replaced with degassed NaOH.
The bottom of the electrophoresis tank was filled with 41 6mM
phosphoric acid (anolyte), and the core assembly containing the tube gels
was lowered into this solution. Care was taken to remove air bubbles
from the ends of the tube gels. Water cooling pipes were attached and the
top tank filled with degassed 20mM NaOH (catholyte). The gels were
prefocused at 200V for 15 mins (3000xi power supply; Bio-Rad), then at
300V for 30 mins and 400V for 30 mins.
Samples were prepared for loading by the addition of an equal
volume of sample buffer (9.5M urea, 2% nonidet P-40, 2% ampholines
and 1% dithiothreitol) and enough urea to readjust the final
concentration to 9.5M (28mg urea : 50pl sample). Each such sample
mixture was incubated at room temperature for 15 mins, centrifuged at
13000 rpm for 3 minutes and the supernatant loaded onto the tube gels.
Each gel was loaded with equal cpm (250-350,000) radiolabeled protein. In
order to measure the pH gradient created by the ampholines, blank gels
were loaded with 60pl of sample buffer alone. Gels were focused at 400V
for 14h, followed by 2h at 800V.
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Gels were extruded from the glass tubes using water pressure, then
incubated in equilibration buffer [0.5M Tris-HCl, pH 6.8, 10% sodium
dodecyl sulphate (SDS; Sigma), 0.05% bromophenol blue (Bio-Rad)] for 3
mins at room temperature. The gels were frozen rapidly in dry
ice/ethanol, and stored at -40°C. The blank gels were cut into 24x5mm
segments each of which was placed in 1.4ml clean water. The pH of the
water was measured 4 and 6h later.
8.2.4. Protein separation on the basis of molecular weight (second
dimension separation)
Slab gels were prepared by degassing a solution consisting of 40mls 1.5M
Tris-HCl, pH 8.8, 58.65ml 30% acrylamide and 60.15ml clean water. This
amount is sufficient for 4 gels. The glass plates used to make the gels were
cleaned with pyroneg, washed thoroughly in clean water and polished
with ethanol. Polymerisation of the gel mix was initiated by the addition
of 1.2ml 10% ammonium persulphate and 36|il TEMED. Once poured the
gels were overlaid with water-saturated secondary butanol (Aldrich), and
left for a maximum of 1.5h to polymerise. The butanol was then removed
and the top of the gel washed thoroughly with clean water. If the gels
were for immediate use they were overlaid with separating gel buffer
(1.5M Tris-HCl diluted 1:4) for a further 2-3h. If the gels were for use on
the following day, then once the separating gel buffer was in place the top
of the gel cast was sealed and the unit stored at 4°C overnight. The next
step was to remove the buffer and wash the gel thoroughly with clean
water. 1% agarose (Sigma) was used to make wells for the molecular
weight markers. Frozen tube gels were thawed at room temperature then
positioned carefully on the top of the slab gel. Care was taken to ensure
tight contact between the tube gel and the slab gel; all air bubbles were
carefully removed. Molecular weight markers (Bio-Rad) were loaded. The
running buffer used consisted of 0.3% Tris base (Sigma), 1.44% glycine
(Sigma) and 0.1% SDS in clean water. The gels were run at either
38mA/gel (constant current) for 2.5h, or overnight at 25mA/gel for 10
mins, then 5mA/gel overnight and 40mA/gel for 15 mins.
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8.2.5. Silver staining
Gels were fixed in 40% methanol, 10% acetic acid for a minimum of 30
mins followed by 10% ethanol, 5% acetic acid, also for 30 mins. The gels
were then stained using the Bio-Rad silver staining kit; gels were washed
in oxidising solution for 5 minutes and then washed in clean water for 2
periods of 30 mins. They were then washed in silver staining solution for
20 mins followed by a short rinse in clean water. Developer was added
until a smokey precipitate appeared, the solution was then removed and
replaced with fresh developer for a further 5 mins. The developing
solution was replaced again, and the fresh developer was left on the gels
until they appeared to be optimally stained. The developing reaction was
stopped by the addition of 5% acetic acid, and the gels were either stored
in clean water or dried down immediately. Prior to drying gels, were
washed for 20 mins in Amplify (Amersham), they were then dried for 2h
at 62°C on a model 543 drier (Bio-Rad).
8.2.6. Developing Autoradiographs
Dried gels were exposed to X-ray film (Kodak X-OMAT ARS) at -80°C for
21-28 days. Autorads were allowed to warm to room temperature before
being developed. To do this the film was placed in developer (Kodak) for
4 mins, washed thoroughly with tap water and then fixed (Kodak
fixative), washed again and allowed to dry.
8.3. Results
8.3.1. Secretion of newly synthesized proteins.
There was no significant difference in the incorporation of 35S-
methionine into newly secreted Leydig cell proteins cultured in the
presence or absence of hCG (Figure 8.1). Leydig cells isolated from rats
treated 3, 7 or 14 days earlier with MAA also showed no difference in the
level of 35S-methionine incorporation into newly secreted proteins
(Figure 8.2).
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8.3.2. Patterns of protein secretion.
Analysis by 2-D SDS-PAGE of newly synthesized proteins secreted by rat
Leydig cells in the presence and absence of hCG is shown in Figure 8.3. It
can be seen that Leydig cells in vitro secrete over 70 proteins. There are no
obviously different proteins secreted by Leydig cells cultured in the
presence or absence of hCG. The proteins or protein groups labelled on
the gels have similar Mrs to proteins which are known Leydig cell
products. The pregnancy specific Pi-glycoproteins (PSG) are a
heterogeneous family of proteins which have been localized to Leydig
cells in the rat testis (Ogilvie et al., 1990, Richardson et al., 1991). PSGs
have Mrs in the 90kDa range, and protein group 1 has Mrs in this range.
Leydig cells also secrete the calcium binding protein named, secreted
protein, acidic and rich in cysteine (SPARC; Vernon & Sage, 1989). The Mr
of SPARC is 43kDa, coincident with that of protein 2. The 3 proteins
comprising group 3 have similar Mrs (30kDa) to the 3 forms of platelet
derived growth factor (PDGF) which are found in rat Leydig cells (Gnessi
et al.,1992).
Leydig cells isolated on different days (3, 7, 14) following
administration of MAA, and cultured under basal conditions did not
show any major differences in the proteins they secreted (Figure 8.4.).
There was one basic protein, with an apparent Mr of 35kDa that was
secreted by Leydig cells isolated on days 3 and 14 after MAA treatment that
did not appear to be secreted by Leydig cells isolated at 7 days after MAA
treatment (protein 4). This protein was not secreted by Leydig cells
isolated from control animals and cultured under basal conditions
(Figure 8.4.), but Leydig cells isolated from control animals and cultured
in the presence of hCG appeared to secrete small amounts of this protein
(Figure 8.4.).
There was a remarkable similarity in the proteins secreted by rat
and human Leydig cells in vitro (in the absence of hCG), at least as judged
by Mr and pi. On this basis, nine potentially homologous proteins or
protein groups have been identified (Figure 8.5.). Of these proteins 5 and 9
appeared in equal concentrations in rat and man. Proteins 1 and 4
appeared to be more abundant in the rat, however the majority of these
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proteins were produced to a greater extent by human Leydig cells
compared to the rat.
8.4. Discussion
The experiments described in this chapter examined Leydig cell protein
production, and how this is influenced by the seminiferous epithelium.
The preceding chapter demonstrated that altering the normal germ cell
complement in vivo affected Leydig cell testosterone production in vitro.
Surprisingly, the relationship between germ cells and Leydig cells seemed
to be confined to germ cells at a specific stage of the spermatogenic cycle.
In this chapter the influence of germ cells on Leydig cell protein secretion
was investigated. Also, a comparison was made of the proteins secreted by
rat and human Leydig cells in vitro.
Analysis of proteins secreted by Leydig cells in vitro has shown that
neither the incorporation of 35S-methionine into newly secreted proteins,
nor the actual proteins produced, were affected greatly by in vitro
exposure to hCG or by the in vivo depletion of specific types of germ cell
prior to Leydig cell isolation. The in vivo absence of either PS or RS at
days 3 and 14 after treatment with MAA, while not affecting the overall
level of protein secretion by isolated Leydig cells, resulted in the secretion
of a 35kDa basic protein which was not secreted by Leydig cells isolated
from either control animals, or animals 7 days after MAA administration.
This protein also appeared to be secreted in small quantities by Leydig
cells isolated from control animals but cultured in the presence of hCG.
In general, non-steroidal Leydig cell products have not been
thoroughly investigated and to date most of the work on Leydig cell
protein production relates to intracellular proteins. These proteins are not
secreted into the interstitium but have potential roles as intracellular
modulators of steroidogenesis. Themmen et al. (1985, 1986) described how
LH and PMA stimulated the phosphorylation of 17 and 33 kDa proteins,
which are believed to be part of the mechanism by which LH mediates its
effects. Leydig cells have also been found to contain a 28kDa protein the
production of which is induced by oestrogen. This protein is also
speculated to have a role in intracellular regulation of steroidogenesis
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Figure 8.1. The effect of hCG on the incorporation of 35S-
methionine into newly synthesized proteins secreted in vitro by
rat Leydig cells.
Each column is the mean±S.D. of 9 separate experiments.
or
S-methionineincorporation (cpm/105Leydigcells/20hr )
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Figure 8.2. The effects of administration of MAA on the
incorporation of 35S-methionine into newly synthesized proteins
secreted in vitro by rat Leydig cells at successive intervals after
treatment.
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Chapter Eight Leydig cell proteins 157
Figure 8.3. Comparison of the pattern of proteins secreted by
isolated rat Leydig cells in the absence (top) or presence (bottom)
of hCG during a 20h incubation.
Comparable fluorograms were obtained on 5 (minus hCG) and 3 (plus
hCG) separate occasions. Proteins/protein groups which have comparable
Mrs to known Leydig cell products have been circled and numbered.
Protein group 1 has a comparable Mr to PSG, protein 2 has a comparable
Mr to SPARC and protein group 3 has a comparable Mr to PDGF. Protein 4
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Figure 8.4. Comparison of the pattern of proteins secreted in
vitro by Leydig cells isolated from the testes of adult rats at
various times after administration of MAA.
A. control (no MAA administered). B. 3 days after administration of
MAA. C. 7 days after administration of MAA. D. 14 days after
administration of MAA. Comparable fluorograms were obtained on 2
separate occasions. Proteins/protein groups which have comparable Mrs
to known Leydig cell products are circled and numbered. Protein group 1
has a comparable Mr to PSG, protein 2 has a comparable Mr to SPARC and
protein group 3 has a comparable Mr to PDGF. Protein 4 was secreted 3
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Figure 8.5. Comparison of the pattern of proteins secreted by
isolated human (top) and (rat) Leydig cells during a 20h
incubation.
Proteins/protein groups with comparable Mrs and pis have been circled
and numbered. They include PSG (1), SPARC (2) and PDGF (3).
Comparable fluorograms were obtained on 5 (rat) and 2 (human) separate
occasions.
MOL.WTX1000
ratLeydigcellproteinshumanL ydigcellproteins oco<ntroOCO-JCO-t>.CDI *-
OCO-VI
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(Ciocca et al., 1986). One of the best characterised intracellular Leydig cell
proteins is sterol carrier protein (SCP2). The effect of SCP2 in vitro is to
accelerate the transfer of phospholipid and cholesterol between
membranes (van Noort et al., 1988), thus facilitating steroidogenesis.
Little is known about the proteins which are secreted by Leydig
cells, although it is possible that such proteins may influence Sertoli cell
function. The importance of paracrine interactions in the testis has been
discussed in previous chapters and has been extensively reviewed (for
example, Skinner, 1991, Sharpe, 1992), although Ratnasooriya & Sharpe
(1989) questioned the importance of Leydig cell products other than
testosterone when they described how spermatogenesis could be
maintained for a 10 week period in testes devoid of Leydig cells but
supplemented with testosterone. While few Leydig cell secretory products
have been identified or characterised, those that have, such as the POM-C
peptides, inhibin and IGF-1, are thought to be involved in cell-cell
interactions (Skinner, 1991). Another protein secreted by Leydig cells is
testicular immunosuppressive protein, thought to be involved in
conferring immune privilege on the testicular interstitium (Pollanen et
al., 1988). However, with an Mr of 130kDa, testicular immunosuppressive
protein is too large to be resolved on the gels used in these experiments.
Proteins which are known to be secreted by Leydig cells in vitro and
which do have an Mr within the limits defined by the gels include
interleukin-1 (IL-1; 17kDa, pi 5.5, Bellve & Zheng, 1989), nerve growth
factor (NGF; 13kDa, pi 9.3, Bellve & Zheng, 1989), SPARC (43kDa; Vernon
& Sage, 1989), PSG (Richardson et al., 1991), IGF- 1 binding protein (IGF-1
BP; Cailleau et al., 1990) and PDGF (Gnessi et al., 1992). There were no
proteins on the gel with similar Mr and pi to IL-1, NGF or IGF-1 BP. It is
possible that these proteins are either not produced in culture or are
produced in insufficient amounts for visualisation on the gels. Protein 1,
labelled on the gels in Figure 8.3., has a comparable Mr to PSG. PSG
consists of a heterogeneous group of glycoproteins which are synthesised
in large quantities in the placenta. PSG mRNA has also been detected in
the rat testis and PSG immunoreactivity has been localised to Leydig cells,
as well as late spermatids (Ogilvie et al., 1990). PSG mRNA has also been
reported in the human testis (Chan et al., 1988) and PSG protein has been
found in human semen (Rosen, 1986). Sequence analysis of PSG cDNAs
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has revealed the presence of domains with immunoglobulin-like motifs
(Richardson et al., 1991). Its function in the placenta is unknown, though
it is postulated to have a role in preventing immune rejection of the fetus
(Richardson et al., 1991). Similarly, it is possible that PSG in the testis acts
as an immunosuppressive factor, and is one of the factors which allows
the testis to function as an immune-privileged site.
Protein 2 (Figure 8.3.) has a similar Mr to SPARC. Vernon & Sage
(1989) demonstrated that SPARC was synthesized and secreted by Leydig
cells isolated from adult mice. SPARC is a calcium-binding protein and is
secreted in vitro by endothelial cells which are undergoing migratory and
proliferative responses (Sage et al., 1986). It is not clear what role SPARC
produced by Leydig cells would have. Vernon & Sage (1989) postulated
that SPARC was involved in depolymerisation of cytoskeletal elements
allowing closer association between lipid droplets and mitochondria
thereby facilitating cholesterol uptake by the mitochondria. However this
does not explain why Leydig cells secrete SPARC.
A protein localised to Leydig cells which has been proposed to have
a paracrine function is PDGF. This protein exists as a dimer of 2
homologous polypeptides, the A and B chains, each with an Mr of about
30kDa. Three forms of PDGF exist, AA, BB and AB (Westermark, 1990).
Adult rat Leydig cells produce a PDGF-like activity (Gnessi et al., 1992) and
the proteins comprising group 3 (Figure 8.3.) have a comparable Mrto
PDGF. PDGF has been shown to act synergistically with transforming
growth factor-(3 to stimulate contraction of rat testicular peritubular cells
in culture (Tung & Fritz, 1991).
Figure 8.4. shows the presence of a protein (protein 4) on days 3 and
14 after administration of MAA that is not present on day 7 post-MAA.
While protein 4 is not secreted by Leydig cells isolated from control
animals and cultured in the absence of hCG, it is secreted by Leydig cells
isolated from control animals and cultured in the presence of hCG
(Figure 8.3). As it is at days 3 and 14 but not day 7 post-MAA that in vitro
testosterone production is raised comparative to controls, it appears that
the synthesis of protein 4 is associated with increased testosterone
production by Leydig cells. The presence of this protein cannot be
associated with increased LH(hCG)-stimulation, as serum LH levels are
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not significantly different from control levels at 3 and 14 days after MAA
administration (Allenby et al, 1991).
The proteins secreted by rat and human Leydig cells are compared
in Figure 8.5. There are nine major proteins or protein groups with
comparable Mr and pi. These include the proteins tentatively identified in
the rat as SPARC, PSG and PDGF. However it appears that while all 3
forms of PDGF may be present in the rat testis, only 2 are produced by
human Leydig cells.
In conclusion rat and human Leydig cells have been shown to
secrete over 70 proteins. In the rat the influence of the seminiferous
epithelium on Leydig cell function does not seem to extend to protein
secretion. While culturing Leydig cells in the presence of hCG does not
greatly affect protein secretion, conditions of high testosterone production
appear to be associated with the production of a novel 35kDa basic
protein. Finally, the proteins secreted by rat and human Leydig cells in
vitro were found to be remarkably similar.
9. in vitro interactions between seminiferous
tubules and Leydig cells
Chapter 7 described the influence of germ cells, probably acting through
Sertoli cells, on Leydig cell function. Depletion of pachytene
spermatocytes and/or round spermatids was shown to result in an
indirect inhibitory effect on Leydig cell testosterone production, however,
only the presence/absence of these germ cells from some spermatogenic
stages appeared to have this effect. Specifically, it was suggested that the
absence of either pachytene spermatocytes or round spermatids from stage
I tubules led to an increase in testosterone production. In chapter 8, the
effect of pachytene spermatocytes and/or round spermatids on Leydig cell
protein production was assessed and it was found that in situations of
high testosterone output in vitro, such as the presence of hCG, or the
absence of pachytene spermatocytes and/or round spermatids in vivo, a
protein was secreted that did not appear under basal testosterone
conditions. While this protein might have a role in negative feedback to
the tubules, these experiments did not shed any light on the mechanism
by which germ cells can affect testosterone production. In this chapter
staged seminiferous tubules have been used both in co-cultures and to
produce conditioned medium, to further examine the nature of the
interaction between Leydig cells and the seminiferous epithelium.
Testosterone metabolism in the absence and presence of pachytene
spermatocytes was measured to see whether these cells act by influencing
the rate of testosterone metabolism.
9.1. Introduction
Testicular function is predominantly under the control of pituitary
hormones, yet, as has been discussed previously, different cell types in the
testis have been shown to influence the function of other testicular cell
types, probably by specific secretions. For example, Sertoli cells undergo
cyclic changes as the surrounding germ cell population matures. The
secretion of many Sertoli cell products is stage-dependent, and frequently
Chapter Nine Leydig cell/seminiferous tubule interactions 164
these fluctuations correlate with specific events of spermatogenesis
(Parvinen, 1982). The influence of one cell type on another appears to
extend beyond the seminiferous epithelium and into the interstitium, as
the size of peritubular Leydig cells relates to the stage of the adjacent
tubules, with the largest Leydig cells being found around stage VII and
VIII tubules (Bergh, 1983). The results presented in chapter 7 also indicate
an inter-compartmental interaction, with germ cells apparently able to
inhibit the secretion of Sertoli cell factors which stimulate Leydig cell
function.
Sertoli cell conditioned medium and Sertoli/Leydig cell co-cultures
have been used as experimental models to investigate cross-compartment
communication. Sertoli cells isolated from immature (Verhoeven &
Cailleau, 1985, Janecki et al.r 1985, Grootenhuis et al, 1990) and also adult
(Papadopoulos et al., 1987b) rats produce a factor(s) which is able to
stimulate testosterone production by rat Leydig cells. The activity is
contained within the 10-30kDa Mr range (Verhoeven & Cailleau, 1986),
and its secretion appears to be positively regulated by FSH in immature
Sertoli cells (Verhoeven & Cailleau, 1986, Janecki et al., 1985) but not in
adult Sertoli cells (Papadopoulos et al., 1987b).
Interstitial fluid (IF) which surrounds Leydig cells and
seminiferous tubules is the medium through which Leydig cells and
Sertoli cells must communicate. Sharpe & Cooper (1984) demonstrated
that IF contained a factor(s) which could stimulate testosterone
production by cultured Leydig cells. It is not known if this factor
corresponds to the 10-30kDa activity described above. Sharpe & Cooper
(1984) also showed that IF isolated from germ cell depleted cryptorchid
testes had a higher stimulatory effect than control IF. While this points to
Sertoli cells as the source of the IF factor, it also suggests that germ cells
negatively modulate the secretion of the Sertoli cell factor. A similar
interpretation can be made in the study by Papadopoulos et al. (1987b), in
which seminiferous tubule conditioned medium from irradiated rat
testes had greater stimulatory activity than conditioned medium from
control rats.
Again, this is in agreement with the experiments described in
chapter 7 which demonstrated how depleting seminiferous tubules of
pachytene spermatocytes (PS) or round spermatids (RS) in vivo led to
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increased testosterone production in vitro, that is, that PS and RS can
negatively modulate the secretion of stimulatory factors from the
seminiferous epithelium. However, the effects caused by the absence of
PS and RS were not always apparent, in fact, they appeared to be stage-
dependent.
The experiments presented in the following chapter have either
used co-culture of Leydig cells and seminiferous tubules, or else the
addition of seminiferous tubule conditioned medium (STM) to Leydig
cells in order to examine the nature of the communication between
Leydig cells and the seminiferous epithelium (stimulatory or inhibitory).
In order to assess how this interaction changes with the stage of the
spermatogenic cycle, as suggested by the experiments described above, all
co-cultures used staged seminiferous tubules, and STM was also prepared
from staged tubules. As the possibility that germ cells can influence
Sertoli cell function has been raised by many authors (see Sharpe, 1992 for
review), in some experiments PS were depleted from the seminiferous
epithelium using the germ cell toxicant, MAA. The PS-depleted tubules
were isolated and staged and cultured with Leydig cells isolated from
untreated rats. In this way, the influence of PS on Sertoli cell secretions in
tubules of grouped stages was examined. One way in which germ cells
could influence the intra-tubular concentration of testosterone is by
controlling the rate at which Sertoli cells metabolise testosterone. Thus an
increase in testosterone concentrations in the absence of PS would suggest
a slower rate of metabolism by Sertoli cells. In order to assess whether
isolated seminiferous tubules metabolised significant amounts of
testosterone during their co-culture with Leydig cells, staged tubules were
incubated alone, and a known amount of testosterone was added to the
wells at the start of the culture period. The difference between this value
and the amount of testosterone remaining in the medium at the end of
the culture period was considered to represent metabolism. Tubules
prepared from MAA-treated animals were used to assess the influence, if
any, of PS on the rate of metabolism of testosterone.
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9.2. Experimental Procedures
9.2.1. Isolation of rat seminiferous tubules
The dissection of seminiferous tubules for co-cultures and for the
preparation of seminiferous tubule conditioned medium (STM) was
performed by Dr Richard Sharpe.
The testes from a single animal were placed in a glass scintillation vial
which was kept on ice until the dissection was performed. When required
a testis was decapsulated and placed in a petri dish containing ice-cold
Dulbecco's phosphate buffered saline (I.C.N. Flow). This was kept on a
trans-illuminated stage, through which ice-cold water was pumped
continuously, and which was mounted on a Leitz dissecting microscope.
Watchmakers forceps were used to gently tease apart 2-5cm lengths of
tubule. These lengths were transferred to fresh phosphate buffered saline.
Using the criteria described by Parvinen (1982) the tubules were cut into
segments at stages II-V, VI-VIII and IX-I. These segments were never less
than 0.5cm in length. In some experiments tubules were dissected from
animals that had been treated with MAA 3 days earlier. The preparation
and administration of MAA is described in the preceding chapter.
9.2.2. Preparation of staged rat STM
Tubules were dissected as described above and a total of 11.25cm
(3.75cm/100|il) of tubules per stage were transferred to separate wells of a
24-well tissue culture plate containing 300|il medium 199 with Earle's
salts (M199E) supplemented with 4mM L-glutamine, 0.5mg/ml BSA,
lOOU/ml penicillin and 100|ig/ml streptomycin. The tubules were
cultured for 24h at 32°C under a humidified atmosphere of 5% CC>2:95%
air. After incubation STM was aspirated carefully and centrifuged at lOOOg
for 5mins to sediment any cellular debris. The supernatant was stored at -
20°C until required.
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9.2.3. Preparation of unstaged rat STM
Tubules were dissected as described above, but were not staged.
Equivalent lengths of unstaged tubules were cultured under the
conditions described above, and STM was collected in the same way.
9.2.4. Effect of staged and unstaged rat STM on rat Leydig cell cultures
Staged and unstaged STM were tested for their ability to alter basal and
hCG-stimulated testosterone production by Leydig cells in vitro. Leydig
cells were prepared from control animals as described previously.
Following a 2h pre-incubation period, 50,000 Leydig cells were cultured
for a further 20h in the presence of 100(0.1 STM in a total incubation
volume of 300|il, the volume being made up with M199E. The culture
medium was then collected to measure testosterone production by RIA.
The amount of testosterone in the STM before its addition to the cultures
was also measured.
9.2.5. Co-culture of rat Leydig cells and seminiferous tubules
3.5cm lengths of staged seminiferous tubules were prepared from both
control and MAA treated animals. The tubules were added to wells
containing 50,000 Leydig cells in 300|il supplemented M199E.
Morphometry has shown that in the rat testis there are approximately
200cm seminiferous tubules per 3xl06 Leydig cells (Wing & Christensen,
1982). The ratio of Leydig cells to seminiferous tubules used in these co-
cultures was therefore within the physiological range. The effect of the
presence of seminiferous tubules at stages II-V,VI-VIII or IX-I from
control or MAA-treated rats on basal and hCG-stimulated testosterone
production by Leydig cells during a 20h culture period was measured. The
amount of testosterone in wells containing only seminiferous tubules
was also measured.
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9.2.6. Assessment of testosterone metabolism by rat seminiferous tubules
The amount of testosterone produced by rat Leydig cells in a 20h culture
period was determined to be 138±55ng/106 cells (basal conditions, n=41
experiments) and 927±388ng/106 cells (hCG-stimulated conditions, n=31).
Staged seminiferous tubules, prepared from control and MAA-treated rats
were therefore incubated for 20h in supplemented M199E, to which was
added either 8gl or 50|il of a solution of 927ng/ml testosterone in M199E
(corresponding to basal and hCG-stimulated levels of testosterone. The
total incubation volume of 300pl was such that seminiferous tubules
were therefore cultured in medium containing a concentration of
testosterone that would have been produced over 20h by Leydig cells
cultured under these conditions.
9.2.7. Preparation of unstaged human STM
STM was prepared from the testes of a male aged 66 years. The testes were
treated according to the protocol described for the preparation of human
Leydig cells. That is, the testes were initially subjected to a 50min
collagenase digestion, before seminiferous tubule lengths were teased
apart with watchmakers forceps. The protocol for incubation was as
described for the preparation of unstaged rat STM, except that
approximately 50 cm of tubules were incubated in 400pl supplemented
M199E for 20h. The total length of tubules was greater than for the rat
because of the considerably smaller diameter of human seminiferous
tubules.
9.2.8. Effect of unstaged human STM on human Leydig cell cultures
Human STM was tested for its ability to alter basal and hCG-stimulated
testosterone production by human Leydig cells in vitro. Leydig cells were
prepared as described in section 3.3.3. Following a 2h Leydig cell pre¬
incubation period, Leydig cells were cultured for a further 20h in the
presence of lOOpl STM in a total incubation volume of 300pl M199E
supplemented as above. The amount of testosterone in the STM prior to
its addition to Leydig cells was also measured.
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9.2.9. Statistics
One-way ANOVA, followed by Students' t-test was used to compare the
effects of STM from different stages. Comparisons between the effects of
different stages of tubules isolated from either control or MAA treated
animals were made using two-way ANOVA followed by Students' t-test.
9.3. Results
9.3.1. The effect of staged rat STM on rat Leydig cell cultures
The effects of STM prepared from tubules at stages II-V, VI-VIII and IX-I
on basal and hCG-stimulated testosterone production by rat Leydig cells in
vitro was assessed in two separate experiments. In one experiment, STM
from stages II-V and VI-VIII had no effect on basal testosterone
production, while the presence of STM from stages IX-I had a significant
stimulatory effect when compared to testosterone production in the
absence of STM (p <0.01, Figure 9.1.A). In the second experiment
testosterone production was not affected by the presence of STM from any
stage (ANOVA p =0.206, Figure 9.1.C). In the first experiment STM from
all stages had a significant stimulatory effect on hCG-stimulated
testosterone production (p <0.05, Figure 9.1.B). However, in the second
experiment, STM from stages II-V and IX-I did not have a significant
effect on hCG-stimulated testosterone production, while STM from stages
VI-VIII had a significant inhibitory effect (p <0.05, Figure 9.1.D).
9.3.2. Co-culture of rat Leydig cells and seminiferous tubules
Testosterone production by Leydig cells co-cultured with seminiferous
tubules from either of the three stage groupings was very variable. Only
stage II-V tubules which had been isolated from control rats appeared to
have any influence on testosterone production by Leydig cells. When
compared to the amount of testosterone produced by Leydig cell-only
cultures, stage II-V tubules had an inhibitory effect on basal testosterone
production (p < 0.05, Figure 9.2A).
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At 3 days after administration of MAA, seminiferous tubules at
most stages are depleted of 80-100% of pachytene spermatocytes (PS).
However, tubules prepared from MAA-treated animals and cultured with
Leydig cells, did not produce effects different to those seen with tubules
isolated from control animals, except that the inhibitory effect of stages II-
V was not evident with tubules prepared from MAA-treated animals
(Figure 9.2.A). Figure 9.2B demonstrates that there was no significant
effect of tubules at any stage, from control or MAA-treated animals, on
hCG-stimulated testosterone production by Leydig cells (ANOVA p
=0.978).
9.3.3. Testosterone metabolism by seminiferous tubules
The ability of seminiferous tubules prepared from either control or MAA-
treated rats to metabolise a known amount of testosterone in vitro was
compared in two separate experiments. Seminiferous tubules in all stage
groupings metabolised appreciable amounts of testosterone, ranging from
7.4-49% (basal) and 12.5-50.7% (hCG-stimulated) The control values in
the graphs comprising Figure 9.3., represent the amount of testosterone
added initially to each well. In one group of wells the amount of
testosterone added to each well was of an equivalent order to the 20h
basal rate of testosterone production by Leydig cells. In the first
experiment, the extent of testosterone metabolism by any one group of
stages (II-V, VI-VIII, IX-I), was independent of whether the tubules had
been prepared from control or MAA-treated animals (Figure 9.3.A ). In
the second experiment stage IX-I tubules from MAA-treated animals
metabolised significantly less testosterone than did tubules from control
animals (/? <0.01, Figure 9.3.B). While a significantly greater amount of
testosterone had been added to tubules prepared from MAA-treated
animals than to those prepared from control animals, this alone does not
account for the discrepancy between the groups.
When the amount of testosterone added to each well was of an
equivalent order to the 20h hCG-stimulated rate of testosterone
production by Leydig cells, similar results were found. In both
experiments, whether the tubules had been prepared from control or
MAA-treated animals did not effect the ability of any particular grouping
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of stages to metabolise testosterone (Figure 9.3.C and D). As the absence of
PS, caused by in vivo treatment with MAA had no consistent significant
effect on the activity of seminiferous tubules in the stage groupings used
in these experiments, only results from experiments with control tubules
will be discussed further. The degree of testosterone metabolism by
tubules prepared from control animals in 3 separate experiments is
shown in Table 9.1. Although the individual variation in the metabolism
of the 'basal' amount of testosterone is high, tubules at stages VI-VIII
metabolised a significantly greater amount of testosterone than did
tubules at stages II-V or IX-I (p <0.05, Table 9.1.). No significant difference
was found in the ability of tubules at any stage grouping to metabolise the
'hCG-stimulated' amount of testosterone (ANOVA p =0.729, Table 9.1).
In Figures 9.4. and 9.5. the amounts of testosterone measured in
Leydig cell and seminiferous tubule co-cultures have been 'corrected' by
the appropriate factor to take into account the metabolism of testosterone
measured in the experiment described previously. The results of two
separate experiments are shown. Figure 9.4.A demonstrates how the
amount of testosterone metabolised by all stage groupings of control
tubules significantly affected the measure of basal testosterone production
by Leydig cells. This was also found in the second experiment for all stages
considered (Figure 9.4.B). The distorting affect of metabolism by
seminiferous tubules on the assessment of hCG-stimulated production of
testosterone by Leydig cells in co-culture, was less clear-cut. In one
experiment, only testosterone metabolism by stage IX-I tubules
significantly affected the measured level of testosterone (Figure 9.4.C),
while in the second experiment, while metabolism by stages II-V and VI¬
VE did significantly affect the measured level of testosterone, stages IX-I
did not (Figure 9.4.D).
9.3.4. The effect of unstaged rat STM on rat Leydig cell cultures and of
unstaged human STM on human Leydig cell cultures
Unstaged rat STM had no effect on basal testosterone production by rat
Leydig cells during culture for either 4 or 20h (Figure 9.5.A). The effect of
STM on hCG-stimulated testosterone production was inhibitory at both
time points (p <0.01, Figure 9.5.A).
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Figure 9.1. The effect of staged rat STM on testosterone
production by rat Leydig cells cultured for 20h.
A. basal testosterone production in a single experiment. B. hCG-
stimulated testosterone production in the same experiment. C. basal
testosterone production in a second experiment. D. hCG-stimulated
testosterone production in the second experiment. Each point is the
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Figure 9.2. 20h co-culture of rat Leydig cells with control and
germ cell depleted seminiferous tubules - effect on testosterone
production.
A. basal testosterone production by rat Leydig cells (n=5 for co-cultures
with control seminiferous tubules, n=3 for co-cultures with germ cell
depleted seminiferous tubules). B. hCG-stimulated testosterone
production by rat Leydig cells (n=5 for co-cultures with control
seminiferous tubules, n=3 for co-cultures with germ cell depleted
seminiferous tubules). Each point is the mean±S.D. of n experiments. *p
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Figure 9.3. Testosterone metabolism by control and germ cell
depleted seminiferous tubules cultured for 20h.
A. metabolism of 'basal' testosterone levels in a single experiment. B.
metabolism of 'basal' testosterone levels in a second experiment. C.
metabolism of 'hCG-stimulated' testosterone levels in the first
experiment. D. metabolism of 'hCG-stimulated' testosterone levels in the
second experiment. Each point is the mean±S.D. of triplicate wells. *p
<0.05, **p <0.01 level in germ cell depleted tubules significantly different
from levels in control tubules at the same stage.
controlII-VVI III stage-groupingof seminiferoustubules






Chapter Nine Leydig cell/seminiferous tubule interactions 175
Table 9.1. The extent of testosterone metabolism by seminiferous
tubules cultured for 20h.
The results from 3 experiments and the mean values of those
experiments are shown. * p <0.05 significantly different from other stages.
percentage of 'basal' testosterone metabolised by seminiferous tubules










percentage of 'hCG-stimulated' testosterone metabolised by seminiferous
tubules
stage II-V VI-VIII IX-I
expt.no
1 12.5 18.4 26.4
2 40.4 30.1 50.7
3 35.6 29.9 20.6
average±SD 29.5±14.9 26.1±6.7 32.6±15.9
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Figure 9.4. The effect of correcting for testosterone metabolism
by seminiferous tubules on the levels of testosterone measured in
culture medium in 20h Leydig cell/seminiferous tubule co-
cultures.
A. uncorrected and corrected measurements of basal testosterone
production in a single experiment. B. uncorrected and corrected
measurements of basal testosterone production in a second experiment.
C. uncorrected and corrected measurements of hCG-stimulated
testosterone production in the first experiment. D. uncorrected and
corrected measurements of hCG-stimulated testosterone production in
the second experiment. Each point is the mean±S.D. of triplicate wells. *p
<0.05, **p <0.01 corrected value significantly different from uncorrected
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Figure 9.5. The effect of unstaged rat and human STM on
testosterone production by rat and human Leydig cells
respectively, each cultured for 4 and 20h.
A. testosterone production by rat Leydig cells in one experiment.
B. testosterone production by human Leydig cells in a single experiment.
C. testosterone production by human Leydig cells in a second experiment.
Each point is the mean+S.D. of triplicate wells. *p <0.05, **p <0.01
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The effect of human STM prepared from a man aged 66 years, was tested
on 2 occasions. In both experiments STM had a stimulatory effect on basal
testosterone production at 4h (p <0.01, Figures 9.5.B and C), and in one
experiment the stimulatory effect was also seen at 20h (p <0.05, Figure
9.5.C). The effect of human STM on hCG-stimulated testosterone
production was variable. In the first experiment STM had a stimulatory
effect on hCG-stimulated testosterone production (p <0.01, Figure 9.5.B),
while in the second STM was found to have an inhibitory effect on hCG-
stimulated testosterone production (p <0.01, Figure 9.5.C).
9.4. Discussion
The aims of the experiments described in this chapter were to use Leydig
cell/seminiferous tubule co-cultures as a model system for examining
cell-cell interactions in the rat and human testis. It was hoped that by
using the germ cell specific toxin, MAA, to deplete the seminiferous
epithelium of PS and then co-culturing Leydig cells with such germ cell
depleted seminiferous tubules, it would be possible to assess the
contribution that germ cells make to Leydig cell regulation. In chapter 7 it
was postulated that it is seminiferous tubules at stage I which secrete a
factor(s) with an inhibitory action on Leydig cell steroidogenesis, thus an
additional aim of these experiments was to use staged seminiferous
tubules from MAA-treated rats to examine this hypothesis further.
Locally produced paracrine factors are believed to contribute to the
coordinated action of the interstitial compartment and the seminiferous
epithelium. For example, during testicular development FSH increases
the capacity of Leydig cells to produce testosterone in response to LH
stimulation (Odell & Swerdloff, 1976) and promotes Leydig cell
maturation (Kerr & Sharpe, 1985), yet receptors for FSH are found only in
the tubular compartment. More recent and more direct evidence of
interactions between these testicular compartments has already been
detailed in chapter 7. In general, most authors have taken one of two
approaches to investigate cell-cell interactions in the testis. One method is
to co-culture Leydig cells with Sertoli cells, or Leydig cells with
seminiferous tubules and examine the effect on testosterone production.
The alternative approach is to analyse the effect of spent medium from
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either Sertoli cells or seminiferous tubules on Leydig cell testosterone
production.
Two separate experiments assessed the effects of medium
conditioned by seminiferous tubules at stages II-V, VI-VIII or IX-I on
Leydig cell function. In one experiment the addition of STM from any of
these stage groupings had no effect on basal testosterone production,
while in the second experiment STM from stages IX-I stimulated basal
testosterone production. The effect of STM on hCG-stimulated
testosterone production was also inconsistent between experiments. In
the first, STM from all stages had a significant stimulatory effect on hCG-
stimulated testosterone production, while in the second, STM from stages
II-V or IX-I had no effect and STM from stages VI-VIII was inhibitory.
While these results are inconclusive they do serve to illustrate the
confusion that also exists in the literature regarding the effects of
conditioned media on Leydig cell function. Seminiferous tubule
conditioned media has previously been shown to have stimulatory effects
on testosterone production (Papadopoulos et al., 1987b, Bartlett et al,
1987), inhibitory effects (Syed et al., 1988, Vihko & Huhtaniemi, 1989) and
also to have no effect on testosterone production (Parvinen et al., 1984).
While these differences may be attributable to differences in
methodology, it is not immediately clear what such differences might be.
For example, all the studies quoted used adult rats to isolate the Leydig
cells and seminiferous tubules, and all used Percoll-purified Leydig cells.
The study by Bartlett et al. (1987) was the only one to use collagenase
digestion in the process of isolating seminiferous tubules, yet this cannot
contribute to the differences in effects seen as Bartlett et al. (1987) observed
the same stimulatory effects as Papadopoulos et al. (1987b) who used the
dissection technique described by Parvinen & Vanha-Perttula (1972) to
isolate seminiferous tubules. Neither does the method of co-incubation
appear to influence the effect of STM on Leydig cells as inhibitory effects
have been recorded using monolayer cultures (Syed et al., 1988) and
incubations in a shaking water bath (Vihko & Huhtaniemi, 1989). The
results presented in this chapter which show that overall STM does not
have a consistent effect on basal or hCG-stimulated testosterone
production, are most in agreement with those of Parvinen et al. (1984)
showing no effect of STM on Leydig cell function. These authors
Chapter Nine Leydig cell/seminiferous tubule interactions 180
suggested that the lack of effect of STM may be due to a dynamic
interaction between Leydig cells and seminiferous tubules being a
necessity for cell-cell communication.
To accommodate the possibility that such an interaction is required
for communication, a second series of experiments were undertaken
using co-culture of Leydig cells and staged seminiferous tubules.
Although there was a high degree of variation between experiments, the
presence of tubules at stages II-V consistently had an inhibitory effect on
basal testosterone production, while the presence of tubules at other
stages had no effect. hCG-stimulated testosterone production was not
affected by seminiferous tubules from any stage. Papadopoulos et al.
(1987b) used irradiated rats to show that STM collected from germ cell
depleted seminiferous tubules was able to stimulate 17(3-oestradiol
production more than was STM from control rats. This suggested that
germ cells might have a negative influence on the synthesis of a Sertoli
cell secreted factor, the activity of which had been described in the same
series of experiments. The experiments presented in chapter 7 also
suggested that germ cells, specifically PS and RS, were able to negatively
influence the production of seminiferous epithelial factors with
stimulatory activity on Leydig cell function. To investigate this further,
tubules were isolated from rats in which the testes had been depleted of
PS by the administration of MAA 3 days previously. As with tubules
isolated from control animals the variation between experiments was
quite high. The only difference in effect on Leydig cell testosterone
production caused by using seminiferous tubules depleted of PS, was that
the inhibitory effects of stage II-V tubules were no longer present. In all
other aspects there was no difference between the effects of tubules from
control or MAA-treated rats. The lack of inhibition of stages II-V after the
removal of PS is consistent with the results presented in chapter 7, in
which removal of PS corresponded to the removal of an inhibitory
influence and increased basal testosterone production above control
levels. In these co-culture experiments, the removal of PS also appeared
to be associated with the loss of an inhibitory influence and testosterone
levels were brought back within the control range. However, the lack of
effect of seminiferous tubules isolated from control animals at stages VI-
VIII and IX-I does not agree with previously published studies. As with
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the effects of STM the reported effects of co-cultures vary. Parvinen et al.
(1984) reported inhibitory effects of all stages on both basal and hCG-
stimulated testosterone production by crude preparations of Leydig cells,
although when using Percoll-purified Leydig cells all stages had
stimulatory effects on both basal and hCG-stimulated testosterone
production. Bartlett et al. (1987) found no effect of any stage on either
basal or hCG-stimulated testosterone production. Again it appears that
the methodology used has a great influence on the results obtained. In the
experiments presented in this chapter the minimum length of
seminiferous tubule used was 0.5cm. In the study by Parvinen et al. (1984)
seminiferous tubule were cut into lengths of only 2mm. It has previously
been suggested that leakage from seminiferous tubules is via tubular fluid
escaping from the cut ends of the tubules rather than across the Sertoli
cells and basement membrane (Sharpe & Bartlett, 1985). Thus using many
small pieces of tubule will result in a greater diffusion of tubular fluid
than using fewer large pieces. Leydig cells thus become exposed to Sertoli
or germ cell products that are normally sequestered in tubular fluid. The
significance of this was indicated in a study by Onoda et al. (1991), who
showed that PS proteins added to Leydig cell cultures had a direct
stimulatory effect on testosterone production. The action of such a
protein(s) to which Leydig cells are not normally exposed in vivo could
explain the stimulatory effects seen by Parvinen et al. (1984).
Based on the results of a morphometric study, Bergh (1983)
proposed the existence of a stage-dependent paracrine regulation of Leydig
cells by adjacent Sertoli cells. Evidence suggested that peritubular Leydig
cells surrounding stage VII-VIII tubules were larger than peritubular
Leydig cells surrounding any other stage. This is in agreement with the
proposal that testosterone acts only at stage VII (Russell & Clermont,
1977), and synthesis of ABP is also highest at stages VII-VIII (Ritzen et al.,
1982). However, Parvinen & Huhtaniemi (1990) have shown that per unit
volume the concentration of testosterone in freshly isolated dry-dissected
seminiferous tubules is identical in all stages of the epithelial cycle. To
reconcile this with the apparent differential in testosterone action at
different stages of the spermatogenic cycle an experiment was undertaken
to investigate the extent to which tubules at different stages metabolised
testosterone. Using tubules generated from MAA-treated animals and
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therefore depleted of PS, the effect of PS on testosterone metabolism was
also assessed. Syed et al. (1985) have shown that there are no factors in
seminiferous tubule conditioned medium that can increase the
metabolism of testosterone. Parvinen et al. (1984) demonstrated that in
vitro seminiferous tubules themselves cannot convert Leydig cell derived
precursors to testosterone. The experiments presented in this chapter
show that while tubules at all stages can metabolise testosterone, it is
greatest at stages VI-VIII. This is in agreement with these stages being
testosterone-dependent. The depletion of PS from the tubules had no
effect on the metabolism of testosterone except in one experiment, in
which the absence of PS led to a significantly smaller degree of
testosterone metabolism by tubules depleted of PS when compared to
controls. Less metabolism would presumably result in higher testosterone
levels, again indicating that PS in early stages have an inhibitory effect on
local testosterone concentrations.
If the amount of testosterone produced by Leydig cells in co-culture
is 'corrected' to allow for metabolism by the tubules, the corrected
testosterone level is higher than the measured testosterone level. The
effect seminiferous tubules at different stages on Leydig cell testosterone
production also changes. When no allowance was made for testosterone
metabolism, seminiferous tubules at stages II-V had an inhibitory effect
on basal testosterone production while seminiferous tubules at stages VI-
VIII and IX-I had no effect. After correcting for metabolism, seminiferous
tubules at all stageshad no effect ontestosterone levels in one experiment,
while in the second experiment, the effect of seminiferous tubules at
stages VI-VIII and IX-I were stimulatory while seminiferous tubules at
stages II-V had no effect. After correcting for the effects of metabolism on
hCG-stimulated testosterone production, the presence of seminiferous
tubules at stages II-V and VI-VIII had no effect on hCG-stimulated Leydig
cell testosterone production in either experiment, while seminiferous
tubules at stages IX-I had no effect in one experiment, but were inhibitory
in the other. Before these corrections were made no stage had any effect
on testosterone production. Without reproducible results it is not possible
to speculate on the interactions that occur between Leydig cells and the
seminiferous epithelium and how such interactions might change with
the stage of the cycle. However it is possible to say that in co-cultures of
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Leydig cells and seminiferous tubules, the tubules metabolise a significant
amount of testosterone, and the degree of metabolism is greatest at stages
VI-VIII. The idea that the testosterone produced by Leydig cells in vitro is
metabolised by seminiferous tubules during co-culture has received little,
if any, attention previously. Although no attempt was made to measure
the products of testosterone metabolism, one of the major metabolites is
dihydrotestosterone (DHT), which is known to have a greater affinity for
the androgen receptor than testosterone itself (Rommerts, 1989, for
review). Metabolism to DHT would therefore effectively increase
androgen levels. As the highest degree of testosterone metabolism was by
seminiferous tubules at stages VI-VII, the subsequent maximal
availability of DHT would be consistent with the androgen-dependent
nature of these stages (Sharpe, 1992).
As human seminiferous tubules cannot be dissected into distinct
stages in the way that rat tubules can, any in vitro study of human Leydig
cell/seminiferous tubule interactions must use unstaged seminiferous
tubules. In a single comparative experiment unstaged rat STM was found
to have no effect on basal testosterone production by Leydig cells at either
4 or 20h. The effect on hCG-stimulated testosterone levels was inhibitory
at both time points. In contrast, human STM stimulated basal
testosterone production by human Leydig cells at both 4 and 20h in two
separate experiments. However, in one experiment STM had an
inhibitory action on hCG-stimulated testosterone production, while in
the second its effect was stimulatory. It is interesting to note that the
human STM was prepared from the testes of a man aged 66 years, whose
Leydig cells produced extremely low amounts of testosterone in vitro;
0.5ng/ 106cells/20h basal compared with the average of 69.45ng/
106cells/20h. If seminiferous tubule factors can influence Leydig cell
testosterone output, then it is possible that tubules from testes in which
the Leydig cells have a very low basal testosterone secretion level, might
produce high amounts of a steroidogenesis-stimulating factor(s). Thus the
Leydig cells isolated from the testes from which the STM was prepared
were unable to produce much testosterone in vitro due to the absence of
this factor.
It is also possible that Leydig cells which are low producers of
testosterone might be more responsive to such a tubular factor than
Equivalent measurements of testosterone levels before and after charcoal
extraction revealed that the discrepancy in testosterone levels in these
experiments was not due to binding to ABP.
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Leydig cells which were producing testosterone in sufficient amounts to
maintain spermatogenesis. This is supported by the finding that the
human Leydig cell preparation which was most responsive to the effects
of STM was a lower producer of testosterone in vitro than the preparation
which was less responsive to STM (basal testosterone was
9.4ng/106cells/20h compared with 53.19ng/106cells/20h). This might also
explain the discrepancy between the reported effects of rat and human
STM, as rat STM was prepared from normally fertile animals, with no
problems associated with ageing and all the other reproductive
advantages of their species.
Verhoeven & Cailleau (1987) demonstrated that conditioned
medium from cultured human seminiferous tubule fragments was able
to stimulate testosterone output from a crude preparation of human
interstitial cells. Characterisation of the active factor showed it to have an
Mr in the range 10-30kDa. Verhoeven & Cailleau (1986) had previously
shown that rat Sertoli cells produce a factor(s) with a similar Mr which
stimulates rat Leydig cell activity. In fact conditioned media from rat and
human seminiferous tubule cultures were found to have parallel dose-
response curves. The activities of the rat and human factors were both
increased by in vitro treatment with FSH, and the authors postulated that
rat and human Sertoli cells produce an identical factor the function of
which is to mediate the effects of FSH on Leydig cell function.
Papadopoulos et al. (1991) found that human Sertoli cell cultures produce
a 79kDa protein with a stimulatory effect on Leydig cell function. It is not
known whether either of these factors are responsible for the actions of
human STM described in this study.
In summary, it was not possible to clearly define the influence of
seminiferous tubules from each stage of the spermatogenic cycle on
Leydig cell testosterone production. However, co-culture experiments
indicated that cells in the early stages of the cycle (II-V) have an inhibitory
effect on testosterone production. In co-cultures in which PS had been
depleted from seminiferous tubules at stages II-V, this inhibitory effect
was lost, suggesting the involvement of PS in the production of an
inhibitory factor(s). In an earlier chapter it was suggested that PS at stage I
had an important negative modulation on Sertoli cell function. The
discrepancy reported here, in which PS at stages II-V are the important
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cells could either be because it has not been possible to dissect stage I from
stage II, though it is more likely to mean that PS at all of the early stages of
the spermatogenic cycle exert a negative effect on Sertoli cell modulation
of Leydig cell function-
It was also shown that a significant amount of testosterone was
metabolised by tubules at each stage. The absence of PS from tubules did
not affect testosterone metabolism, thus this is not the mechanism by
which PS alter testosterone levels in vitro. In accordance with stages VI
and VIII being the major sites of testosterone action and also the stages at
which ABP secretion is highest, the greatest degree of testosterone
metabolism occurred at stages VI-VIII.
10. Toxicology of rat and human Leydig cells
Preceding chapters have described many aspects of Leydig cell function,
especially with regard to potential intercellular control mechanisms.
Where possible comparisons were made between rat and human Leydig
cell function, and many similarities were found. This chapter examines
the susceptibility of Leydig cells from both species to the adverse effects of
4 compounds, and shows how the similarity between rat and human
Leydig cells makes rat Leydig cells useful models in toxicological hazard
evaluations.
10.1. Introduction
Rat Leydig cells have been used extensively as convenient models for
human Leydig cells in studies of endocrine and paracrine control of
steroidogenesis, and also in toxicological assessments, when the adverse
effects of new drugs or chemicals on reproductive function are evaluated
(Lamb, 1987). However very little is known about human Leydig cells,
and as many functional variations have been demonstrated in other
species (Saez et ah, 1987, Dufau, 1988), an extrapolation from rat to human
cannot be safely assumed. The aim of the experiments described in this
chapter was to compare, in rat and human Leydig cells, the effects of 4
compounds with adverse effects on steroidogenesis.
Ketoconazole (KCZ) is an imidazole derivative which was used
clinically as an anti-fungal agent. In yeast KCZ inhibits the demethylation
of lanosterol to ergosterol, thus disrupting cell membrane formation. The
clinical administration of KCZ is associated with gynaecomastia in a small
percentage of men. This led to studies of androgen levels after
administration and it was found that doses of between 200 and 600 mg
KCZ caused a dose-dependent decrease in plasma testosterone levels. This
was accompanied by an increase in plasma LH, suggesting that KCZ
exerted its effects at the testicular level. KCZ has since been shown to
inhibit testosterone production in vitro by blocking the action of
cytochrome P45ol7a (Sikka et ah, 1985). The effect of KCZ on highly
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purified human Leydig cells has not been demonstrated previously. In
order to determine whether rat Leydig cells could be used as a guide to the
relative efficacies of related compounds on human Leydig cell function,
the effects of hexaconazole (HCZ), a triazole anti-fungal agent, were
compared in rat and human. Tralkoxydim is a selective herbicide the
mechanism of action of which is unknown, and its effects on
steroidogenesis in the rat and in man were also compared.
Ethane dimethane sulphonate (EDS) is an alkylating agent,
although it is not clear whether this action is related to its in vivo effects
on rat Leydig cells. Administration of EDS to adult rats results in the
destruction of all Leydig cells between 1 and 3 days post-treatment (Kerr et
al., 1985, Morris et al., 1986). Inhibitory effects of EDS on steroidogenesis in
isolated rat Leydig cells has been described previously (Rommerts et al.,
1988), although it was not possible to relate this effect to the destruction of
Leydig cells observed in vivo.
In order to investigate the validity of cultured rat Leydig cells as a
model for human Leydig cell function in vitro, the effects of the above
compounds on basal and hCG-stimulated testosterone production in rat
and human Leydig cells were compared.
10.2. Experimental Procedures
Rat and human Leydig cells were prepared using the methods described
in chapter 3. The effects of various in vitro treatments on both basal and
hCG-stimulated testosterone production was assessed over a 20h culture
period. Preparation of the drug solutions used is described below. ATP
levels were measured at the end of each culture period to confirm that
any effects were not secondary to cell death.
Ketoconazole (KCZ) : Stock solutions were prepared by dissolving KCZ
(Sigma) in 1% DMSO. To achieve final culture well concentrations in the
range 0.01-100gg/ml (Kan et al., 1985), the stock solution was diluted in
medium 199 with Earles' salts (M199E). The final concentration of DMSO
in each well was 0.05%v/v.
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Hexaconazole (HCZ) : Stock solutions were prepared by dissolving HCZ
(ICI, Macclesfield) in 1% DMSO. To achieve final culture well
concentrations in the range 0.01-100pg/ml, the stock solution was diluted
in M199E. The final concentration of DMSO in each well was 0.05%v/v.
Tralkoxydim (TKD) : Stock solutions were prepared by dissolving TKD
(ICI, Macclesfield) in 1% DMSO. To achieve final culture well
concentrations in the range O.l-lOOpg/ml, the stock solution was diluted
in M199E. The final concentration of DMSO in each well was 0.05%v/v.
Ethane dimethane sulphonate (EDS) : EDS was prepared by Dr Rodney
Kelly. EDS solutions were prepared using DMSO and M199E as described
above. The final concentrations of EDS used were 2-230|iM.
10.3. Results
KCZ : Concentrations of 0.1-100pg/ml KCZ had significant inhibitory
effects (p <0.01) on basal testosterone production by rat Leydig cells (Figure
10.1.A.). Only the highest concentrations used (10-100|ig/ml) significantly
inhibited hCG-stimulated testosterone production by rat Leydig cells (p
<0.01, Figure 10.1.B.). On 3 separate occasions concentrations of 0.1-
100pg/ml KCZ significantly inhibited both basal and hCG-stimulated
testosterone production by human Leydig cells (p <0.01, Figures 10.1.C.
and D. and Table 10.1.).
HCZ : A concentration of 0.1 |ig/ml HCZ had a significant stimulatory
effect (p <0.05) on basal testosterone production by rat Leydig cells, while a
concentration of 100pg/ml significantly inhibited basal testosterone
production (p <0.01, Figure 10.2.A.). Variability in the response of isolated
Leydig cells to hCG meant that no overall there was no effect of HCZ on
hCG-stimulated testosterone production by rat Leydig cells (Figure
10.2.B.). On 3 separate occasions concentrations of l-lOOpg/ml HCZ
significantly inhibited both basal and hCG-stimulated testosterone
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production by human Leydig cells (p <0.01, Figures 10.2.C. and D. and
Table 10.2.).
TKD : Addition of 0.1-100pg/ml TKD had no effect on basal testosterone
production by rat Leydig cells (Figure 10.3.A.). The highest concentration
used (lOOjig/ml) significantly inhibited hCG-stimulated testosterone
production (p <0.05, Figure 10.3.B.). On 3 out of 5 occasions 100(ig/ml TKD
significantly inhibited basal testosterone production by human Leydig
cells, while on 2 out of 5 occasions, Ipg/ml TKD significantly stimulated
basal testosterone production by human Leydig cells (Figure 10.3.C. Table
10.3.). A concentration of 100pg/ml TKD significantly inhibited hCG-
stimulated testosterone production on 5 separate occasions. In 3
experiments lOpg/ml TKD also had a significant inhibitory effect (Figure
10.3.D. Table 10.3.).
EDS : Concentrations of 2 and 10|iM EDS significantly stimulated basal
testosterone production by both rat and human Leydig cells (Figures
10.4.A. and C.). Higher doses of EDS (up to 230pM) had no effect on
testosterone production by rat Leydig cells, while 230|iM EDS significantly
inhibited basal testosterone production by human Leydig cells. None of
the concentrations of EDS used had a significant effect on hCG-stimulated
testosterone production by rat Leydig cells (Figure 10.4.B.). The effects of
EDS on hCG-stimulated testosterone production by human Leydig cells,
were comparable to the effects on basal testosterone production (Figure
10.4.D.).
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Figure 10.1. The effects of KCZ on testosterone production by rat
and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=3). B. hCG-
stimulated testosterone production by rat Leydig cells (n=3). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
<0.05, **p <0.01, significantly different from control values.
concentrationfketoconazole(|ag/ml)
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Table 10.1. The effects of KCZ on testosterone production by
human Leydig cells cultured for 20h.
The table shows the effects of KCZ on human Leydig cells in a further 2
experiments. The concentrations of KCZ are in (ig/ml, and the amount of
testosterone is given as ng/106 cells.
Each value is the mean±S.D. of triplicate. *p <0.05, **p <0.01, significantly
different from control values, N.D. = not detectable.
A.Basal controlOO011000 61.1±2.3119.9±54.13* 8.85.6±16.65.7±4.710.4±1.7* 37.14±6.237.3 1.920.5 3.012.8±1.2N.D..
B.hCG-stimulated controlOO011000 244.7±64.8196.2±13.8159.6±12.634 8±5 211.3+1.9.5±0.8 360.7±28.1451.5±9.6258.3±9.65 4 5 8N.D.
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Figure 10.2. The effects of HCZ on testosterone production by rat
and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=5). B. hCG-
stimulated testosterone production by rat Leydig cells (n=5). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
<0.05, **p <0.01, significantly different from control values.
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Table 10.2. The effects of HCZ on testosterone production by
human Leydig cells cultured for 20h.
The table shows the effects of HCZ on human Leydig cells in a further 4
experiments. The concentrations of HCZ are in pg/ml, and the amount of
testosterone is given as ng/106 cells.
Each value is the mean±S.D. of triplicate. *p <0.05, **p <0.01, significantly




















































42.5±5.75.6±9.252.618.53.9±7.64 .5 .1.3±4.4 324.1±29.6302.2±35.6339.2±21.35.3 39.961+12.4**0.4±.0.03**
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Figure 10.3. The effects of TKD on testosterone production by rat
and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=5). B. hCG-
stimulated testosterone production by rat Leydig cells (n=5). C. basal
testosterone production by human Leydig cells (representative results). D.
hCG-stimulated testosterone production by human Leydig cells
(representative results). Each point is the mean±S.D. of n experiments
with rat Leydig cells, and of triplicate wells for human Leydig cells. *p
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Table 10.3. The effects of TKD on testosterone production by
human Leydig cells cultured for 20h.
The table shows the effects of TKD on human Leydig cells in a further 4
experiments. The concentrations of TKD are in pg/ml, and the amount of
testosterone is given as ng/106 cells.
Each value is the mean+S.D. of triplicate. *p <0.05, **p <0.01, significantly
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Figure 10.4. The effects of EDS on testosterone production by rat
and human Leydig cells cultured for 20h.
A. basal testosterone production by rat Leydig cells (n=3). B. hCG-
stimulated testosterone production by rat Leydig cells (n=3). C. basal
testosterone production by human Leydig cells (results of a single
experiment). D. hCG-stimulated testosterone production by human
Leydig cells (results of a single experiment). Each point is the mean±S.D.
of 5 experiments with rat Leydig cells. *p <0.05, **p <0.01, significantly
different from control values.
021045305230 concentrationfEDS(|iM)concen rationfEDS(|0.M)
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10.4. Discussion
The experiments described in this chapter form a comparison of the toxic
effects of 4 compounds on rat and human Leydig cell function.
KCZ is an orally active, imidazole derivative used clinically as an
anti-fungal agent. KCZ has been shown to inhibit testosterone production
both in vivo (Pont et al., 1982) and in vitro (Albertson et al., 1988, De
Coster et al., 1989). However, previous studies of the effects of KCZ on
steroidogenesis in the human testis have used either crude interstitial cell
preparations (De Coster et al., 1989) or preparations of testicular
microsomes (Albertson et al., 1988). This is the first study to examine the
effects of KCZ on purified human Leydig cells. In agreement with
previous reports using rat Leydig cell preparations (Kan et al., 1985, Sikka
et al., 1985), KCZ was found to inhibit both basal and hCG-stimulated
testosterone production. In the rat inhibition is caused by blocking the
action of cytochrome P45ol7cc, which catalyses at least 2 successive
reactions, namely 17a-hydroxylation and the 17-20 lyase reaction (Sikka et
al., 1985, De Coster et al., 1989). Albertson et al. (1988) found that KCZ
inhibited these activities in impure human Leydig cell microsomal
preparations. However, De Coster et al. (1989) demonstrated preferential
inhibition of 17a-hydroxylation in crude human testicular suspensions.
The aims of the present study were purely comparative and examination
of enzyme activities was not made. The study has confirmed that KCZ has
an inhibitory effect on both basal and hCG-stimulated testosterone
secretion by highly purified human Leydig cells. It has also been shown
that human Leydig cells are more sensitive to the inhibitory action of
KCZ, with significant inhibition first seen at 10-fold (basal testosterone)
and 100-1000 fold (hCG-stimulated testosterone) lower concentrations in
the human compared to the rat. De Coster et al. (1989) also found that
testosterone biosynthesis was more sensitive to KCZ in the human than
the rat.
Kan et al. (1985) used a rat model to test the steroidogenesis-
inhibiting properties of several anti-fungal imidazoles, and demonstrated
a cascade of potencies. To assess whether such differences were constant
between species, this study also examined the effects of HCZ on
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testosterone production by rat and human Leydig cells. HCZ is an anti¬
fungal triazole, which acts by inhibiting the action of cytochrome P450I70C.
HCZ had a significant inhibitory effect on basal testosterone production by
rat Leydig cells while the inhibitory effect on hCG-stimulated testosterone
production was not statistically significant. The effects of KCZ were seen
at O.lpg/ml, while no effect of HCZ was seen until concentrations of
lOOpg/ml were used. In the human HCZ inhibited both basal and hCG-
stimulated testosterone production at concentrations of l|ig/ml and
above. As with KCZ, human Leydig cells were more sensitive than rat
Leydig cells to the effects of HCZ. In human Leydig cells, the first effects of
HCZ were seen with a concentration 100 fold lower than that needed to
produce similar effects in the rat. However, as with rat Leydig cells, HCZ
was less potent than KCZ in inhibiting testosterone production in human
Leydig cells. This suggests that when an animal model is required to
represent steroidogenesis in the human, in order to assess the relative
potencies of compounds which inhibit steroidogenesis, then the rat is a
valid model.
To determine whether the validity of the rat model held when
inhibition of testosterone production was not known to be via an effect
on steroidogenic enzymes, a comparison was made between the effects of
TKD and EDS on testosterone production in rat and human Leydig cells.
TKD is an antifungal agent which is unrelated to KCZ or HCZ. TKD
had no effect on basal testosterone production by rat Leydig cells, although
the highest dose used (100pg/ml) did inhibit hCG-stimulated testosterone
production. In the human, basal testosterone production was inhibited by
concentrations of 10pg/ml and above while hCG-stimulated testosterone
production was inhibited by concentrations of 1 pg/ml and above. As
with the imidazole compounds, human Leydig cells were 10-100 times
more sensitive to the effects of TKD than were rat Leydig cells. The rat
model was a reliable indicator of effects in the human, as in both species
the effects of TKD were more pronounced on hCG-stimulated, rather
than basal, testosterone production. The mechanism by which TKD exerts
these effects is not known.
While the in vivo effects of EDS have been well documented (Kerr
et al., 1985, Jackson et al., 1986, Morris et al., 1986), nothing is known of its
mechanism of action, and little of its direct in vitro effects. Rommerts et
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al. (1988) demonstrated that 0.4mM EDS inhibited pregnenolone
production by cultured rat Leydig cells. This study has shown that lower
concentrations of EDS (2-10|iM) can stimulate basal testosterone secretion
by both rat and human Leydig cells. Concentrations of EDS up to 230(iM
had no effect on rat Leydig cells but caused complete inhibition of basal
and hCG-stimulated testosterone production by human Leydig cells.
Again human Leydig cells appeared to be more sensitive than rat Leydig
cells to the adverse effects of EDS on steroidogenesis.
In summary, with all inhibitory compounds tested, rat Leydig cells
proved to be an accurate, if less sensitive model for the actions of the
compounds on human Leydig cell function.
11. General Discussion
Recently there has been increasing concern about the deleterious effects of
environmental compounds on sperm counts in the male (Sharpe, 1992b,
Carlsen et al., 1992). Both studies emphasised the present lack of
understanding of the mechanisms controlling spermatogenesis, especially
in man. A further decline in sperm counts is unlikely to be prevented
unless progress is made in elucidating testicular regulatory pathways.
Spermatogenesis is driven by testosterone, thus the pathways that
regulate testosterone production are potential sites for malfunctions that
could result in impaired sperm output.
The studies presented in this thesis have examined the regulation
of testosterone production in the human testis. Potential mechanisms of
regulation of Leydig cell function in vitro and ex vivo were also
investigated, using the rat as a model. Wherever possible comparisons
were drawn between Leydig cell function in rat and man, in order to
demonstrate when and how rat Leydig cells can be used as a model for
man.
Simpson et al. (1987) described a technique for the isolation of
human Leydig cells which were highly responsive to hCG. Previous
studies using crude interstitial cell preparations had found human Leydig
cells did not show a marked response to hCG in vitro (Huhtaniemi et al.,
1982). A frequent criticism concerning the use of human Leydig cells is
that because they are obtained from an elderly population they may
represent an abnormal population of cells in which the functional
capacity has declined. The studies presented in chapters 4 and 5 oppose
this idea. In a sample group which spanned four decades, the relative
ability of human Leydig cells to produce testosterone in vitro, and to
respond to hCG stimulation, did not decline as a function of increasing
age. It was also established that the cells remaining at the end of the
isolation procedure were representative of the cells found in situ. It was
necessary to establish this, as two populations of Leydig cells are present
in the human testis, distinguished by differential staining with toluidine
blue into light and dark cells. Thus the techniques described in this thesis
result in the isolation of human Leydig cell populations which are
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equivalent to the populations found in vivo, which will produce
testosterone in vitro and which can respond to hCG.
The existence of light and dark Leydig cells in the human testis is
well documented (Schulze, 1984, Simpson et al, 1987) but not understood.
On the basis of studies presented in this thesis no distinction could be
made between light and dark Leydig cells with respect to steroid
production in vitro. Correlations made between the percentage of
testicular volume occupied by various components revealed that light
and dark Leydig cell cytoplasmic volumes did not correlate with the same
factors. While the cytoplasmic volume of both Leydig cell types correlated
with the volume of the testis occupied by germ cells and the volume of
the interstitium, only the cytoplasmic volume of dark Leydig cells
correlated with tubular lumen volume. Light Leydig cell cytoplasmic
volume showed specific correlations to the volume of peritubular tissue
and the volume of blood vessels in the interstitium. These distinct
correlations may be the initial evidence for differential roles for light and
dark Leydig cells in mediating intratesticular interactions.
Rat and human Sertoli cells in vitro secrete a factor(s) which can
stimulate testosterone production by isolated Leydig cells (Verhoeven &
Cailleau, 1985,1986, 1990; Papadopoulos, 1991). There is no definitive
information on the nature of the communicators between Sertoli cells
and Leydig cells, yet there are several factors which have been shown to
affect the function of isolated rat Leydig cells. Two factors for which there
is additional evidence for a Sertoli cell site of production are testicular
LHRH and AVP (see Sharpe, 1992 for review). Human Leydig cells were
shown to respond to AVP and an LHRH agonist in a very similar manner
to rat Leydig cells, suggesting that if AVP and LHRH have a role in
mediating the regulation of Leydig cell function by Sertoli cells, it is a
mechanism that is conserved across species. However, the role of AVP
and LHRH as paracrine regulators of testicular function is not an
established fact. Previous studies in vivo have not supported a paracrine
role for LHRH in the human testis, based on the inability of LHRH-A to
alter hCG-stimulated testosterone level (Rajfer et al., 1987). Also, the
effects of AVP reported in chapter 6 were small.
However, experiments such as those described in chapter 6 may
give only a restricted view of a complex picture. There are several
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examples in the literature of how germ cells can influence Sertoli cell
function. Recently Onoda & Djakiew (1991) have demonstrated that germ
cells influence the secretion of a Sertoli cell factor(s) which can stimulate
steroidogenesis in isolated Leydig cells. However, such an in vitro
approach has many limitations, not least of which is whether it is really
relevant to the complex in vivo situation. The results of these in vitro
experiments, which mixed populations of cells isolated from mature and
immature animals, have been confirmed in the present study. The
influence of germ cells on Sertoli cell-Leydig cell communication was
determined by using MAA to chemically deplete specific populations of
germ cells in vivo and examining Leydig cell function in vitro. The
advantages of this technique are that it avoids using Sertoli cells from
immature rats, which must be used in in vitro experiments, and it leaves
all other pathways of intercellular communication intact, limiting the
disruptive effect on testicular function. The induced absence of pachytene
spermatocytes or round spermatids in vivo was associated with increased
testosterone production in vitro by Leydig cells which were isolated from
these testes. In contrast, the in vivo absence ofelongated spermatids was
not associated with any change in the subsequent function in vitro of
isolated Leydig cells. Thus, it appears that the absence of germ cells,
specifically pachytene spermatocytes or round spermatids, is associated
with the removal of an inhibitory influence on Leydig cell function. The
alternative interpretation, that the depletion of either germ cell type leads
to the secretion of a stimulatory factor, is not supported by the in vitro
work of Onoda et al. (1991) who demonstrated that both pachytene
spermatocyte or round spermatid conditioned medium could inhibit
protein production by isolated Sertoli cells.
Surprisingly, germ cell influences on Leydig cell function appeared
to be related to the absence/presence of pachytene spermatocytes or round
spermatids from seminiferous tubules at certain stages of the
spermatogenic cycle. In particular, the absence of pachytene spermatocytes
or round spermatids at stage I appeared to be associated with increased
testosterone production by Leydig cells isolated from affected testes. When
Leydig cells were either co-cultured with segments of seminiferous
tubules at specific stages of the spermatogenic cycle, or when conditioned
medium prepared from staged seminiferous tubules was added to isolated
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Leydig cells the presence of stage II-V tubules inhibited basal testosterone
production. The results of these experiments indicate that the presence of
germ cells from early stages of the spermatogenic cycle may lead to
inhibition of Leydig cell function. Together these experiments provide
new evidence for an inhibitory influence of the early spermatogenic
stages on testosterone production.
Stage VII is the most androgen-dependent stage (Russell &
Clermont, 1977, Bergh, 1983, Sharpe et al, 1992), and the study examining
the extent to which cultures of seminiferous tubules metabolised
exogenous testosterone demonstrated that the degree of metabolism was
greatest at stages VI-VIII, a finding perhaps reflecting the greater
utilisation of testosterone by androgen-dependent stages.
The metabolism of known amounts of exogenous testosterone
added to cultures of staged seminiferous tubules was unaffected by the
absence of a normal complement of pachytene spermatocytes in the
tubules (chapter 9). Therefore, if pachytene spermatocytes do have a
negative influence on the levels of testosterone measured in Leydig
cell/seminiferous tubule co-cultures, it is not via a stimulatory effect on
the rate at which seminiferous tubules metabolise testosterone.
The experiments presented in this thesis examining the regulation
of steroidogenesis in the rat testis, have all supported the idea that local
control mechanisms are specific to particular stages of the spermatogenic
cycle. If this specificity is taken into consideration it could explain the
difficulty in demonstrating the relevance in vivo for an action described
in vitro. For example, administration of LHRH antagonists has little effect
on intratesticular testosterone concentrations (see Sharpe, 1986 for
review). The results described in this thesis suggest that steroidogenesis is
regulated by local events occurring around each segment of a tubule at a
specific stage. If there are 17.4m of tubules in each rat testis (Wing &
Christensen, 1982), then the result of a paracrine effect on seminiferous
tubules at one or two particular stages would probably not be reflected by
any change in total testicular levels of testosterone due to 'dilution' of
any effect. An attempt to establish the extent of regulation of Leydig cell
function, could be made by isolating Leydig cells from rats in which the
seminiferous tubules had been stage-synchronised by induction of
vitamin A deficiency (Griswold et al., 1989). The effects of potential
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paracrine agents such as AVP and LHRH could then be examined on
Leydig cells which in vivo had only been exposed to the influence of one
spermatogenic stage. The use of MAA to deplete specific germ cells in
vivo (chapter 7) has already shown that the influence of the in vivo
environment is reflected in the performance of Leydig cells when
isolated. Leydig cells isolated from stage-synchronised testes could be co-
cultured with seminiferous tubules prepared from rats lacking selective
germ cell types. This could make the elucidation of testicular intercellular
communication pathways more straightforward.
If it is true that the germ cell complement at a given stage
determines Sertoli cell function and thus potentially has a secondary
effect on Leydig cell function (Sharpe, 1986), then, differences in local
control mechanisms in rat and man might be expected. In the rat stages
are arranged into waves which progress sequentially along the length of a
tubule. In the human the spermatogenic wave proceeds along a spiral, so
that each cross-section of a tubule contains germ cells from several
different stages (Schulze & Rehder, 1984). These differences in spatial
organisation may either be a consequence or a cause of different local
regulatory mechanisms. In this context it is interesting to recall the
presence of light and dark Leydig cells in the human testis, described in
chapters 4 and 5. No correlation was found between the relative
proportions of light and dark cells and the ability of Leydig cells to
produce testosterone in vitro. However, the percentage volume of light
and dark Leydig cells did not correlate with the same testicular cell types
or structures. As evidence from the rat increasingly supports stage-specific
synchrony of events in both the seminiferous epithelium and the
interstitium (Bergh, 1983, McKinnell & Sharpe, 1992 and chapters 7 and 9)
it would be of great interest if light and dark Leydig cells were found to be
associated with specific and different stages of the spermatogenic cycle.
This would require painstaking histological analysis of serial-sectioned
testicular tissue.
An approach that could be used to determine stage specific effects is
in situ hybridisation. A study that would be relevant to some of the
results presented in this thesis would involve mRNA probes to the
newly sequenced GnRH receptor (Tsutsumi, 1992). By using probes to
localise both ligands and their receptors, the production or not of
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testicular GnRH by Sertoli cells, and the presence or absence of GnRH
receptors on Leydig cells could be finally determined if expression of the
mRNA occurs in sufficient amounts. In addition, in situ hybridisation
would allow stage-specific localisation of GnRH mRNA, implying stage-
specific production and action. This technique could be applied to Leydig
cell and Sertoli cell products and would allow comparisons between rat
and man to be made relatively easily. Furthermore, as it does not appear
to be possible to physically separate light and dark Leydig cells, in situ
hybridisation and immunocytochemistry are possibly the only techniques
which could be used to discover whether light and dark Leydig cells do
have different functions.
Although the arguments presented so far have supported the
existence of very specific, local interactions between Leydig cells and
Sertoli cells, and on this basis could imply that the rat Leydig cell may not
be a good model for the human Leydig cell, there is plenty of evidence to
the contrary. The experiments presented in chapters 6 and 10, examining
the effects of various compounds on Leydig cell function have
demonstrated that in vitro, rat and human Leydig cells function in a very
similar manner. AVP and LHRH-A stimulated basal testosterone
production in both rat and human Leydig cells, while ANP did not affect
either type of Leydig cell. The one difference found between the two
species was that rat Leydig cells responded to the presence of diazepam or
DBI, while human Leydig cells did not. However, the actions of DBI are
probably concerned with intracellular regulation of steroidogenesis (see
chapter 6), so are perhaps not relevant to discussions of intercellular
control mechanisms. The effects of various toxicants on testosterone
production by rat and human Leydig cells were remarkably similar,
though human Leydig cells were generally more sensitive than rat Leydig
cells.
The high degree of comparability between the patterns of radio-
labelled proteins secreted by cultured rat and human Leydig cells further
emphasises the similarity between the way rat and human Leydig cells
function in vitro. These similarities would be presumed to extend to in
vivo function. Results such as these indicate that the rat Leydig cell is an
excellent model for studying human Leydig cell function in vitro.
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The intentions of the studies reported in this thesis were to
examine potential mechanisms of regulation of human Leydig cell
function in vitro and at the same time to compare the regulation of rat
and human Leydig cells in vitro. The study of intratesticular control in
the rat emphasised the stage-specific nature of the testicular control
mechanisms. When direct comparisons were made between rat and
human Leydig cell function in vitro, Leydig cells from the two species
were found to be remarkably similar, suggesting the similarity may
extend to local control mechanisms. This is indirectly supported by the
morphometric analysis of human testicular sections. As no simple
relationship was found between the numbers of light or dark Leydig cells
per testis and testosterone production in vitro, a more complex
relationship including other cell types might be implied. The role of germ
cells in altering Leydig cell production, shown experimentally in the rat,
could be determined in man by relating morphometric data on germ cells
to subsequent Leydig cell testosterone production in vitro. To do this,
testicular sections need to be re-examined and different germ cell types
quantified so that the possible relationship between the absence/presence
of specific germ cell types and Leydig cells can be assessed.
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